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Due to the increasing demand in Biotherapeutics, this thesis focussed on investigating novel ways to 
exploit major signalling pathways to enhance recombinant protein production (rP) in yeast and CHO 
cell expression systems. The expression of model recombinant proteins in yeast allowed us to screen 
for specific targets located within important environmental signalling pathways for effects upon 
recombinant protein production. Targets identified within the yeast system and that were conserved 
were then tested within CHO cell expression system. 
 
One of the systems investigated with regards to rP production was target of rapamycin (TOR) pathway. 
TOR signalling is a global regulator of nutrient sensing and energy status. It is a highly conserved 
Ser/Thr protein kinase pathway which is involved in processes such as protein synthesis, ribosome 
biogenesis, cell cycle, gene transcription, autophagy, and metabolism. As TOR is heavily involved in 
the control of protein synthesis, we asked whether it could be manipulated to enhance recombinant 
protein production (rP). We identified that TOR mediated amino acid sensing and autophagy are 
important for maintaining rP production in both yeast and CHO cells systems.  
 
Previous work supporting this thesis suggests that the actin binding protein cofilin can be manipulated 
to enhance both mitochondrial function and environmental sensing. We hypothesised that Cofilin 
functions may be useful in maintaining mitochondrial function during the stress imposed by rP 
production. Using a library of Cofilin strains expressing mutant alleles, we found that the control of 
MAPK signalling, and in particular the downstream effector Ste12, and mitochondrial functionality 
have a significant effect on GLuc expression when driven by the mating factor signal sequence. 
Manipulation of mitochondrial function or STE12 function also led to changes in rP production. In 
many case changes in Gluc expression or secretion were not replicated in a separate Killer toxin 
secretion system. As we did not see the same effects in alterations to killer toxin secretion, we 
concluded that these findings were specific to the presence of the signal sequence from the mating 
alpha factor. The manipulation of MAPK signalling and mating factor signal sequence driven secretion 
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This work highlights the complex nature of manipulating signalling networks to achieve improvements 
in rP yield. However a better understanding of the mechanisms involved and the ability to manipulate 
these changes/responses will be beneficial for enhanced protein production from yeast and 
mammalian expression systems.  
 
Key words: cofilin, MAPK, Target of Rapamycin (TOR), recombinant protein production, autophagy, 
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1.1 Introduction to recombinant protein production  
 
1.1.1 The rise of recombinant biopharmaceuticals 
 
Recombinant proteins are produced from various expression systems by recombinant DNA (rDNA) 
technology, with the demand for heterologous gene products produced in the biopharmaceutical 
industry rising due to an increasing need for healthcare. The biopharmaceutical sector encompasses 
a range of products that can be used for therapeutic applications. In 1982 the first biopharmaceutical 
Humulin, a recombinant human insulin, was produced in Escherichia coli and approved for use to treat 
patients with Type I Diabetes (Walsh, 2010a).  
Now, recombinant protein production is a multibillion-dollar market producing proteins such as 
interferons, erythropoietin, vaccines, industrial enzymes and antibodies (see figure 1.1). Although 
there is an increasing market for biopharmaceutical proteins, there is also a large market for industrial 
enzymes such as proteases, carbohydrates and lipases for animal feed, biofuels and pharmaceutical 
enzymes (Mattanovich et al., 2012). Recombinant proteins are also heavily used in research studying 
proteins involved in disease and to further our understanding in the molecular and cell biology of 
various organisms. For example, enzymes are needed for digesting DNA in cloning and the use of 
antibodies in western immunoblotting and enzyme-linked immunosorbant assays (ELISA) which are 
some of the most commonly used laboratory procedures.  
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 A) 
                                  
B) 
                                  
Figure 1.1 Annual biopharmaceutical sales and product approvals. A) Annual sales (total sale values 
and sales from top 10 selling products between 2010 and 2013). B) Classes of products approved 
between 2010-2014 and cumulative (between 1982-2014) as percentage of total approvals. Data from 
the EU and US markets  (Walsh, 2014). 
 
When comparing various products recently approved, monoclonal antibody (mAbs) production has 
increased to the largest class of protein produced, growing from 11% of total approved 
biopharmaceutical products in the 80’s to 26.5%. Outside of these insulin is one of the most profitable 
non-antibody-based products generating $21.5 billion in 2013 (Walsh, 2014). Antibody-based drugs 
are a fast growing class of protein therapeutics as the development of expression and secretion of 
functional non-glycosylated antibody fragments from E.coli through antibody engineering have been 
developed with high titre production. Although the majority of antibodies are ‘native’ unmodified IgG 
molecules, there have also been some approved with radionuclides or cytotoxic drugs (antibody-drug 
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conjugates) attached for the treatment of cancer (Carter, 2011). For highly selective antigen binding, 
this is dependent on the interaction of the Fc region (base of the antibody) for antibody-dependent 
cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) (Chan and 
Carter, 2010). 
Initially a recombinant protein expression system needs to be investigated to understand their 
physiology so that this may be exploited, then sourcing appropriate genetic elements for 
incorporation/engineering into these systems to meet the needs of industry. A number of criteria need 
to be considered in undertaking engineering strategies such as protein characteristics, quantity 
produced, time required, purity of the protein, cost effectiveness, compliance with safety 
requirements and intellectual property (Sodoyer, 2004).  However, as well as considering 
improvement of recombinant protein expression by genetic modification, many parameters that may 
affect the health of the cell, for example giving the correct nutrients, oxygen levels and temperature, 
should be considered. Media optimisation has been shown to dramatically improve titres of 
recombinant proteins as well as protein quality of culture media, boosting the cell’s growth and 
productivity (Gawlitzek et al., 2009; Jordan et al., 2013). This is not a simple task in mammalian cell 
culture, as media that is defined and serum free can have 50-100 components with very precise 
control of parameters such as pH and osmolarity, eliminating the need for concentrated stock 
solutions which cause instability issues (Jordan et al., 2013).  
Although the knowledge in the field of recombinant protein production and the host cell systems 
utilised is consistently evolving, there is no perfect expression system that can be always used; every 
protein has individual characteristics which determine which expression system will yield optimal 
expression and downstream stability characteristics (Sodoyer, 2004). 
 
1.1.2 Advantages to varied expression systems and their genetic manipulation for 
recombinant protein production 
The production of rP has been examined in a variety of prokaryotic and eukaryotic systems yet only 
particular hosts are exploited within industry. E.coli, yeast and mammalian cells are the most widely 
used along with insect cell lines and transgenic animals (Walsh, 2010a). Approximately 60-70% of rP 
production is currently performed in mammalian cell lines, including Chinese hamster ovary (CHO) 
cells, mouse myeloma (NS0), baby hamster kidney (BHK), human embryo kidney (HEK-293) and human 
retinal cells.  
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The development of all expression systems is a very dynamic field with new research addressing 
specific limitations found amongst different systems. New tools to allow genetic modification and re-
engineering of existing biological pathways are being investigated. Genetic manipulation can include 
the ablation, repression or increased expression of specific genes that may in turn alter a cell’s ability 
to produce rP. For example, improvements have generally relied on random mutagenesis or classical 
breeding techniques to produce cell lines capable of supporting elevated rP production. However, 
techniques to precisely modify promoter strength of a desired gene, knock out or knock-down/up 
gene expression and make precise changes to gene sequences are now all techniques readily applied 
within research labs and industrial labs around the world.  
1.1.2.1 Optimising the expression vector 
There is much to consider when there are so many variables that limit productivity, both due to the 
host selected or the product being produced (Hohenblum et al., 2004). Enhancements in expression 
in mammalian systems for example have been made through good vector design by using alternative 
signal peptides, strong promoters, alternative/enhanced gene codon selection, specifically selected 
introns and the use of transcriptional enhancement regions (for example cytomegalovirus, CMV) (Zhu, 
2012). 
To improve expression levels, strong, tightly regulated promoters are used which are homologous to 
the species as heterologous promoters can sometimes yield bad efficiency of expression (Mattanovich 
et al., 2012). For example in yeast, the constitutive GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) or Gal1-10 which is induced by galactose whereas in E.coli, heat-shock promoter 
hsp60 is used and a common inducer is the sugar molecule isopropyl-beta-D-thiogalactopyranoside 
(IPTG) (Mattanovich et al., 2012). Auto-inducible promoters which are upregulated with changes to 
culture media can occur near the end of log growth phase. The advantage being that this process 
doesn’t require intervention or the addition of inducers (Sodoyer, 2004).  Other factors to consider as 
potential bottlenecks are codon usage of the recombinant gene, translations signals, translocation of 
the protein determined by the secretion signal peptide, processing and folding in the ER and Golgi 
before it is secreted out of the cell (Hohenblum et al., 2004).  
1.1.2.2 The use of mammalian model systems 
Mammalian cells are the most widely used model system for producing human proteins due to the 
increasing need for specific post-translational modifications, in particular glycosylation (discussed in 
more detail below) and are estimated to produce approximately 36% of approved recombinant 
proteins (see figure 1.2). When comparing quantitatively, microbial production however still produces 
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more recombinant protein, estimated at 17.9 metric tonnes (68%) in 2010 with 8.5 metric tonnes 
(32%) derived from mammalian systems (Walsh, 2014).  
 
 
                         
Figure 1.2 Expression systems used in the manufacture of biopharmaceutical products. Cumulative 
products approved as a percentage of the total between 1982-2014; and between 2010-2014 for more 
recent approvals (Walsh, 2014). 
 
The mammalian cell lines employed for rP production can be either adherent or cultured in 
suspension, with suspension cells being more common due to their capacity for single-cell suspension 
growth (Wurm, 2004). CHO systems in particular have robust proliferation in large-scale suspension 
culture, are easily adaptable to serum and serum free media, have high cloning efficiency and are easy 
to manipulate (Fan et al., 2012). Industry benefits from mammalian cell expression systems as many 
of the rP products that are designed for therapeutic use require complex protein processing and post-
translational modification that cannot be accomplished by bacterial or native yeast systems.  
However, drawbacks include high costs due to the requirement for complex media (Hamilton and 
Gerngross, 2007). 
After synthesis of therapeutic proteins, the majority require post-translational modification (PTM) for 
therapeutic application which can vary between organisms, the most common being glycosylation, 
carboxylation, hydroxylation, amidation and sulfation, proteolytic processing and disulphide bond 
formation. Eukaryotes can undertake covalent modifications and many have been characterised to 
influence structure and function of the protein and so are essential to its activity (Walsh, 2010a). For 
example N-glycosylation is important for protein folding, in vivo half-life and function, and is often 
Chapter 1 - Introduction 
12 | P a g e  
 
needed in the production and secretion of glycoproteins. Overexpression of glycosyltransfereases for 
example in CHO cells leads to the enhancement of glycan quality (Andersen and Krummen, 2002; Zhu, 
2012). Although glycosylation is possible in yeast and fungi for example, it can often be different in 
microorganisms producing heterogenous high mannose type N-glycans (which are immunogenic to 
mammal cells) compared to mammalian cells which have N-glycans which are mainly complex or 
hybrid type (De Pourcq et al., 2010). 
Most mammalian cell lines will produce glycoproteins containing N-glycolylneuraminic acid (Neu5Gc), 
which in humans is absent, leading to an immune response if subjected to the glycoprotein. Although 
CHO cell lines contain lower levels of Neu5Gc sialylation compared to murine cell lines, Neu5Gc still 
needs to be controlled (Xu et al., 2011).  It was discovered that the level of Neu5Gc can be controlled 
through environmental factors such as the addition of sodium butyrate (SB) that decreased the levels 
of Neu5Gc by 50-62%. The same study also reported that Neu5Gc levels were lowered by 59% with a 
low temperature shift closer to stationary phase which is commonly used to increase culture duration 
and titre in industry. This likely changes metabolic states effecting NADH levels, and cells accumulate 
at different phases of the cell cycle (Borys et al., 2010). Sodium butyrate (SB) is a short chain fatty acid 
shown to modify oligosaccharide content of glycoproteins, it was suggested that SB can cause changes 
to sialylation with the ability to effect the recycling of sialic acid from existing glycoproteins, bypassing 
de novo synthesis (Kreuter, 1996; Borys et al., 2010).  
A number of conventional gene knockouts by homologous recombination in CHO cells have been 
useful in creating high rP producers. An important tool used for silencing gene expression in cells or 
organisms is RNA interference (RNAi). This technology is used to increase cellular productivity and 
improving the quantity of rP production. RNAi is induced by small double-stranded RNA molecules 
which can negatively regulate gene expression. Genes can be silenced using siRNA (small interfering 
RNA) which are a class of double stranded RNA molecules or by the use or shRNA (short hairpin RNA 
molecules) which are encoded by plasmids or viral vectors. These are structurally related to 
microRNAs which are produced by the cell to regulate gene expression (S.C. Wu, 2009). However, for 
knockdown in mammalian cells, shRNA-expressing DNA is delivered to the nucleus to be transcribed 
whereby it is then processed by Dicer-dependent cleavage in the cytoplasm into siRNA. This siRNA is 
incorporated into the RNAi-induced silencing complex (RISC) which released the complementary 
strand to the target mRNA and is degraded. With the target mRNA, RISC finds the complementary 
sequence and cleaves the mRNA (Hannon and Conklin, 2004; Mikuma et al., 2004; Takahashi et al., 
2009). 
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However, latest genome editing includes the use of double-stand break (DSB)-inducing nucleases in 
targeting specific sites, such as zinc finger nucleases (ZFNs) or clustered regularly interspace, short 
palindromic repeat (CRISPR) technology from bacteria. CRISPR  generates DSBs using the RNA guided 
Cas9 endonuclease, using base-paring between the target DNA and the engineered RNA (Mali et al., 
2013; Sander and Joung, 2014). An advantage to this technology is the ability to simultaneously 
introduce multiple gene mutations as multiple guided RNA can be used. These DSB introduced by 
endonucleases are repaired by the cell through two different pathways; the first is known as 
nonhomologous end joining (NHEJ) where random mutations occur disrupting the gene, the second is 
homology-directed repair (HDR), where precise point mutations are introduced using a donor 
template(Sander and Joung, 2014). 
Engineered cell lines can be created transiently (introducing a plasmid DNA) or have the cells secrete 
the rP permanently in a stable cell line which need to be isolated and characterised. Although transient 
expression is the less time consuming option, scalability of this process is limited due to culture surface 
needed and the fact the plasmid is lost from the cell during division result in low yields (Durocher et 
al., 2002; Pham et al., 2006)(Agrawal & Bal, 2012). There have been attempts to scale–up transient 
cell line manufacturing by growing them in roller bottles, as well as transferring these adherent cells 
to microcarriers or suspension culture, although these methods had limited success (Pham et al., 
2006). Transient production has been scaled up to more than 150 litre volumes, generating grams of 
antibodies, suitable for small scale production for antibody screening and therefore does now offer 
an option for the rapid generation of early stage material (Baldi et al., 2007; Jäger et al., 2013).  
For CHO cells in particular, the development of high producing cell lines is slow due to the cell line 
generation and selection processes where thousands of individual cell lines are screened to obtain a 
sufficient number which exhibit desirable productivity and cell growth. For commercial 
biotherapeutics, stable clone selection with high productivity takes several months at least. Once a 
reliable host has been selected, the expression system needs optimisation, with media development 
and nutrient feeding strategies before the high producers are selected. This classic selection process 
method is where roughly one cell is deposited in each well of a microplate with conditioned media for 
good growth conditions; however this limits the number of clones screened and is inefficient (Agrawal 
& Bal, 2012). More recent methods for selection include the use of fluorescence-activated cell sorting, 
and measurement of the relative mRNA transcript levels. It is preferred that the selection process is 
performed early in clinical development of the product as this avoids any potential changes in the 
glycosylation profile which is important in antibody production for example (Shukla and Thömmes, 
2010).  
Chapter 1 - Introduction 
14 | P a g e  
 
1.1.2.3 The use of yeast as model systems 
Microorganisms offer advantages over mammalian cell systems in that they can be grown and evolved 
rapidly, are much cheaper to grow in culture and are relatively easy to modify by genetic manipulation. 
Thanks to advances in genetic engineering, both prokaryotic and eukaryotic microorganisms such as 
the yeast S.cerevisiae and E.coli have been used successfully to produce heterologous proteins for 
industrial processes. However, as with mammalian systems, micro-organisms also possess drawbacks 
(discussed below). 
In yeast, the two major expression systems used are Saccharomyces cerevisiae and Pichia pastoris 
(Andersen and Krummen, 2002). Yeast cells grow to high cell densities, are easily maintained in 
suspension culture and being eukaryotic, are capable of performing glycosylation reactions. Although 
as mentioned above, they produce naturally high mannose type N-glycans, re-engineering of the N-
glycosylation pathway in yeast creating ‘humanised’ glycoproteins is possible (De Pourcq et al., 2010). 
All model systems in rP production have their limitations, in yeast, folding and disulphide bond 
formation are an issue as the chaperone BiP (binding protein) is induced which is a signal for the 
unfolded protein response (UPR) (described in more detail later on) (Hohenblum et al., 2004; Bravo et 
al., 2012). Therefore, the secretion capacity of yeast systems may also be less than for mammalian 
systems (Idiris et al., 2010). 
Specific yeasts, such as Zygosaccharomyces bailii are capable of growing in highly acidic conditions (pH 
2), while S.cerevisiae also have a high tolerance to environmental stress such as low oxygen levels 
giving these microorganisms an advantage where multiple stresses can affect an organism’s ability for 
optimal rP production (Nielsen and Arneborg, 2007; Çelik and Çalık, 2012). 
S.cerevisiae have been used and developed in the use of baking, brewing and wine and are one of the 
best characterised systems and regarded as a safe organism to use. This organism is also believed to 
have one of the most comprehensive experimental data sets available on the internet such as the 
Saccharomyces Genome Database (SGD) (Çelik and Çalık, 2012). In industrial fermentation, 
S.cerevisiae can grow in low pH and in high sugar and ethanol concentrations with the ability to grow 
anaerobically with resistance to high osmotic pressure and oxidative stress. This yeast has the 
potential with genetic engineering for the massive production of biofuels such as bioethanol but also 
non-fuel products such as glycerol, pyruvate, and organic acids (Mattanovich et al., 2012). In terms of 
rP production, S.cerevisiae has been used to produce human insulin, hepatitis vaccines and human 
papillomavirus (HPV) vaccines. This yeast has been used as a model organism in investigating the cell 
and molecular biology behind protein secretion and in strategies for engineering in improving protein 
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production. This involves selecting the best signal sequence, using the best expression vector and 
engineering the organism for better folding and PTMs (Idiris et al., 2010; Hou et al., 2012).  
Pichia pastoris is another species of yeast commonly used in recombinant protein production, such as 
secreting high levels of human serum albumin. This species of yeast is methylotophic and so can use 
methanol as a carbon source when carbon is unavailable. The gene alcohol oxidase 1(AOX1) for 
methanol utilisation has one of the strongest and tightly controlled promoters in eukaryotes which 
has been used for expressing a variety of proteins (Hartner et al., 2008; Çelik and Çalık, 2012). During 
fermentation, P. pastoris prefer respiratory instead of the fermentative mode of growth and so there 
is no build-up of fermentation products such as ethanol and acetic acid enabling culture to grow to a 
higher cell density making them a good candidate for rP production. Compared to S.cerevisiae, 
P.pastoris secrete proteins with high molecular weight, with low levels of endogenous proteins 
secreted ensuring simpler purification (Çelik and Çalık, 2012). P.pastoris also have the ability to 
glycosylate (S.cerevisiae have hyperglycosylation) with correct disulphide bond formation and 
proteolytic processing. Additionally, this yeast been reported to produce humanised glycoproteins and 
engineered to produce a more effective recombinant rat erythropoietin secreted, raising hematocrit 
levels compared to the wild type P.pastoris (Hamilton et al., 2006; Çelik et al., 2007). This strain was 
able to secrete human glycoproteins with fully complex terminally sialylated N-glycans by removing 
genes for yeast-specific glycosylation and introduced heterologous genes to replicate human 
glycosylation (Hamilton et al., 2006).  
1.1.2.3 The use of E.coli as a model system 
Escherichia coli (E.coli) is the most common choice for production of recombinant proteins in 
microorganisms, being used for both studies to gather information on microbial physiology and the 
use of molecular tools such as engineered phages, gene expression cassettes and plasmids (Ferrer-
Miralles et al., 2009). Many heterologous proteins have been produced within the periplasm that 
possesses an oxidising environment where disulphide bond formation occurs which are necessary in 
proteins such as antibody fragments, many peptide hormones and enables proper folding of proteins 
into their native conformation (Schlegel et al., 2013).  
A major drawback of using E.coli systems has been in the production of extracellular protein which 
reduces downstream processing needed, however lab strains and engineered strains have the ability 
to secrete proteins via dedicated secretion systems that naturally exist and co-expression of a lysis-
promoting protein (Ni and Chen, 2009; Chen, 2012). In the past saturating Sec-translocon capacity (the 
protein-conducting channel for heterologous protein to reach the periplasm) has been a major 
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bottleneck, which mediates the transfer of secretory proteins across the cytoplasmic membrane. 
Therefore adjustment in the expression levels of the gene of interest so that the Sec-translocon 
capacity is no longer saturated, reducing toxin effects has been undertaken (Schlegel et al., 2013). 
Remarkably, due to engineering and high throughput screening, the level of secretion had reached 
several grams per litre by 2009 with the highest cases being proteins directed to the periplasm, 
however the exact mechanism by which proteins cross the outer membrane is unknown (Ni and Chen, 
2009).  
Due to differences in the chemical environment in bacteria and the ER in eukaryotes, even if 
recombinant proteins are made they may not be correctly folded (Overton, 2014). E.coli expression 
systems often yield insoluble products that are deposited within inclusion bodies which then require 
downstream processing to recover folded and active product (Porro et al., 2005). Until recently it was 
thought that glycosylation of recombinant proteins in E.coli was not possible due to their cellular 
structure lacking the ER and Golgi apparatus (sites for post-translational modification). Recently, the 
N-linked glycosylation system in Gram-negative bacterium Camplobacter jejuni was discovered and 
subsequently transferred into E.coli (Wacker et al., 2002; Chen, 2012). However, at present the system 
yields glycosylation that is often incomplete and most recombinant proteins are not glycosylated at 
all (Chen, 2012). 
1.1.2.4 The use of insect cells and plant based systems 
Insect cell lines such as SF-9 and High-Five can produce protein with some theoretical advantages over 
other expression systems such as viral safety. Another interesting adaptation is that they have the 
genetic potential to perform sialyation of glycoproteins but this requires metabolic engineering 
(Sodoyer, 2004). Overexpression of galactosyltransferases and sialyltransferases led to success in 
generating sialylated oligosaccharides on proteins derived from insects (Andersen and Krummen, 
2002). Cultured insect cells are used as hosts for recombinant baculovirus infection, however the 
production of viral vector for gene expression is time-consuming, cell growth is slow and growth 
medium  expensive (Ferrer-Miralles et al., 2009). Although genetic engineering has been used to select 
transgenic cell lines, there have only been three products approved, an influenza vaccine Flubok, 
Provenge treating prostate cancer, and Cervarix for the human papilloma virus (HPV) vaccine (Walsh, 
2014).  
Plant-based systems have much potential due to the expected high yields, being cost effective with 
media which is simple, cheap and well defined with a strong viral safety component. Plants have the 
potential to become an ‘edible vaccine’ but come with much controversy (due to issues with proof of 
Chapter 1 - Introduction 
17 | P a g e  
 
principle as well as standardisation of antigen dose) (Sodoyer, 2004).  Improved plant production is 
due to improved production practices and varieties of plant generated through plant breeding, tissue 
culture and biotechnology. Nevertheless there are additional challenges due to concerns over the 
release of genetically engineered plants into the environment (Mattanovich et al., 2012).  
The first recombinant protein produced was human growth hormone from a tobacco plant, however 
since then antibodies, the surface antigen of Hepatitis-B-virus, industrial enzymes and milk proteins 
have been produced in plants (Ferrer-Miralles et al., 2009). Plants also have the capability for post-
translational modifications, however proteins produced in plants can be hyperglycosylated, containing 
sugar moieties immunogenic to humans (Walsh, 2014). More recently the experimental Ebola 
product, ZMapp containing three humanised mABs against the Ebola Zaire virus strain was produced 
in low-nicotine tobacco variety (Nicotiana benthamiana) which lacked plant-specific N-glycans 
(Olinger et al., 2012). With further research into plant biology and recent significant progress in 
understanding the bottlenecks in protein expression, this model organism is now being considered as 
an alternative producer (T.K. Huang & McDonald, 2009). Indeed, the first plant cell culture 
recombinant protein drug is now on the market after approval from the FDA, being produced in carrot 
cells (Walsh, 2010b). 
 
1.2 mRNA translation/protein synthesis and protein secretion in eukaryotes 
 
1.2.1 Introduction to mRNA translation 
Understanding the process of mRNA translation and how the different stages of this process are 
regulated is key to exploiting protein production in all organisms. mRNA translation is controlled at 
multiple stages; initiation, elongation and termination. At each stage, translation factors transiently 
associate with the ribosome to facilitate and control the process of polypeptide production. Although 
these steps are highly conserved between prokaryotes and eukaryotes,  initiation is more complex in 
eukaryotes as they require at least 12 initiation factors compared to 3 in prokaryotes (Passmore et al., 
2007). Our understanding of the eukaryotic ribosome (which is larger) is also sparse compared to the 
prokaryote. Ribosomes are large macromolecules which consist of ribosomal RNA (rRNA) and 50-80 
ribosomal proteins determined using X-ray crystallography and 3D cryo-EM  (Spahn et al., 2001). All 
ribosomes are composed of two subunits, the 60S subunit in S.cerevisiae is the largest consisting of 
three rRNA molecules (25S, 5.8S and 5S) with 46 proteins compared to the 40S subunit containing one 
rRNA chain (18S) and 33 proteins. There is variation between yeast and humans in the makeup of 
certain rRNA however the protein components are very similar (Jenner et al., 2012).   
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1.2.1.1 Translation Initiation in Eukaryotes 
There are important control mechanisms in place at initiation where the ribosome is recruited and 
assembled at the 5’ region of the mRNA. This recruitment is undertaken by the ternary complex 
containing eIF2 and initiator Met-tRNA binding to the 40S subunit, aided by other factors forming the 
MFC (multifactor complex) forming 43S preinitiation complex (PIC) (see figure 1.3 for more 
detail)(Mead et al., 2014). The PIC scans downstream to enter the P site (reading AUG) for 
complementarity to the anticodon of Met-tRNAi. eIF2-GDP and other eIFs are released  and the large 
60S joins forming the 80S initiator complex which is then ready to accept the suitable aminoacyl-tRNA 
into the A (aminoacyl) site to synthesise the first peptide bond (Sonenberg and Hinnebusch, 2009). 
This regulation allows for rapid, reversible and spatial control of gene expression which has been has 
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Figure 1.3 Schematic of eukaryotic cap-dependent translation initiation and its regulation. To 
assemble the 43S preinitiation complex (PIC), the 80s ribosome is dissociated by eIFs 1, 1A, 3 and 5 
which bind the ternary complex (eIF2-GTP-Met-tRNA) and the 40S ribosomal subunit. eIF6 which binds 
to 60S is also important in ribosome dissociation(Sonenberg and Hinnebusch, 2009). The mRNA 
becomes activated and circularised by eIF4F (eIF4E-eIF4G-eIF4A) binding to the cap and PABP binding 
to the poly (A) tail. PABP binds to eIF-4G via it’s C-terminal (Gorgoni and Gray, 2004). The 43S PIC binds 
the cap and scans for the leader for the AUG codon (an ATP dependent reaction) where there is a 
partial hydrolysis of eIF2-bound GTP to eIF2-GDP-Pi. The 43S binding is due to eIF3/eIF5 interacting 
with eIF4G/eIF4B. Pi and eIF2-GDP are released when the AUG site is recognised triggering the 
dissociation from 40S. 60S ribosome joins with release of other eIFs, catalysed by eIF5B-GDP. The 
hydrolyses of GTP triggers the release of eIF5B-GTP and eIF1A giving the final 80S complex ready for 
the elongation phase (Sonenberg and Hinnebusch, 2009).  
 
1.2.1.2 Controlling initiation for efficient gene expression 
Initiation is a rate limiting step where the complex of proteins eIF4F and PABP bound poly(A) tail both 
bind to the cap at the 5’ end, which synergistically enhances initiation efficiency (Gingold and Pilpel, 
2011).  The association of PABP1 to eIF4G is important for enhanced affinity of eIF4G to the cap and 
PABP1 to the poly (A) tail. It is this interaction which promotes the PIC recruitment (Gorgoni and Gray, 
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2004). There have been extensive studies into the interaction of PABP with eIF4G. For example, there 
was evidence that overexpression of mutant eIF4G caused reduced poly (A)-mediated translation. 
Another group investigating PABP discovered that overexpression of the PABP-interacting protein 
(Paip-1) in mammalian cell lines has conferred a modest increase of reporter mRNAs (Wilkie et al., 
2003; Gingold and Pilpel, 2011). Once the PIC is recruited to the 5’ end, scanning begins of the 40S 
ribosomal subunit until AUG recognition which is flanked by the short sequence known as the ‘Kozak 
sequence’ (Marilyn Kozak, 1986). Once AUG is recognised, scanning ceases along with the reaction of 
hydrolysis of GTP bound to eIF2 in the TC, a reaction which is irreversible. However, leaky scanning 
can occur when the AUG is in a suboptimal context where this can be bypassed and initiation begins 
at a downstream initiator methionine codon (Racine and Duncan, 2010). 
Kozak proposed the scanning hypothesis where it was observed that additions of secondary structures 
at the 5’UTR could block translation (M Kozak, 1986; Hinnebusch, 2014). It was discovered that the 
shortening of the 5’UTR caused a negative effect on the efficiency of initiation beyond about 20 
nucleotides. In yeast when investigating the expression of PGK1, the shortening on the 5’UTR lead to 
a reduction in translational efficiency (Hinnebusch, 2011). The optimal context for translation 
initiation in mammals is GCCRCCaugG (with a purine for R), where a strong context contains A at -3 
and a G at +4. Since then further research has found that for animals, fungi, plants and protists, 
nucleotides -3A/G (crucial for improved initiation), -2A/c and +5C were common (Marilyn Kozak, 1986; 
Van Der Kelen et al., 2009).  Additionally, repetition of G or A are important for initiation (Nakagawa 
et al., 2008; Van Der Kelen et al., 2009). Tikole et al (2008) created a neural network approach to 
predict translation initiation sites in human mRNA sequences with a weak Kozak context (Tikole and 
Sankararamakrishnan, 2008).  
 1.2.1.3 Effect of stress and starvation on initiation 
A number of signalling pathways control translation, for example in response to starvation, stress or 
growth factors (in mammals) (see figure 1.3). For the regulation of protein synthesis during 
environmental stresses, eIF2α is phosphorylated, inhibiting the formation of TC complex needed for 
the ribosome to bind to the start 34site of the mRNA. With further understanding of how this initiation 
factor is controlled and its effects on translation, engineering strategies can be used to enhance yield 
and quality of recombinant therapeutic proteins (Underhill et al., 2005). During amino acid starvation 
in yeast, free tRNA’a which accumulate directly activate GCN2 (general control nonderepressible 
protein 2) by binding to the histidyl-tRNA synthetase (HisRS)-like domain. When GCN2 phosphorylates 
eIF2α, this causes low levels of TC as eIF2 becomes a competitive inhibitor of the GEF eIF2B 
(Magazinnik et al., 2005).  
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In contrast to this, although phosphorylation of eIF2α causes inhibition of global translation, the 
translation of GCN4 is upregulated. When amino acids are plentiful, the ribosome translate uORF1 of 
GCN4, resume scanning and reacquire a TC before reaching the following 3 uORFs. After translation 
of the later uORFs, most ribosomes disassociate from the mRNA. However, when eIF2α is 
phosphorylated and there are lower levels of TC, ribosomes re-acquire the TC slowly after scanning 
through the remaining uORFs and reinitiate at the GCN4 ORF (Holcik and Sonenberg, 2005; Magazinnik 
et al., 2005). Expression of this transcriptional activator causes expression of most amino acid 
biosynthesis enzymes necessary. In mammalian cells, the phosphorylation of eIF2α also triggers the 
translation of ATF4 (via a similar method to GCN4) containing two uORFs. This transcription factor 
targets genes such as ASN and CHOP. As in yeast where GCN2 phosphorylates eIF2 α, the other kinases 
HRI, PERK, PEK  and PKR are also controlling the initiation factor (Gale Jr et al., 2000).  
Through understanding of the mechanisms behind the factors involved in translation and careful 
investigation into how these various factors are controlled, many novel ideas have been tested in 
improving rPP. Through the control of eIF2 phosphorylation, it has also been shown that when 
investigating the expression of a luciferase reporter, it expression was enhanced when simultaneously 
expressed it a mutated non-phosphorylatable eIF2αSer51Ala (Underhill et al., 2003). Additionally, 
Underhill et al. (2005) proposed that as they found levels of GADD34 (activated by CHOP) correlated 
with eIF2α dephosphorylation levels and a recovery in protein synthesis, that GADD34 should be 
overexpressed in CHO cells. Another approach in prolonging protein synthesis was to overexpress p58 
(which inhibits the kinases PKR and PERK), delaying eIF2α phosphorylation (Roobol et al., 2015). 
However, when it comes to controlling specific factors involved in translation, there are multiple 
pathways involved which have the potential to be exploited. For example, phosphorylation of factors 
such as 4E-BP and 4B depend on growth signals from pathways TOR (target of rapamycin) and MAPK, 
which are inactivated under certain circumstances such as starvation thereby directly effecting 
translation (Sonenberg and Hinnebusch, 2009), see more details on these pathways in sections 1.3.4. 
1.2.1.4 Elongation and termination 
This step requires elongation factors eEF1A and eEF1B for peptide chain elongation. eEF1A binds GTP 
and recruits aminoacyl-tRNAs to the A-site matching the codon at the site, where eEF1B acts as a GEF 
for eEF1A (Proud, 2007). This GEF is needed as upon codon-anticodon interaction GTP hydrolysis 
results in the eEF1A:GDP complex which needs to be exchanged preparing eEF1A for a new elongation 
cycle (Mansilla et al., 2002). The peptidyl transferase centre catalyses formation of the peptide bond 
leaving a deacylated tRNA in the ribosomal P-site with the newly formed peptidyl-tRNA in the A-site. 
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eEF2 is also needed to catalyse the co-ordinated movement of the two tRNA molecules, the mRNA 
and conformational changes to the ribosome (Kaul et al., 2011).  
The mRNA contains a stop codon (UAA, UAG or UGA) which the ribosome encounters when elongation 
of the polypeptide is complete. At the point where the stop codon reaches the A-site, the ribosome 
releases the polypeptide. This process depends on the release factor eRF1 (SUP45 in yeast) which 
causes peptide release by inducing hydrolysis of the peptidyl-tRNA:peptide bond (Merritt et al., 2010; 
Blanchet et al., 2015). eRF3 (SUP35 in yeast) physically interacts with eRF1 depending on its hydrolysis 
of GTP although the molecular details of stop codon decoding are unclear (Merritt et al., 2010). 
1.2.1.5 Controlling the speed of translation elongation 
Protein synthesis is mostly regulated at initiation, however there have been investigations into 
elongation and what parameters may slow down translation. The speed of translation depends on 
various factors such as the mRNA structure, abundance of translation factors, ribosome availability 
and the adaptation of the coding sequence to the cellular tRNA pool. The abundance of tRNA and 
codons of the gene will determine the speed of translation elongation as a selection of the appropriate 
tRNA matching the codon in the ribosomal A-site is needed (Tuller et al., 2010). tRNA biogenesis 
therefore effects the speed of the decoding process impacting the speed of ribosome movement 
(Tarrant and von der Haar, 2014).  Translation rates can slow due to the length of the open reading 
frame ORF or if it contains a stable RNA secondary structure which will cause pausing of elongation. 
In recombinant protein production there have been strategies towards improving translation by codon 
optimisation where the nucleotide sequence must be modified to optimise its codon preference 
without changing the amino acid sequence to suit the host (Mattanovich et al., 2012). For example 
there is an inherent codon bias when producing protein as some transfer RNAs (tRNAs) are found in 
limited amounts; these are arginine, proline, isoleucine and leucine. One approach is to create a 
plasmid containing extra copies of the rare tRNAs, while another is to alter the gene with the majority 
of rare codons replaced by ones which are more frequent. An example is the gene Gaussia luciferase 
which was codon-optimised for efficient expression in mammalian cells (Tannous et al., 2005). 
Aminoacylated tRNAs will interact with the A-site of a ribosome (which requires aminoacyl-tRNA 
synthases) with eEF1A and GTP. These aminoacylated tRNA’s are classed into three groups, the first 
being non-cognate (non-complementary to codon), near cognate tRNA (with non-matching codon but 
limited complementarity) and cognate tRNA (with matching amino acid to the codon) (Tarrant and 
von der Haar, 2014). It is important to consider the trade-off between speed and accuracy as tRNA 
and decoding are the most error prone (Wohlgemuth et al., 2011).  
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The frequency of ribosome binding to the mRNA needs to match the amount of the protein required 
by the cell, which is particularly important to consider when attempting to intrinsically enhance 
protein production (von der Haar et al., 2004). A good availability of ribosomes is needed for faster 
translation and abundance of factors which control binding to form the 80S initiation complex (Mitarai 
et al., 2008). For example fast-growing organisms such as yeast need a large abundance of ribosomes 
however possess very few free ribosomes during log phase (von der Haar, 2008), and the ribosomes 
that bind to the initiation region must transit efficiently for the next ribosome to start initiation (von 
der Haar, 2008; Tarrant and von der Haar, 2014). The speed of ribosome movement on mRNA can be 
reduced by the slow rate of peptidyl transfer reaction of certain amino acids (i.e glycine and proline), 
but also by the interactions between the nascent peptide and the ribosomal exit tunnel. Ribosome 
stalling can occur where a ribosome is already in front on the mRNA, therefore slowing movement 
(Mitarai et al., 2008). 
Although much work has been done investigating the speed of initiation and elongation, further 
optimisation to translation also includes removing unstable signal sequences, removing potential 
splicing sites and increasing the GC content which has been shown to increase expression (Zhu, 2012). 
Evidence has also shown that the rate of elongation has a significant impact of the quality of protein 
folding, where by partially inhibiting elongation (using inhibitors such as cycloheximide and emetine), 
this can correct for folding defects (Meriin et al., 2012). The drug guanabenz which leads to the 
upregulation of eIF2 phosphorylation, had also caused improvement to folding, possibly by reducing 
the load on ER chaperones (Sherman and Qian, 2013). With our knowledge of various model systems 
(as discussed above) and their advantages as expression systems combined with our increasing 
knowledge on translation, recombinant protein secretion is continuously improving. Detail on the 
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1.2.2 Secretion of protein  
 
1.2.2.1 Introduction to the secretory pathway 
In all eukaryotic cells, proteins destined for secretion or insertion into the plasma membrane, are 
transported into and through the endoplasmic reticulum (ER). The ER forms part of an ordered 
membranous network that comprises the secretory pathway (Schröder and Kaufman, 2005). Secretory 
proteins can be co-translated across the ER membrane as a consequence of an N-terminal signal 
peptide directing it to the ER post-translationally with the help of cytosolic molecular chaperones 
which belong to the Hsp70 and Hsp40 families. In S.cerevisiae,  both the co-translational and post-
translational pathways are equally important, compared to mammalian cells where the co-
translational pathway is dominant (Zimmermann et al., 2011).  
In co-translation, a signal recognition particle (SRP) involved in ER targeting, binds to the signal peptide 
which is a ribosome-nascent chain complex causing translational elongation arrest. The SRP then 
transfers the complex to the ER (Idiris et al., 2010). Once the ribosome docks to the ER membrane, 
the SRP binds to its receptor on the ER surface (SRP-receptor, SR). There is a transfer of the nascent 
polypeptide into a channel of the ER known as the Sec61 complex, which in turn relieves the 
elongation block. Due to this, the polypeptide is translocated across the ER lipid bilayer while it is being 
synthesised, preventing improper localisation in the cytosol (Kaufman, 2004; Vannuvel et al., 2013) 
(see figure 1.4).  
After entering the ER, folding and any assembly and processing, secretory proteins typically transit to 
the Golgi complex for further processing. This organelle was identified as membrane-enclosed 
flattened cisternae held as parallel stacks with tubular networks. Properly folded proteins are 
packaged in membrane bound vesicles and sent, to the cis-Golgi network which is the acceptor 
compartment and the trans-Golgi network responsible for sorting proteins to their next destination 
(Farhan and Rabouille, 2011). These vesicles selectively incorporate proteins from the ER and are 
targeted for the Golgi by coat protein complex II (COPII) (Gasser et al., 2008)(figure 1.4). A retrograde 
transport pathway relies on the balance of COPII and COPI to recycle vesicle components, which 
involve the components activated Sar1 which recruits Sec23-Sec24 dimeric complex capturing cargo 
protein. An outer layer of the pre-budding complex is formed with Sec13-Sec31, and with the help of 
Sec16 forms a strong association with the ER membrane, fusing the vesicle to the cis-Golgi network 
(Farhan and Rabouille, 2011).  
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Within this organelle, proteins also undergo PTM (post-translational modifications) such as the 
biosynthesis of O-linked glycans and remodelling of N-linked oligosaccharides (more detail below) 
(Teasdale and Jackson, 1996; De Matteis and Luini, 2008). After protein processing, different cargo 
molecules are sorted and targeted for their final destinations such as the cell surface or early 
endosomes and vacuoles directly, or via the late endosome/mutivesicular body (MVB)(Bowers and 
Stevens, 2005). For trafficking of these proteins, sorting signals containing sequence motifs or 
structural determinants interact with recognition proteins, although PTM of the cargo has also been 
known to affect its sorting (De Matteis and Luini, 2008). Exocytosis of secretory proteins involves 
vesicles which dock to and fuse to the plasma membrane releasing the cargo outside the cell. The 
mutiprotein complex exocyst mediates this by interacting with v-SNAREs (Snc1/2 proteins in vesicles 
in yeast) and t-SNAREs (where the target membrane has Sso1/2 and Sec9) (Gasser et al., 2008).  
 
Figure 1.4 Transport of cargo between the ER and the Golgi. Soluble secretory cargo, as well as fully 
folded integral membrane cargo, are exported out of the ER by the coat protein complex II (COPII) 
transport vesicles and travels to the Golgi in an anterograde direction. To retrieve ER resident proteins 
such as chaperones and recycle vesicle components, COPI coats bud vesicles from the Golgi which are 




Chapter 1 - Introduction 
26 | P a g e  
 
1.2.2.2 Protein folding and quality control 
 
The ER plays a role in the folding, sorting and delivery of proteins to the appropriate cellular 
destination as described above. With the help of chaperones, newly synthesised proteins are correctly 
folded and undergo PTMs (Bravo et al., 2012). Proteins folding inside and outside the ER are governed 
by the same principles; and although the ER provides a suitable environment its physiochemical, 
chemical, and biochemical features can contribute to folding problems. Most PTMs are introduced via 
specific enzymatic steps and/or pathways. Some are more common than others for example 
glycosylation is common while AMPylation is rare. Certain PTMs are predominatly or exclusively 
associated with intracellular or extracellular proteins. Phosphorylation and ADP ribosylation are 
needed intracellularly whereas glycosylation, disulphide linkage formation and carboxylation are 
extracellular (Walsh, 2010a).  
Glycosylation is the most complex PTM when it comes to therapeutic proteins (Walsh, 2010a). For 
protein folding, glycosylation increases the stability of glycoproteins due to the hydrophilic nature of 
carbohydrates. Due to their large hydrated volume, they also shield the attachment area from 
surrounding proteins acting as a chaperone and can interact with the peptide backbone, stabilising its 
conformation (Schröder and Kaufman, 2005). Initial glycosylation can occur during translocation which 
comes in two varieties in yeast, N-linked and O-linked. N-linked glycosylation in the ER is completed 
by oligosaccharyl transferase (OST) where a 14 sugar glycan tree is added to an asparagine residue. O-
linked glycosylation however is catalysed by O-mannosyltransferases (PTMs) where a single mannose 
is transferred to the hydroxyl groups of serine and threonine of the peptide. Subsequent addition can 
occur in the Golgi (Hou et al., 2012; Hakamata et al., 2015). 
The chaperone BiP (also known as GRP78 and Kar2) binds to hydrophobic areas of the peptide and 
plays a role in both protein translocation and in folding alongside other Hsp40 co-chaperones and 
Grp94 (which is not present in unicellular eukaryotes) (Brodsky and Skach, 2011) (see figure 1.5). 
Disulphide bond formations are catalysed by protein disulphide isomerases (PDI) which passes an 
electron from the disulphide bonds to FAD-dependent oxidases Ero1p and Erv2p (Schröder and 
Kaufman, 2005; Hou et al., 2012). Disulphide bonds help to stabilize and maintain the tertiary structure 
and quaternary structure in multi-subunit proteins such as antibodies. As oxidation and reduction 
coexist in the ER, disequilibrium can cause ER stress as a reducing environment in the ER (as is in the 
cytosol) prevents the formation of disulphide bonds, while over-oxidation will stabilise non-native 
bonds causing misfolding (Margittai and Sitia, 2011).  
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After glycan attachment, glucosidase I (GlcI) and GlcII remove the first and second glucose 
consecutively, for high affinity to the proteins calnexin (CNX) and calreticulin (CRT). Where CNX is 
membrane bound and binds co-translationally, CRT is a soluble protein which will interacts with the 
protein after it is released by the ribosome and free in the ER lumen (Brodsky and Skach, 2011). At 
this point when the glycoprotein is either CNX or CRT bound, ERp57 will form disulphide bonds. If 
there is improper folding, the glycoprotein is reglucosylated by uridine diphosphate 
glucose:glycoprotein glycosyl transferase (UGGT) (Naidoo, 2009). The functions of these enzymes are 
summarised in table 1.1 below. 
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Table 1.1 Enzymes involved in protein processing and folding in the secretory pathway.  Adapted from 





ER chaperone involved in protein folding and degradation. Part of 
HSP70 family 
Glucose regulated protein 
78 (GRP94) 
Chaperone part of HSP90 family involved in protein folding 
Protein disulphide 
isomerase (PDI) 
Thiol-disulphide oxidoreductase - Folding and disulphide bond 
formation. Role in degradation. 
Ero1 FAD-bound oxidoreductin 1 – accepts electrons from PDI in 
disulphide bond formation 
ERp57 Thiol-disulphide oxidoreductase - Disulphide bond formation 
Calreticulin (CRT) Role in folding glycoproteins 
Calnexin (CNX) Role in folding glycoproteins (membrane bound) and quality 
control 
UGGT Reglucosylation of misfolded glycoproteins 
Glucosidase I/II  (Glc I/II) Trims off terminal glucoses on glycans 
oligosaccharyl transferase 
(OST) 
Role in N-glycosylation of peptide 
O-mannosyltransferases 
(PMT) 
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Figure 1.5 Simplified schematic of processes and chaperones involved in protein folding in the ER. (a) 
The signal peptide is recognised by the signal recognition particle (SRP) which associates with the 
ribosome when a protein is entering the secretary pathway. At this point the SRP binds to its receptor 
on the ER surface (SRP-receptor, SR).  (b) BiP activity is involved as the growing peptide passes through 
the translocon. (c) Once the peptide enters the ER, chaperones BiP, calnexin (CNX) and calreticulin 
(CRT) act to fold the protein whereas disulphide-bond formation is formed in protein by the activity 
of Ero1 through the protein disulphide isomerase (PDI). ERp57 associates with CXN or CRT for access 
to the protein where bonds formed are modified. (d) COPII-coated vesicles are formed for the exit of 
properly folded proteins. (e) If proteins are misfolded, they can associate with CNX, PDI and BiP for 
retrotranslocation for ATP-dependent ubiquitylation and broken down by the proteome (Naidoo, 
2009). 
 
1.2.2.3 ER stress 
 
Research has shown that processes within the ER actively monitor the folding status of its cargo. These 
systems communicate with other cellular compartments to elicit responses such as increased 
expression of genes involved in protein folding or indeed the induction of apoptosis.  An example of 
this occurs if the folding capacity of the ER is exhausted, the normal physiological state of the ER is 
perturbed inducing the unfolded protein response (UPR) (Schröder and Kaufman, 2005).The  UPR is 
involved in increasing the capacity of the secretory pathway by clearing misfolded proteins. Usually a 
portion of BiP is associated with immature proteins while the majority are associated with the ER 
transmembrane protein Ire1 preventing dimerization. However, with an increase in BiP bound-
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misfolded proteins, Ire1 dimerizes and the cytoplasmic portion self-phosphorylates (Hou et al., 2012). 
Now activated, this catalyses the splicing of the pre-mRNA HAC1/XBP1 (removing the inhibitory 
intron), thereby allowing translation of Hac1/XBP1 and its nuclear transport and transcriptional 
activation at promoters of unfolded response element  (UPRE) (Buchberger et al., 2010).  
In yeast, UPR is only initiated via the IRE system, however in mammals there are two additional UPR 
transducers known as PERK and ATF6, which transiently inhibit new protein synthesis and reduce 
components that may enhance stress. PERK phosphorylates eIF2α globally attenuating protein 
synthesis by limiting mRNA translation initiation; however ATF4, GRP94 and BiP are translated 
efficiently increasing protein levels. Increased ATF4 leads to an increase in CHOP (a pro-apoptotic TF)  
(Bravo et al., 2012; Brodsky & Skach, 2011). ATF6 migrates to the Golgi where it is cleaved by proteases 
S1P and S2P, releasing a fragment into the cytosol that then migrates to the nucleus, activating 
transcription of BiP, GRP94 and PDI (Naidoo, 2009). To increase folding, as molecular chaperones are 
upregulated and recruited; the size of the ER increases diluting the unfolded protein load thus 
reducing stress on the ER (Schröder and Kaufman, 2005). In combination these 3 proteins initiate an 
ER-to-nucleus signalling cascades to improve cellular function and protect the cell from further stress 
(Wu et al., 2007).  
Due to adaptive signalling of the UPR,  slowly folding or permanently unfolded proteins are targeted 
for proteasomal degradation through the ER-associated degradation (ERAD) complex (Ellgaard, 1999; 
Vannuvel et al., 2013). Proteins targeted for degradation have two routes, the first being 
retrotranslocation into the cytosol and ubiquitination before proteasomal degradation (ERAD 
pathway) or autophagy where parts of the ER are targeted to lysosomes or vacuoles (although it is not 
well understood to what extent this is involved) (Schröder, 2008).  Unfolded glycoproteins are 
mannose trimmed by ER mannosidase (Mns1) which is targeted for ERAD when recognised by 
homologous Yos9 (yeast) or OS-9/XTP3-B (mammalian) proteins. The chaperones BiP and PDI also 
associate with ERAD proteins along with E3 ubiquitin ligases such as carboxyl-terminus of Hsp70 
interacting protein (CHIP) targeting chaperone substrates for degradation (Ballinger et al., 1999; 
Buchberger et al., 2010; Brodsky and Skach, 2011). 
In mammalian cells these ER chaperones and folding enzymes have established a highly redundant 
system where individual members recognise their substrates differently, so if one chaperone fails, 
another will interact with an incompletely folded protein (Ellgaard, 1999; Braakman and Bulleid, 
2011). ER stress can cause many knock on effects to the cells and the organism. In lower eukaryotes, 
vacuolar membranes are affected and assembly of the cell wall and function of the plasma hindered. 
In humans, mutation to a cargo receptor causes loss of secretion of specific proteins leading to 
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diseases such as haemophilia due to no blood coagulation factors V and VIII. Accumulation of folding-
incompetent proteins which are resistant to proteasomal degradation can cause neurodegenerative 
diseases such as Parkinson’s by disrupting ER function and activating apoptotic-signalling pathways 
causing cell death (Davis et al., 1999; Schröder and Kaufman, 2005; Naidoo, 2009; Dancourt and 
Barlowe, 2010).  
1.2.2.4 Secretion and processing of recombinant protein  
To produce authentic therapeutic proteins such as monoclonal antibodies in mammalian cells, the 
protein is normally directed through the secretory pathway. This strategy generally achieves high 
yields and accurate protein folding (Jossé et al., 2010). However, the over expression of rP can lead to 
protein aggregation within the ER system and associated proteotoxicity (Jossé et al., 2010). As roles 
of genes and a better understanding of protein folding is unveiled, engineering of cells can be 
investigated in the hope of improve folding. It was expected that by increasing BiP levels, this would 
stimulate secretion levels because of an increase in folding capacity, and it has been previously 
reported that BiP transcription was induced from high levels of heterologous proteins expressed, 
however findings when this was undertaken were inconsistent (Robinson and Wittrup, 1995; Gasser 
et al., 2008). In the fungus A.niger, it was discovered that a certain threshold of BiP overexpression 
was needed; similarly PDI overexpression once optimised improved plant sweet protein thaumatin 
production (Moralejo et al., 2001; De Pourcq et al., 2010).  It may be that fine-tuned expression of 
these genes are required and that co-expression of genes such as chaperones may strongly depend 
on the properties of the target protein (Gasser et al., 2008). 
As discussed above, a signal sequence is needed to interact with the SRP which directs the peptide to 
the ER. A number of N-terminal sequences have been devolved for the use of host systems, for 
example the signal MFα1 from the mating pheromone α-factor is commonly used in yeast (as is used 
in chapter 3 of this thesis) (Rothblatt et al., 1987; Idiris et al., 2010). As an example, human IgG1 
production in yeast has been engineered, increasing levels up to 180-fold over the wild type. As well 
as the use of MFα1, invertase (SUC2, hydrolyses of sucrose) and acid phosphatase (PHO5, phosphate 
metabolism) are other examples used in yeast (Chaudhuri et al., 1992; Li et al., 2007). In addition the 
viral K28 preprotoxin (pptox) signal peptide has been used as an example of how we can harness viral 
signal peptides in rP production (Idiris et al., 2010) (more information on this in chapter 3). The 
information above is proof of how our understanding of the secretory pathway can be manipulated 
to our advantage for improving rP production at different points during peptide processing. 
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1.3 Cell signalling and its regulation 
 
1.3.1 The actin binding protein cofilin and its regulation in yeast 
1.3.1.1 The actin cytoskeleton  
Actin is a highly dynamic protein/molecule and well conserved amongst eukaryotes.  As well as being 
an essential part of the cytoskeleton of eukaryotes, it participates in a number of essential cellular 
processes including endocytosis and vesicle trafficking, the generation of cell morphology, polarity, 
motility and cell division (Dominguez and Holmes, 2011). Actin from the budding yeast  Saccharomyces 
cerevisiae is encoded by a single gene, ACT1 which encodes for a protein which has approximately 
85% homology to the actin found within vertebrates (Aghamohammadzadeh and Ayscough, 2010). 
The high degree of conservation is shown in the alignments of the human and yeast actin shown in 
figure 1.7. 
 
Figure 1.7 Actin sequence in humans and S.cereivisiae. The sequences of actin in humans and 
S.cerevisiae were retrieved from the NCBI protein database. This shows their sequence alignment 
comparison performed on EBI-clustalW online tool illustrating how conserved actin is. An asterisks (*) 
represents a single fully conserved residue.  A colon (:) represents conservation between groups of 
strongly similar properties. A Period (.) indicates conservation but with weakly similar properties and 
a gap indicates residues with no conservation. NCBI protein database address 
(http:www.ncbi.nlm.nih.gov/protein/) and EBI-clustalW online tool 
(hhtp://www.ebi.ac.uk/tools/msa/clustalw2/) 
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Actin has the ability to change between monomeric G-actin, and filamentous F-actin. Polymerisation 
of F-actin occurs by the addition of monomeric actin to form filaments, a process that is aided by a 
number of actin binding and regulatory proteins (Aghamohammadzadeh and Ayscough, 2010). The 
rapid addition of monomers at the fast growing or barbed end of filaments, coupled to the dissociation 
at the opposite, pointed end of filaments gives rise to the phenomena of actin filament treadmilling. 
Associated actin-binding proteins (ABPs) have various functions such as actin monomer sequestration, 
filament severing, filament cross linking and filament barbed-end and pointed end capping 
(Dominguez and Holmes, 2011). As actin is highly conserved, so are its components and functions 
which has lead yeast geneticists and cell biologists to use the experimental power of yeast for 
investigating the regulation of actin. The visualization of the cytoskeleton through the cell cycle is 
important in these studies. Rhodamine-phalloidin has been used to stain F-actin to reveal the actin-
based cytoskeletal structures mentioned above (Amberg, 1998). Filamentous actin structures found 
in S.cerevisiae comprise of cortical actin patches, actin cables and actin-myosin contractile rings 
(Adams and Pringle, 1984; Aghamohammadzadeh and Ayscough, 2010). 
In mammals, changes in the cytoskeleton result in processes such as initiation of neurite outgrowth, 
axonogenesis and axon pathfinding. The larger number of regulatory pathways that impinge on the 
ADF/cofilin family suggests that they play a central role in integration of many of these signalling 
cascades (Sarmiere and Bamburg, 2004). 
Although is well known that actin has a central role in the cell, recent research suggests actin also acts 
as a biosensor of environmental perturbations, linking actin to signalling process in the cell (Smethurst 
et al., 2013). For example, actin has a critical role in endocytosis which helps regulate cell surface 
composition ensuring the appropriate receptors and transporters are exposed which is important for 
survival (Aghamohammadzadeh and Ayscough, 2010). Another role for actin is by the movement of 
organelles such as the ER, mitochondria and peroxisomes transporting them throughout the cell via 
actin cables (Moseley and Goode, 2006; Aghamohammadzadeh and Ayscough, 2010). Actin has an 
additional role in protecting newly formed buds from accumulating damaged proteins from the 
mother cell and prevents aggregation of mitochondria, playing a protective role in yeast (Aguilaniu et 
al., 2003; Liu et al., 2010) . It has also been suggested that actin dynamics play a role in cell death and 
stress responses (Gourlay et al., 2004; Kotiadis et al., 2012). With these potential roles in cellular 
responses by actin to the cell environment it is not surprising that links can be found between actin 
and signalling pathways such as MAPK (in cell wall integrity),TOR signalling (via TORC2) and cAMP/PKA 
pathway in apoptosis (Schmidt et al., 1996; Gourlay et al., 2004; Levin, 2011).  
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1.3.1.2 Cofilin’s primary role in the cell 
Cofilin is a well characterised actin-binding protein which belongs to a group of small molecules (15-
20 kDa), the actin depolymerising factor (ADF)/cofilin family. Unicellular organisms such as S.cerevisiae 
produce only one member of this family compared to metazoans which often have up to three 
different genes encoding ADF/Cofilin proteins (Bamburg and Wiggan, 2002; Aghamohammadzadeh 
and Ayscough, 2010). Mammals produce three members of the ADF/cofilin family, ADF (also known 
as destrin), cofilin-1 (non-muscle tissue) and cofilin-2 (in differentiated muscle) (Bamburg and 
Bernstein, 2010).  These isoforms have similar, but not identical, biochemical activities (Van Troys et 
al., 2008). In mice, knockout of the cofilin-1 gene is embryonic lethal, whereas  the only consequence 
of ADF knockout in mice is postnatal blindness due to thickening of the cornea after about 4 weeks of 
birth (Bamburg and Bernstein, 2010). 
Regulators of actin dynamics have various functions to regulate the ability for actin to polymerise and 
depolymerise. This includes those that are monomer binding, capping proteins, depolymerising 
proteins and filament stabilisers. An actin monomer-binding protein, profilin, has been found to 
interact with formins at sites of actin cable nucleation (Bertling et al., 2007; Aghamohammadzadeh 
and Ayscough, 2010). Profilin catalyses the exchange of ADP for ATP, returning subunits to the pool of 
ATP-actin bound to profilin ready to elongate barbed ends as they become available but blocking 
binding to filament point ends (Pollard and Borisy, 2003; Smethurst et al., 2013). Cofilin (Cof1) is a 
member of the ADF/cofilin family of actin binding proteins, which disassembles actin filaments at the 
pointed/minus end (depolymerisation end). It binds to both filaments and monomers and prefers to 
bind to ADP-G-actin (Bernstein and Bamburg, 2010). 
1.3.1.3 Regulation of cofilin 
The predominant enzyme that phosphorylates cofilin in mammalian cells is LIM kinase (LIMK) at serine 
3. Although regulation of cofilin by phosphorylation has not been identified, alignment of cofilin in 
S.cerevisiae shows serine 4 (corresponding to serine 3 in vertebrates), and mutation of the serine site 
to glutamine creates a lethal phenotype (Lappalainen et al., 1997; DesMarais et al., 2005). There are 
two isoforms of this kinase. LIMK1, which is expressed in neural tissue as well as most others and 
growth cones of cultured neurons compared to LIMK2 which is ubiquitously expressed. LIMK1 is 
regulated by small GTPase Rac and Cdc42, but a downstream target of these proteins is PAK1, a protein 
kinase and is a direct regulator through phosphorylation of Thr508. LIMK2 is regulated by Cdc42 and 
Rho (via the protein kinase ROCK, a direct activator on thr505)(Amano et al., 2001; Sumi et al., 2001; 
Mizuno, 2013). Testicular protein kinase 1 (TESK1) is another kinase which is closely related to LIM-
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kinases (50% amino acid identity). TESK1 also phosphorylates the cofilin proteins. Yet in contrast to 
LIM-kinases, TESK1 is not stimulated by either PAK or ROCK (Toshima et al., 2001; Mizuno, 2013). 
After phosphorylation, cofilin proteins are reactivated by dephosphorylation due to the binding of 
general phosphatases such as slingshot (SSH) and so have a counteractive effect to the AC(ADF/Cofilin) 
kinases (Niwa et al., 2002; Bamburg and Wiggan, 2002; Van Troys et al., 2008)(see figure 1.8). Another 
mode of regulating actin dynamics is the stabilisation of the inactive form of AC and the interactions 
with AC binding proteins by the 14-3-3 family. This is a family of proteins consisting of 7 isoforms. Once 
bound, the conformation of cofilin proteins is not affected upon phosphorylation. 14-3-3 proteins 
protect cofilin proteins from dephosphorylation by decreasing the availability of inactive AC, 
regulating the cellular phosphocofilin pool (Birkenfeld et al., 2003; Han et al., 2007). 
                    
Figure 1.8: The activity and regulation of ADF/cofilin. These proteins bind to F-actin with the highest 
affinity for ADP-actin subunits. From the pointed end, ADF/cofilin proteins enhance the rate of subunit 
dissociation and sever filaments. This creates new pointed and barbed ends which can elongate or 
shorten. ADF/cofilin proteins are inactivated by phosphorylation of LIMK or TES. These can be 
reactivated by phosphatases. Abbreviations: D, ADP-actin; T, ATP-actin; Pi, inorganic phosphate 
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1.3.1.4 Other roles of cofilin 
In yeast S.cerevisiae, the identification of a cofilin homolog has opened new avenues for studying its 
function and as it is an essential gene, using yeast molecular genetics to identify cofilin residues 
important for cofilin-actin interactions (Lappalainen et al., 1997), in addition discovering new roles of 
cofilin is possible. Previous studies had identified actin related activities of cofilin to be inhibited by 
phospholipids, in particular phosphatidylinositol 4,5-bisphosphate (PIP2). The PIP2 binding site was 
mapped on cofilin which overlaps with the area important for F-actin binding (Ojala et al., 2001; 
DesMarais et al., 2005). Although the function of PIP2 binding to cofilin is unknown, and as PIP2 can 
be found in multiple compartment of the cell, it has been suggested that this interaction could be an 
important for cytoskeletal dynamics and signalling (Kotiadis et al., 2012).  
1.3.1.5 Cofilin and the mitochondria 
Actin has no nuclear localization sequence but there is evidence that cofilin chaperones actin to the 
nucleus. This may facilitate actin’s functions in chromatin remodelling, formation of heterogeneous 
nuclear ribonucleoprotein complexes, and gene expression ( Zheng, Han, Bernier, & Wen, 2009). Yet 
actin binding is not required for translocation of cofilin to the mitochondria or the release of 
cytochrome c. However, apoptosis is blocked by mutating the actin-binding domain. If actin dynamics 
are reduced, it is believed to cause a decrease in mitochondrial membrane potential as well as an 
increase in ROS levels (Chua et al., 2003; Bernstein and Bamburg, 2010) 
Mitochondria are membrane-enclosed organelles found in most eukaryotic cells needed for cellular 
respiration. Mitochondrial structure and function can be regulated through signalling pathways in 
response to environmental change, for example in nutrients or oxygen availability, (McBride et al, 
2006). Oxidative phosphorylation is carried out in the inner membrane of mitochondria by a series of 
protein complexes known as the Electron Transport Chain (ETC). As some of the components of the 
ETC function as transmembrane proton carriers, a proton gradient is generated from the IMS to the 
matrix when electrons pass through the ETC. This proton gradient is necessary for conformational 
changes associated with ATP generation at the ATP synthase (Jarmuszkiewicz et al., 2010). 
Mitochondria contain their own DNA (mtDNA), in S.cerevisiae these include mitochondrial-specific 
tRNA genes, two rRNA genes and genes encoding proteins involved in the electron transport chain. 
However, nuclear DNA also encodes for proteins that localize to the mitochondrion (Lipinski et al., 
2010).  
Mitochondria are also crucial in decision points of cellular life or death. Apoptosis in yeast occurs via 
a simple intrinsic (mitochondrial) derived mechanism which is driven by the permeabilisation of the 
outer mitochondrial membrane (MOMP) and the production of ROS (Green and Kroemer, 2004; Klamt 
Chapter 1 - Introduction 
37 | P a g e  
 
et al., 2009). MOMP leads to the release of destructive proteins such as AIF (apoptosis-inducing factor) 
and endonuclease G which travel to the nucleus and degrade the genomic DNA (Li et al., 2001).  In 
addition, cytochrome c is released into the cytosol and mitochondrial fragmentation occurs. Prior to 
MOMP it is reported that mitochondrial hyperpolarisation occurs which is then followed by an 
oxidative burst, ROS production and the breakdown of mitochondrial membrane potential (Eisenberg 
et al., 2007). In higher multicellular eukaryotes too little or too much apoptosis can result in disease 
(Mizushima et al., 2008). It is believed that in yeast the control of cell death is also important for the 
management of multi-cell formations such as colonies or bio-films (Kuthan et al., 2003). Recent work 
has shown that changes in the dynamic status of the actin cytoskeleton can act to modulate the 
apoptotic response to yeast, plants and animals (Franklin-Tong and Gourlay, 2008). 
Communication between organelles is important throughout the cell; signalling between ER and 
mitochondria in yeast is acheived through the physical connection of the protein complex referred to 
as ERMES (ER-mitochondria encounter structure)(Kornmann et al., 2009). It is believed that the ERMES 
may be responsible for mitochondrial membrane biogenesis, genome replication, Ca2+ signalling and 
protein import; all regulating mitochondrial and cell physiology (Kornmann and Walter, 2010; Murley 
et al., 2013). Ca2+ signalling in particular is important for modulating mitochondrial bioenergetics, 
influencing metabolism and survival. 
During ER stress such as that experienced due to the accumulation of misfolded proteins, this leads to 
the triggering of the UPR to restore folding capacity as described in section 1.2.2.3 above. This 
enhances mitochondrial bioenergetics and ATP production, however prolonged UPR signalling from 
persistent stress will cause mitochondrial collapse, triggering cell death by apoptosis (Liu et al., 1996; 
Bravo et al., 2012). Although mitochondria can also buffer Ca2+ in the cytosol, preventing cytotoxic 
effects, it will eventually cause an opening of the permeabilization transition pore, releasing 
cytochrome c leading to apoptosis (Pinton et al., 2008; Denton, 2009; Kornmann and Walter, 2010).  
1.3.1.6 Cofilin’s interaction with signal transduction and stress response pathways 
Cofilin is an essential gene in eukaryotes and plays an important role in the control of a number of 
signalling pathways. It is believed that there is an integration of cytoskeletal activity with stress 
signalling. Previous and unpublished data from within the Gourlay lab suggests that in yeast cofilin 
may act as a regulator of three major networks which are controlled by TOR (Target of Rapamycin), 
Ras and MAP (mitogen-activated protein) kinase signal transduction cascades. More on these 
pathways are detailed below. 
It has been determined that in CHO cells, transient knockdown of cofilin enhanced productivity of 
human secreted alkaline phosphatase (SEAP) by up to 80% suggesting that modulation of this protein 
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influences cellular properties that impact upon rP production. Cofilin was identified as a key protein 
through transcriptome and proteome profiling of cell lines which identified cytoskeletal proteins as 
new genetic targets (Hammond and Lee, 2012). As cytoskeletal proteins play a role in a large number 
of cellular processes such as cell cycle progression, secretory vehicle transport and metabolism these 
may be key targets for engineering strategies. Other research in mammalian cells has also suggested 
that phosphorylated cofilin might control phospholipase D (PLD2) which affects vesicular trafficking 
and therefore secretion (Han et al., 2007). However this is all through the roles of cofilin in actin 
binding. Roles outside of cofilin’s actin binding region have highlighted how mutations to this protein 
cause increased mitochondrial biogenesis, and as it is known that ER stress leads to changes in 
mitochondrial function, it is possible that these mutants may have better protection (with enhanced 
mitochondrial function) against stress caused from rP production (Kotiadis et al., 2012; Curwin et al., 
2012). Preliminary data from the Gourlay lab also suggests that proteotoxic effects from rPP leads to 
loss of mitochondrial function. This evidence points towards cofilin acting as a homeostatic sensor 
outside its role in actin binding where it can act as a signalling molecule under stress, altering 
mitochondrial function. In the work reported here it was envisaged to investigate how other stress 
signalling pathways interact with this as there is already evidence from the Gourlay lab that cofilin 
mutant alleles have altered RAS, MAPK and TOR signalling. These signalling pathways are introduced 
in detail below.  
 
1.3.2 Ras/cAMP/PKA pathway 
 
Ras and cyclic AMP (cAMP) signalling in yeast coordinates cell growth and proliferation with nutritional 
sensing. During the exponential growth phase, RAS, a small GTPase is activated and promotes the 
upregulation of cAMP production from adenylate cyclase. This in turn activates three protein kinase 
A (PKA) subunits which act to downregulate stress tolerance, and promote cell cycle progression 
(Cazzaniga et al., 2008). It has been demonstrated that a decrease in actin dynamics leads to ROS 
generation due to abnormal mitochondrial functionality. This was the first time a link had been 
established between actin dynamics, mitochondrial function and cellular health (Gourlay et al., 
2004)(Kotiadis et al., 2012). Subsequent research found that this link was through Ras/cAMP/PKA 
signalling, regulating ROS production and cell fate (Campbell W Gourlay and Ayscough, 2005). Work 
from the Gourlay lab has provided evidence that cofilin mutations that stabilise F-actin also trigger 
hyperactivation of Ras leading to loss of mitochondrial function and apoptosis (Kotiadis et al., 2012).  
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1.3.3 MAPK signalling and its role in stress signalling 
MAPK are serine-threonine protein kinases which are activated by a range of stimuli such as cytokines, 
growth factors, neurotransmitters, hormones, cellular stress and cell adherence being among the 
most widely characterised (Widmann and Gibson, 1999; Cargnello and Roux, 2011). There are four 
MAPK pathways in S.cerevisiae involved in mating (Fus3), filamentous and invasive growth (Kss1), high 













Figure 1.9 An overview of the three-compartment module of the 4 MAPK pathways in yeast. The 
diagram indicates stimulus which trigger these pathways and the response to these signals. Ste5 acts 
as a scaffold to Ste11, Ste7 and Fus3and promotes Ste7 Fus3 signalling. A MAPKKK has not been 
identified during meiosis. Adapted from (Saito, 2010).  
The MAPK cascades consist of three protein kinases that act sequentially and which are conserved 
from yeast to higher eukaryotes. Components of this cascade have a highly conserved molecular 
structure; therefore molecular mechanisms are in place to allow for the selective activation of each 
pathway. This specificity is conferred by the use of specific binding motifs that determine sequential 
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protein kinases starts with an activated MAPK kinase kinase (MAPKKK) which activates a MAPK kinase 
(MAPKK); this in turn activates a MAPK.  The MAPK kinase cascade is initiated by phosphorylating 
MAPKKK by upstream events including processes such as occupancy of receptors coupled to 
heterotrimeric G proteins by their cognate agonists and/or the binding of the appropriate ligands to 
other classes of receptors that stimulate production of activated monomeric G-proteins (Chen and 
Thorner, 2007). 
MAPK signalling pathways use overlapping sets of signalling components, the MAPKKK Ste11 is found 
in three out of the five signalling pathways. Due to insulation mechanisms, cross talk is avoided 
between pathways with shared components. One is through interactions with their substrates 
through docking domains, enhancing their fidelity and efficiency of action, these docking sites are 
short amino acid stretches (Sharrocks et al., 2000; Saito, 2010). However, there is evidence that 
indicates that a coordinated interaction between these pathways is required. An example where this 
applies is when there is polarized growth in pseudohyphal development and mating. This requires the 
control by mating and filamentation signalling pathways as well as cell wall remodelling; therefore 
coordination is necessary between the CWI and other MAPK pathways (Rodríguez‐Peña et al., 2010).  
1.3.3.1 MAPK in yeast mating and filamentous growth  
During mating, the pheromone MAPK pathway is activated by cell–type specific mating pheromones. 
Yeast cells exist as either diploid or in haploid form, there are two sexual phenotypes. In S.cerevisiae 
during mating to create the diploid form, cells are controlled by the a or α pheromones which are 
controlled by the expression of a set of genes involved in mating (Madhani and Fink, 1998; Ydenberg 
and Rose, 2008). Pheromones bind to their receptors which are coupled to a heterotrimeric G protein 
which is activated leading to the dissociation of the βγ-complex from the α-GTP, this then stimulates 
the mating pathway. This βγ-complex contains Ste4 and Ste8 which activates Ste20, signalling to the 
MAPK module (Ste11Ste7Fus3) (Widmann and Gibson, 1999; Kholodenko and Birtwistle, 2009). 
The kinase Ste5 acts as scaffold protein, binding to Ste11, Ste7 and Fus3, changing the affinity of Fus3 
as it acts as a substrate co-catalyst. Once Fus3 (MAPK) is activated, it signals to transcription factor 
Ste12 and temporarily arrests the cell cycle in G1 phase (Oehlen et al., 1996; Saito, 2010; Wong Sak 
Hoi and Dumas, 2010). This is done by Ste12 inducing Far1 transcription as the cells must not grow. 
This induces remodelling of the cytoskeleton and the cell wall causing the cell to fuse with the mating 
partner (Tedford et al., 1997; Widmann and Gibson, 1999; Wong Sak Hoi and Dumas, 2010). Mating 
in the fission yeast, S.pombe, also involves homologs of the yeast MAPK module but is controlled by 
different upstream regulators.   
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Filamentous growth (FG) is where cells become elongated, and mother and daughter cells remain 
attached to each other. This forms filaments of cells called pseudohyphae; cells go through this 
developmental change when there are poor nutritional conditions. Therefore when carbon or 
nitrogen is limited in the environment, this stimulates the FG MAPK pathway (Ste11 Ste7  Kss1) 
allowing sessile cells to seek out scarce nutritional resources. Kss1 controls cell adhesion, cell 
elongation as well as the reorganization of cell polarity through the activation of transcription factors 
Ste12 and Tec1 (Madhani and Fink, 1997; Bardwell et al., 1998; Martín et al., 2005). 
The pheromone and FG pathway share Ste11 (the MAPKKK) and Ste7 signalling (the MAPKK). Yet 
pheromone activated Ste7 only activates Fus3 (MAPK), and Ste7 signalling induced by starvation only 
induces Kss1. Pheromone signalling activates both Fus3 and Kss1, but this is under tight control. Kss1 
is controlled transiently where Fus3 is only activated when pheromone concentrations are above a 
certain threshold (Ydenberg and Rose, 2008; Saito, 2010). Therefore when Kss1 is activated, the FG 
pathway induces cell elongation, helping the cell to reach mating partners.  
Ste12 is phosphorylated by Fus3 in pheromone response and Kss1 during filamentous growth. Ste12 
is also regulated by Dig1 and Dig2 which block its activity (Bardwell et al., 1998; Engelberg et al., 2014) 
which are controlled by Fus3 and Kss1 (Wong Sak Hoi and Dumas, 2010). The way in which Ste12 is 
able to control two pathways is through different MAPKs and by binding to a DNA element called the 
PRE (pheromone response element) as a homomulitimer or as a heteromultimer with Mcm1, a protein 
which binds to the P box. This response to pheromone activates mating genes (Madhani and Fink, 
1998; Bao et al., 2004; Su et al., 2010a). For filamentous growth during starvation, Tec1 binds with 
Ste12 which associates with the filamentous response element (FRE) which is a combination of the 
motif PRE and TCS (TEA/ATTS consensus sequence). However, some filamentous genes do not contain 
PRE motifs so regulation may be due to TCS. This results in the activation of genes needed for 
filamentation (Wong Sak Hoi and Dumas, 2010). 
 
 
1.3.4 TOR signalling and its regulation in protein production 
 
1.3.4.1 What is the role of TOR signalling? 
Another major signalling pathway is TOR (target of rapamycin) which is involved in nutrient sensing, 
and if inhibited by the drug rapamycin or poor nutrient sources leads to prolonging of cell division and 
reduced cell size. The role of TOR in nutrient control of cell size is well conserved (Petersen, 2009). 
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Like other eukaryotes, Saccharomyces cerevisiae contains two TOR complexes, TORC1 and TORC2, but 
only TORC1 is rapamycin sensitive. In yeast, treatment with rapamycin induces phenotypic changes, 
for example, cell cycle arrest and entry into G0 phase, accumulation of the reserve carbohydrate 
glycogen and the stress protectant trehalose, general downregulation of protein synthesis, 
upregulation of stress response genes, autophagy and alterations in nitrogen and carbon sources. 
Studies from the late 1980’s led to the identification of the TORC1 binding protein FKBP12 (encoded 
by the FRP1 gene) in budding yeast. FKB12 was subsequently shown to be the target of rapamycin and 
to be required for its toxic, anti-proliferation action. Rapamycin does not therefore directly inhibit TOR 
kinase activity, but blocks interactions with regulatory proteins causing a conformational change or 
through steric hindrance that prevents function of this essential pathway (Heitman et al., 1991; Fingar 
and Blenis, 2004; Hands et al., 2009). This drug is a bacterial macrolide and is used as an antitumor 
and immunosuppressant drug by limiting cell growth (Barbet et al., 1996; Claudio De Virgilio and 
Loewith, 2006; Jacinto and Lorberg, 2008). TORC2 is less well characterised in comparison and is 
thought to regulate the special aspects of growth including actin polarisation (Galdieri et al., 2010). In 
mammalian cells, TOR is highly conserved with both TOR complexes but with a single gene mTOR (see 
figure 1.10 below). 
 
Figure 1.10 Comparison of the TOR complexes in yeast and mammalian cells. In yeast TORC1 has either 
Tor1 or Tor2 and the components Tco89, Kog1 and LST8. The TOR complexes sense nutrient 
availability, particularly leucine. Mammalian cells on the other hand have only one TOR gene, mTOR 
with Raptor, mLst8, Deptor and PRAS40. This complex and mTORC1 sense nutrients and growth 
factors in the environment. Adapted from Inoki et al., (2005); Jewell, Russell, & Guan, (2013). 
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In the TORC1 complex, mammalian cells contain raptor (KOG1 in yeast), which interacts with mTOR 
and is also believed to be sensitive to rapamycin and nutrients. This protein serves as a scaffold to 
present substrates to mTOR. As in mammals, KOG1 in budding yeast is an essential gene known to 
contain four internal heat repeats and seven C-terminal WD40 repeats. Lst8 is made up entirely of 
seven WD40 repeats and is found in both complexes in mammals and budding yeast. It is believed to 
act as a chaperone and is required for amino acid permease transport of Gap1 from the Golgi to the 
cell surface. Lst8 works by binding to the kinase domain of mTOR to stimulate mTOR kinase activity 
and its knockdown leads to defects in actin cytoskeleton reorganisation, indicating it also functions in 
mTORC2 (Jacinto and Lorberg, 2008). In yeast, TORC2 also contains AVO1, AVO2, AVO3 and BIT61. 
AVO1 and AVO3 are required for TORC2 integrity; AVO2 is nonessential and may recruit substrates to 
TOR2 (Wullschleger et al., 2006). TORC1 also contains the subunit TCO89 a nonessential protein which 
was found to block glycerol uptake during osmotic stress when mutated. When Tco89 expression is 
knocked out/down, cells became hypersensitive to rapamycin suggesting a positive function in TORC1. 
1.3.4.2 Upstream and downstream regulators of TORC1 
In order for cells and organisms to integrate information from the environment with TORC1 and TORC2 
signalling, these stimuli are detected by various upstream regulators of cell growth. In mammalian 
cells, stimuli such as growth factors stimulate AKT which phosphorylates tuberous sclerosis complex 
(TSC). TSC is comprised of TSC1 and TSC2 which together act as a GTPase-activating protein (GAP) for 
the small GTPase Rheb (RAS homologue enriched in brain) so converting Rheb into its inactive state 
(GDP bound). Therefore growth factors inhibit TSC, promote Rheb which in turn activates mTORC1 
kinase activity. When glucose or intracellular energy (low ATP: ADP ratio) is low, this sensing inhibits 
mTORC1 directly by AMP-activated protein kinase (AMPK) which phosphorylates RAPTOR, and 
indirectly through TSC2. AMPK can also phosphorylate TSC2, reducing mTORC1 activity. TOR also 
balances energy metabolism/requirements by controlling mitochondrial genes. PGC1-α, a nuclear 
cofactor, plays a key role in mitochondrial biogenesis and oxidative metabolism, by directly altering 
its physical interaction with another transcription factor, yin-yang 1 (YY1) (Cunningham et al., 2007). 
The mechanisms by which amino acids are sensed and how this information is transmitted to mTORC1 
in mammalian cells is less clear. The amino acids Leu, Gln and Arg have been implicated in the 
activation of mTORC1, yet it is not known for certain where the amino acids are first detected (Jewell 
et al., 2013). In S.cerevisiae, nitrogen starvation and rapamcyin treatment cause a very similar 
responses suggesting TORC1 is regulated by the abundance of nitrogen. This nutrient signalling 
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cascade upstream of TORC1 at the vacuole (lysosome in mammals) where it is sensed by the EGO 
protein complex (Claudio De Virgilio and Loewith, 2006).   
In yeast, TOR signalling may also mediate some of the responses to glucose and almost certainly 
exhibits cross talk with the Ras/cAMP pathway (Bertram et al., 2002; Kuranda et al., 2006). During 
rapamycin treatment, the transcript levels of several genes induced by glucose decrease and a number 
of glucose-repressed genes are expressed to higher levels. It has been reported that 14-3-3 proteins 
(Bmh1/Bmh2) in the presence of glucose, interact with Yak1 (cAMP/PKA pathway) which is 
phosphorylated by PKA. When Yak1 is activated it phosphorylates Crf1, a transcriptional inhibitor of 
ribosomal genes (Moriya et al., 2001; Gancedo, 2008). 
TORC1 positively regulates protein synthesis by controlling translation initiation, expression and 
assembly of the translation machinery. It also has a role in mRNA turnover and regulates the activity 
of high affinity amino acid permeases such as NPR1 (seen with rapamycin treatment). eIF4E-binding 
proteins (4E-BPs) are prevented from binding and inhibiting eIF4E by phosphorylation through 
mTORC1 for protein synthesis to occur (Sonenberg and Hinnebusch, 2009). TORC1 directly and 
indirectly controls protein synthesis by phosphorylating eIF4G, but also phosphorylates the major 
kinase Sch9 (S6K in mammals) which is then able to phosphorylate eIF4B required for its interaction 
with eIF3 during initiation (see figure 1.3 earlier in chapter) (Proud, 2007). During elongation, TORC1 
(through S6K) keep eEF2K inactive, preventing phosphorylation of eEF2, yet when there is loss of 
TORC1 signalling, eEF2 becomes phosphorylated, slowing elongation (Proud, 2009). 
TOR is an important cell size regulator and increases translation of mRNA transcripts coding for 
ribosomal proteins and other translational regulators. In yeast it was found that mutation in Tap42 
inhibited polyribosome formation, and TPD3 (a subunit of PP2A) and SIT4 function upstream of RNA 
pol III and pol II respectively (van Zyl et al., 1992; Inoki et al., 2005). Several factors regulate ribosomal 
protein gene expression through TORC1. In yeast, FHL1 for example binds to ribosomal protein 
promoters, when CRF1 forms a complex, expression is suppressed. When FHL1 has formed a complex 
with IFH1, expression of ribosomal protein genes are still stimulated.  In the absence of these genes, 
SFP1, a transcription factor also regulates ribosomal protein genes. It is also known that TOCR1 
controls mRNA turnover as both nutrient limitation and rapamycin treatment result in enhanced 
turnover of some but not all mRNAs (Martin et al., 2004; C De Virgilio and Loewith, 2006a). 
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Figure 1.11 Simplified TORC1 pathway in yeast. Upstream and downstream regulators of TORC1 can 
be found in the cytoplasm and nucleus. Stimuli such as nutrients and amino acid signal through TORC1 
to other kinases leading to changes in transcription and translation. The green P indicates 
phosphorylation. Key above shows arrows representing interactions. Adapted from Smets et al., 2010.  
1.3.4.2.1 Sch9  
The protein kinase Sch9 (in yeast) is an important component of the TOR signalling pathway and plays 
a central role in nutrient-mediated signalling. Sch9 functions in both the cytoplasm and the nucleus. 
Loss of this kinase results in slow growth, reduced cell size and small colony formation.  
Overexpression of a component of the PKA pathway (CDC25, maintaining cAMP levels) suppresses 
these phenotypes (Toda et al., 1988; Hartley et al., 1994; Smets et al., 2010). Sch9p protein kinase is 
thought to work in parallel to RAS/cAMP/PKA signalling as they regulate common genes required for 
entry into the G0 phase regulated by Rim15 (Rohde et al., 2008). The regulation of Rim15 by 
phosphorylation of Sch9 was found to be dependent on TORC1 signalling as expected. Sch9 also 
independently regulates the effectors Msn2/4 and Gis1 explaining why Sch9 and TORC1 can have 
opposed effects to the expression of stress responsive genes (Urban et al., 2007; Wei et al., 2008; 
Smets et al., 2010) (see figure 1.11). 
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It is thought that Sch9 is subject to negative feedback control as it negatively regulates Sfp1 
(transcriptional activator of ribosomal biogenesis) which itself is activated by TORC1. Sch9p has also 
been implicated as a transcriptional regulator and is involved in osmotic stress associating with Sko1 
and Hog1 from the HOG pathway (Pascual-Ahuir and Proft, 2007; Smets et al., 2010). 
Sch9 belongs to the AGC kinase (protein kinase A/protein kinase G/protein kinase C) family where TOR 
targets the conserved hydrophobic motif located at the C-terminal tail. It was originally believed that 
protein kinase B (PKB/AKT) was the mammalian homologue due to its pronounced homology at the 
catalytic domain and C-terminus. Both PKB and Sch9 are activated by the TORC1 and the kinase PDK1 
(orthologs Pkh1 and Pkh2 in yeast). However, other work has shown that the TORC1 substrate S6K1 is 
more closely related to Sch9 with S6K1 also being regulated by TORC1 and performs similar functions. 
In yeast Sch9 is able to phosphorylate Rps6 (mammalian RPS6) regulating translation initiation as well 
as ribosomal biogenesis (Urban et al., 2007).  
1.3.4.3 Nutritional sensing of TORC1 via the EGO complex 
In yeast amino acids activate TORC1 through the conserved GTPases, Gtr1 and Gtr2. These form a 
heterodimeric complex which binds different forms of guanine nucleotides (Valbuena, Guan, 
&Moreno, 2012). In contrast, mammals have four RAG proteins, where RagA and RagB (Gtr1) share a 
similar sequence and are functionally redundant, and RagC and RagD (Gtr2) with a high sequence 
similarity and are functionally equivalent. These pairs form a heterodimer which is important for RAG 
protein stability as well as mTORC1 activation (Nakashima et al., 1996; Hirose et al., 1998; Jewell et 
al., 2013).  
 In S.cerevisiae, Vam6 (Vps39 in mammals) acts as a guanine exchange factor in order to activate Gtr1 
which then signals to TORC1. When Gtr1 is bound to GTP, and Gtr2 to GDP, this activates signalling to 
raptor, the subunit of TORC1. The role of Vam6 is not clear but in S.pombe a Vam6 mutant had 
numerous small vesicles which was thought to be due to lack of vacuolar fusion (Valbuena et al., 2012). 
Vam6 along other Vam proteins are required for the last step of vacuolar assembly where small 
vacuolar precursors fuse into a large vacuolar compartment which are important for the storage of 
primary and secondary metabolites (Nakamura et al., 1997; Binda et al., 2009). In mammalian cells 
however is believed that Ragulator, which is a pentameric complex is responsible for GEF activity and 
anchoring of the RAG proteins;  contains the components p18, p14, mp1, HBXIP and CForf59 (Bar-
Peled et al., 2012). 
Within the EGO complex, Gtr1 and Gtr2 are known to interact with the proteins Ego1 (also known as 
Gse2) and Ego3 (also known as Gse1). This complex localises to the endosomal and vacuolar 
membrane (Walsh, 2010b; Kogan et al., 2010) (Kogan et al., 2010) (see figure 1.12). The EGO complex 
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controls the exit from rapamycin-induced growth arrest and acts as the counterbalance of the 
rapamycin-induced, macroautophagy-mediated membrane influx towards the vacuolar membrane. 
This process is for the resumption of growth following rapamycin treatment (Dubouloz et al., 2005). 
Currently there is no homologue for Ego1 and Ego3 in mammalian cells. However, Ego3 was shown to 
closely resemble subunits of the complex containing MP1 and p14 which are also found in the mTOR 








Figure 1.12 The EGO complex in yeast and mammalian systems needed for amino acid sensing in the 
TORC1 pathway. This complex sits on the vacuole/lysosome. Once Gtr1 is GTP bound, it signals to Kog1 
in TORC1 for growth and protein synthesis. 
 
In S. pombe cells, Vam6 also co-localises with the GTR proteins at the vacuole membrane where amino 
acids in the medium stimulates the Gtr1-Gtr2 heterodimer to associate with Mip1 (KOG1 in yeast). 
When amino acid levels are sufficient and sensed by the EGO complex, TORC1 localises to the vacuole 
when Gtr1 is GTP bound, however it is unknown how TORC1 moves to the vacuole membrane (Bar-
Peled et al., 2012).  
The removal of amino acids or even leucine alone from the media inhibits TOR signalling in all 
eukaryotes. Cells respond to leucine as it is an essential branched chain amino acid and leucine 
starvation results in the accumulation of uncharged serine and threonine tRNAs as well as leucine 
tRNAs (Gallinetti et al., 2013) (Kim et al., 2013). In CHO cells, loss of amino acids results in rapid 
dephosphorylation of S6K (sch9) and 4E-BP1, yet adding back amino acids lacking leucine or arginine, 
reduces S6K activity by 90% or 70% respectively (Gallinetti et al., 2013). Glutamine plays an important 
role in growth and metabolism as it is a precursor for nucleotides and other amino acids (Durán et al., 
2012). However, glutamine is required for leucine to activate TOR as leucine regulates glutamate 
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hydrogenase (GDH), the second step involved in glutaminolysis producing α-ketoglutarate (KG) from 
glutamate. Conversely, if glutaminolysis was inhibited or there is a lack of glutamine, this effects the 
loading of GTP to RagB preventing localisation of TORC1 to the lysosome and inhibition of protein 
synthesis (Jewell and Guan, 2013). In yeast, uncharged tRNA are sensed by GCN2 which 
phosphorylates eIF2 preventing efficient translation initiation. This in turn evokes translation of 
specific mRNA’s such as GCN4, coding a transcription factor activating genes involved in amino acid 
synthesis (Bushman et al., 1993; Gallinetti et al., 2013; Engelberg et al., 2014).  
1.3.4.4 Autophagy is inhibited by TOR  
TORC1 signalling stimulates anabolic processes such as translation initiation, but also inhibits catabolic 
processes such as autophagy. Autophagy is under tight control depending on the cell’s energy and 
nutrition status and is necessary for the degradation and recycling of damaged or redundant proteins 
and organelles (Scott et al., 2007; Dunlop and Tee, 2013). Protein synthesis is a costly process with an 
estimated proportion of 30-40% of total ATP (and GTP) energy usage which is why autophagy is 
important for homeostasis of the cell (Hands et al., 2009)(Mizushima et al., 2008). Autophagy is a pro-
survival process as it is induced during ER stress, development, infection and diseases where there is 
accumulation of protein aggregates. There is cross talk between autophagy and apoptosis as these 
two pathways are regulated by common components as pro-apoptotic protein Bcl-2 inhibits Beclin 1 
disrupting its inhibitory interaction activating autophagy (Pattingre et al., 2005; Mizushima et al., 
2008). 
 There are three types of autophagy based on their mechanism and function, microautophagy where 
cytosolic components are sequestered directly by the lysosome, macroautophagy where for example 
organelles are sequestered by vesicle formation known as an autophagasome which can fuse to an 
endosome or lysosome producing hydrolases breaking down the contents. The last type, chaperone-
mediated autophagy (CMA) (only found in mammals) is needed for direct translocation of unfolded 
proteins which is undertaken in a selective matter (Sakai et al., 1998; Massey et al., 2004; Mizushima 
et al., 2008). 
It is known TOR negatively regulates autophagy as rapamycin treatment activates autophagy even 
when there are nutrients in the environment. During the initial stages of autophagy, TORC1 directly 
phosphorylates Atg1 (ULK1/2 in mammals) which when dephosphorylated forms a complex with 
Atg13; it is not yet fully understood how Atg1 is modulated (Y. Chen & Klionsky, 2011) . However, in 
mammalian cells and not yeast, the protein focal adhesion kinase family interacting protein of 200 kD 
(FIP200) was identified in 2008 as an ULK binding protein which forms part of the ATG13-ULK1/2 
complex and is needed for stability and phosphorylation of ULK1 (Hara et al., 2008). Autophagy 
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involves the action of more than 30 ATG proteins which were first identified in yeast, and which are 
largely conserved amongst eukaryotes (Zustiak et al., 2008; Dunlop and Tee, 2013). The intracellular 
endomembrane system including the ER, Golgi complex, plasma membrane and the lysosome (or 
vacuole in yeast) is maintained by dynamic membrane flow between compartments. This is in contrast 
to autophagy which employs a unique membrane rearrangement. Formation of a vesicle begins with 
nucleation of a core membrane termed the phagophore, in yeast this occurs at a peri-vacuolar location 
known as the phagophore assembly site (PAS). However in mammalian cells it is unclear where this 
site is, but has been observed between the cisternae of the ER (Yorimitsu and Klionsky, 2007). In 
mammalian cells the two complexes, ULK1-ATG13-FIP200 complex and Beclin-Vps34 complex function 
to produce the phagophore membrane (initial phase of autophagosome formation) (Mizushima et al., 
2003; Dunlop and Tee, 2013).  
TOR is not the only pathway controlling autophagy, the PKA pathway is also implicated in its control 
as elevated levels of PKA activity inhibit autophagy. In S.cerevisiae it was discovered that Atg1/Atg13 
complex serves as an important point of signal interaction between these pathways as these may 
respond to distinct cues from different types of starvation (Stephan et al., 2014). These are more 
examples of how different signalling pathways cross talk for the most effective cellular responses to 
nutrition and stress in the environment.  
 
 
1.4 Research objectives of the PhD project 
 
In this project, the focus was on exploiting yeast and CHO systems in the development of screening 
strategies to select for cell lines with genetic alterations that may improve rP production. A major aim 
of the project was also to investigate how upstream and downstream regulators of TOR can be 
manipulated to influence rP production and secretion using yeast and CHO cells.  To achieve this, a 
secreted Gaussia luciferase (GLuc) protein was used as a reporter of recombinant protein synthesis in 
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1. To develop screening strategies for investigate changes to recombinant protein production 
in yeast  
A yeast model system for investigating recombinant protein production was developed using 
a plasmid constructed at The University of Kent containing Gaussia luciferase (GLuc). The GLuc 
assay was utilised to develop a screen where GLuc oxidises a substrate, emitting light which 
can be measured as an assessment of protein level and activity. Detection and quantification 
of Gluc expression was also assessed by western blotting. As an alternative we employed a 
second yeast secretion system that monitors the release of a killer toxin. 
 
2. Characterisation of TOR and MAPK signalling in relation to the protein cofilin in yeast 
Cell biological and biochemical methods were used to assess the activity of TOR and MAPK 
signalling pathways which impact on protein synthesis in response to mutations in the protein 
cofilin and how these impact upon rP production in yeast. In addition, this objective set out to 
determine whether mitochondrial function was linked to rP production in yeast. 
 
3. To analyse changes in TOR signalling for altered protein production through screening 
methods in yeast 
Through cell engineering, to investigate how manipulation of upstream and downstream 
regulators of TOR can either enhance or perturb recombinant protein synthesis.  A variety of 
screening techniques using yeast strains deleted for individual genes within the TOR signalling 
network were investigated to identify key targets for manipulation of TOR signalling that may 
affect rP production 
 
4. To establish whether the effects of manipulation of TOR signalling in yeast can be translated 
into the CHO cell expression systems 
TOR is a highly conserved pathway across all eukaryotes. Under this objective it was envisaged 
to knock down homologous TOR signalling components within the CHO system that were 
identified as important in yeast using RNAi and determine the influence on recombinant 
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2.1 Yeast Strains, E. coli Strains, Mammalian Cell Lines and DNA 
2.1.1 Strains 
The strains of yeast and their source used throughout this study are described in Table 2.1.1 and 
2.1.2 below. 
2.1.1.1 Yeast strains 
Table 2.1.1 Cofilin strains expressing mutant alleles.   
Strain Genotype allele Source/Reference 
CGY384 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
COF1::LEU2 
COF1 Lappalainen et al , 1997 
CGY385 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-4::LEU2 
cof1-4 Lappalainen et al , 1997 
CGY386 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-5::LEU2 
cof1-5 Lappalainen et al , 1997 
CGY387 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-6::LEU2 
cof1-6 Lappalainen et al , 1997 
CGY388 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-7::LEU2 
cof1-7 Lappalainen et al , 1997 
CGY389 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof-10::LEU2 
cof1-10 Lappalainen et al , 1997 
CGY390 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof-8::LEU2 
Cof1-8 Lappalainen et al , 1997 
CGY391 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-11::LEU2 
cof1-11 Lappalainen et al , 1997 
CGY392 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-12::LEU2 
cof1-12 Lappalainen et al , 1997 
CGY393 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-13::LEU2 
cof1-13 Lappalainen et al , 1997 
CGY394 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-15::LEU2 
cof1-15 Lappalainen et al , 1997 
CGY395 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-18::LEU2 
cof1-18 Lappalainen et al , 1997 
CGY396 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-19::LEU2 
cof1-19 Lappalainen et al , 1997 
CGY397 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-21::LEU2 
cof1-21 Lappalainen et al , 1997 
CGY398 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-22::LEU2 
cof1-22 Lappalainen et al , 1997 
CGY992 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
COF1::LEU2 
Δpdr1::His 
COF1 This study 
CGY993 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-11::LEU2 
Δpdr1::His 
cof1-11 This study 
CGY994 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-12::LEU2 
Δpdr1::His 
cof1-12 This study 
CGY995 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-15::LEU2 
cof1-15 This study 
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Δpdr1::His 
CGY996 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-18::LEU2 
Δpdr1::His 
cof1-18 This study 
CGY998 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
COF1::LEU2 ΔSTE12::His 
COF1 This study 
CGY999 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-4::LEU2 ΔSTE12::His 
cof1-4 This study 
CGY1000 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-6::LEU2 ΔSTE12::His 
cof1-6 This study 
CGY1001 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-7::LEU2 ΔSTE12::His 
cof1-7 This study 
CGY1002 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-11::LEU2 ΔSTE12::His 
cof1-11 This study 
CGY1003 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-12::LEU2 ΔSTE12::His 
cof1-12 This study 
CGY1004 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-18::LEU2 ΔSTE12::His 
cof1-18 This study 
CGY1005 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-19::LEU2 ΔSTE12::His 
cof1-19 This study 
CGY1006 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-21::LEU2 ΔSTE12::His 
cof1-21 This study 
CGY1007 Matα ura3-52 his3Δ200 leu2-3,112 lys2-801 ade2-101 
cof1-22::LEU2 ΔSTE12::His 
cof1-22 This study 
 
Table 2.1.2 Strains used in this study. *Yeast Mat a Collection was made by the EUROpean 
Saccharomyces Cerevisiae Archive for Functional analysis (EUROSCARF) and purchased from Open 
Biosystems. 
 Strain Genotype Source/Reference 
BY4741 Mata his3∆0, leu2∆0, met15∆0 
ura3∆0 
CWG collection 
∆Atg1 BY4741 atg1::KANMX Mat a knockout collection* 
∆Atg13 BY4741 atg13::KANMX Mat a knockout collection* 
∆Gis1 BY4741 gis1::KANMX Mat a knockout collection* 
∆Gln3 BY4741 gln3::KANMX Mat a knockout collection* 
∆Gtr1 BY4741 gtr1::KANMX Mat a knockout collection* 
∆Gtr2 BY4741 gtr2::KANMX Mat a knockout collection* 
∆Hog1 BY4741 hog1::KANMX Mat a knockout collection* 
∆Msn2 BY4741 msn2::KANMX Mat a knockout collection* 
∆Msn4 BY4741 msn4::KANMX Mat a knockout collection* 
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∆Pkh1 BY4741 pkh1::KANMX Mat a knockout collection* 
∆Pkh2 BY4741 pkh2::KANMX Mat a knockout collection* 
∆PDR1 BY4741 pdr1::KANMX Mat a knockout collection* 
∆PDR3 BY4741 pdr3::KANMX Mat a knockout collection* 
∆PDR5 BY4741 pdr5::KANMX Mat a knockout collection* 
∆PDR8 BY4741 pdr8::KANMX Mat a knockout collection* 
∆PDR10 BY4741 pdr10::KANMX Mat a knockout collection* 
∆PDR11 BY4741 pdr11::KANMX Mat a knockout collection* 
∆PDR12 BY4741 pdr12::KANMX Mat a knockout collection* 
∆PDR15 BY4741 pdr15::KANMX Mat a knockout collection* 
∆PDR18 BY4741 pdr18::KANMX Mat a knockout collection* 
∆Pkh1 BY4741 pkh1::KANMX Mat a knockout collection* 
∆Pkh2 BY4741 pkh2::KANMX Mat a knockout collection* 
∆Rps6A BY4741 rps6A::KANMX Mat a knockout collection* 
∆Rps6B BY4741 rps6B::KANMX Mat a knockout collection* 
∆Rtg1 BY4741 rtg1::KANMX Mat a knockout collection* 
∆Rtg3 BY4741 rtg3::KANMX Mat a knockout collection* 
∆Sfp1 BY4741 sfp1::KANMX Mat a knockout collection* 
∆Sit4 BY4741 sit4::KANMX Mat a knockout collection* 
SNQ2 BY4741 snq2::KANMX Mat a knockout collection* 
∆Tco89 BY4741 tco89::KANMX Mat a knockout collection* 
∆Vam6 BY4741 vam6::KANMX Mat a knockout collection* 
∆YOR1 BY4741 yor1::KANMX Mat a knockout collection* 
∆YRR1 BY4741 yrr1::KANMX Mat a knockout collection* 
S7 (dsRNA-) sensitive strain to K1 
toxin 
Oliver et al, 1977 
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2.1.1.2. Mammalian Cell Lines 
The mammalian CHO cell line engineered to stably express the GLuc reporter gene is described in 
table 2.2 below. 
Table 2.2 CHO cell lines used in this study 
Cell Line Genotype  Source  
CHOK1-GLuc CHO Flip-in GLuc FRT, hygromycin Invitrogen 
2.1.1.3 E.coli strains 
The strain of E.coli and variations used throughout this study are described in table 2.3 below. 
Table 2.3 E.coli stains used in this study. 
Strain  
DH5α F- deoR endA1 recA1 relA1 gyrA96 hsdT17(rk- mk+) 





The plasmids used throughout this study and their source are described in detail in tables 2.4 and 2.5 
below. 
2.1.2.1.1 Yeast Plasmids 
 
Table 2.4 Plasmids used in yeast in this study 
Name  Description  Reference  
pAG415 pAG415GPD-ccdB, Gateway expression vector, CEN, LEU, Invitrogen 
pCG226 pUG27, HIS3 LoxP template KO cassette (Gueldener et al., 2002) 
pCG394 BHUM212 FRE::CYC1::LacZ, Ste12p activity vector (Mösch et al., 1999) 
pCG483 pRS416- Sch9-5HA, URA (Urban et al., 2007) 
pCG495 pBevy-U-gluc1 Smales Lab 
pCG528 VAM6 Donar entry vectors(pDONR221) PlasmID 
pCG529 TCO89 Donar entry vectors(pDONR221 PlasmID 
pCG530 GTR1 Donar entry vectors(pDONR221 PlasmID 
pCG531 GTR2 Donar entry vectors(pDONR221 PlasmID 
pCG532 ATG1 Donar entry vectors(pDONR221 PlasmID 
pCG543 pAG415GPD-ccdB+VAM6 CEN LEU This study 
pCG545 pAG415GPD-ccdB+ TCO89 CEN LEU This study 
pCG546 pAG415GPD-ccdB+ GTR1 CEN LEU This study 
pCG547 pAG415GPD-ccdB+ GTR2 CEN LEU This study 
pCG548 pAG415GPD-ccdB+ ATG1 CEN LEU This study 
pCG556 pVT100U-KT, 2µ,URA (Zhu and Bussey, 1991) 
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Figure 2.1.1 pCG495 containing the Gaussia luciferase gene with the alpha factor signal sequence. 
 
 
Figure 2.1.2 pAG415 is a destination vector used in the Gateway cloning to create overexpression 
plasmids used in chapter 5. 
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2.1.2.1.2 Mammalian Plasmids 
 
Table 2.5 Plasmids used in CHO cell lines. 
Name  Description  Reference  
pGene clip pGeneClip Puromycin Promega 
     
 
                                  
Figure 2.2 pGeneClipTM Puromycin vector used for knocking down mammalian genes once ligated to 
hairpin oligonucleotides targeting a specific gene. Oligonucleotides were used from table 2.6. 
 
 
2.1.2.2 Oligonucleotide Primers 
The primers used throughout this study are described in tables 2.6 and 2.7 below. All primers were 
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2.1.2.2.1 Yeast Oligonucleotide Primers 
Table 2.6 Yeast Oligonucleotides used in chapter 4 and 5. 
Primer  Sequence 5’3’  
PDR1 LoxP Knock out Forward ATGCGAGGCTTGACACCTAAGAACGGTGTACATATTGA
GACGGGCAGTTGAAGCTTCGTACGC 
PDR1 LoxP Knock out Reverse TTAACTATCTGGATAAACGTCGCTCCACAGGATACTGTA
GAGGTCGCATAGGCCACTAGTGGATCTG 
VAM6 Forward GAACGCATGTCATCGTATGG 
VAM6 Reverse TATTTCTGCCTTCCCTGGTG 
TCO89 Forward TGCAAGTGCAAAGATTCAGG 
TCO89 Reverse CGTGCATTCTGTGAAGCAGT 
GTR1 Forward TGCCACCATTGATGTAGAGC 
GTR1 Reverse TAACACCTGCACCATCTGGA 
GTR2 Forward TAATGCAACGGACAGGTGAA 
GTR2 Reverse GCTCCGGTATCAGTTTCTGC 
ATG1 Forward CCCCACCGTACAGTCAAACT 
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2.1.2.2.2. Mammalian Oligonucleotide Primers 
 
Table 2.7 Mammalian primers used for qRT-PCR and oligonucleotides used in cloning to create hairpin 
inserts (see figure 2.1), for knocking down specific genes in chapter 6 once ligated to the pGeneClipTM 
Puromycin vector. 
Primer  Sequence 5’3’  
Scrambled ULK1 Hairpin Forward (control) 
TCTCGTACCTACGATATTACGGTGCGGCTTCCTGTCACC
GCACCGTAATATCGTAGGTACCCT 
Scrambled ULK1 Hairpin Reverse (control) 
CTGCAGGTACCTACGATATTACGGTGCGGTGACAGGAA
GCCGCACCGTAATATCGTAGGTACC 
ULK1 Hairpin Forward 
TCTCGCCTGGTTATGGAGTACTGCAACCTTCCTGTCAGT
TGCAGTACTCCATAACCAGGCCT 
ULK1 Hairpin Reverse 
CTGCAGGCCTGGTTATGGAGTACTGCAACTGACAGGAA
GGTTGCAGTACTCCATAACCAGGC 
Vps39 Hairpin Forward 
TCTCGCATGGTGTGTAAGAAGAAGATCTTCCTGTCAATC
TTCTTCTTACACACCATGCCT 
Vps39 Hairpin Reverse 
CTGCAGGCATGGTGTGTAAGAAGAAGATTGACAGGAA
GATCTTCTTCTTACACACCATGC 
RagC Hairpin Forward 
TCTCGGACTTCACATTACTGTTTCTACTTCCTGTCATAGA
AACAGTAATGTGAAGCCCT 
RagC Hairpin Reverse 
CTGCAGGGCTTCACATTACTGTTTCTATGACAGGAAGTA
GAAACAGTAATGTGAAGTCC 
RagD Hairpin Forward 
TCTCGCGGCAAGTCGTCTATTCAGAACTTCCTGTCATTCT
GAATAGACGACTTGCCGCCT 
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2.2 Growth conditions for Escherichia coli, Saccharomyces cerevisiae and 
CHOK1 cells 
 
2.2.1 Growth of S.cerevisiae 
2.2.1.1 Yeast Extract-Peptone-Dextrose (YPD) 
To prepare YP, 2% w/v glucose ; 1% w/v yeast extract (Difco), 2% w/v peptone (Difco), 2% w/v agar 
(Difco) for solid media.  
2.2.1.2 Synthetic minimal without amino acids (synthetic minimal selective medium) 
This requires 0.67% w/v Yeast Nitrogen Base without Amino Acids (Sigma), for solid media add 1% 
Agar w/v (Difco), 2% w/v glucose and Yeast Synthetic Complete Drop-out Media Supplement (Sigma) 
added to manufacturers’ guidelines.  
2.2.2 Growth of E.coli  
2.2.2.1 YT 
This requires 1% w/v yeast extract (Difco), 6 g Trypton (Difco), 0.5% w/v NaCl (Fisher) and add 1% w/v 
agar for solid media. Once cooled to 50°C, antibiotics such as ampicillin (10 µl/ml) can be added.  
2.3 Tissue culture techniques 
 
2.3.1 Maintenance of cell lines 
2.3.1.1 Routine maintenance of cell lines 
Adherent CHO-K1 Flip-in cell lines were maintained in F12 media in flat T flasks (T25, T75 and T175; 
Starstedt). The F12 HAM (Gibco) also contained 6 mM L-glutamine, 10 ug/ml Hygromycin and 10% 
Heat inactivated foetal bovine serum (FBS) (Lonza). Cells were grown at 37°C in 5% CO2 atmosphere. 
All cells were passaged at 70% confluence. The cells were washed with 1xPBS (Oxoid) and detached 
using 0.25% trypsin which was left at 37°C for up to 5 minutes. To inactivate the trypsin once the cells 
have detached, serum containing medium was added.  Adherent cells were cultured in vented flasks 
(Sarstedt) and welled plates (CELLSTAR, Grenier Bio-one). 
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2.3.1.2 Cryopreservation and recovery of cells 
Cells in exponential phase of growth were washed in PBS and treated with 0.25% trypsin. These were 
then centrifuged at 1000 rpm for 5 minutes and resuspended in media containing 10% dimethyl 
sulfomine (DMSO, Sigma-Aldrich). Cryotubes were frozen at -80°C overnight then transferred to liquid 
nitrogen.  
To revive cells, the cells were warmed to 37°C to thaw and then 9 ml of media (at 37°C) added. Next 
the cells were centrifuged again at 1000 rpm for 5 minutes, and the pellet resuspended in 1 ml of 
media. This was transferred to a T25 flask containing 9 ml of media. 
 
2.3.2 Transient expression of plasmids  
In a 6 well plate, cells were seeded at 5x105 viable cells per ml of growth media. 24 hours later cells 
were washed and new media added. For each transfection, 1 µg of DNA was mixed with 250 µl of 
Optimum (Invitrogen), and in another tube 12 µl of lipofectamine 2000 (Invitrogen) was mixed with 
250 µl Optimum. These were left for 5 minutes at RT then mixed and incubated for 20 minutes at RT. 
500 µl of this mixture was added to the well and incubated at 37°C for 4 hours, after which the media 
was changed.  
 
2.4 Yeast Genetic techniques 
 
2.4.1 Yeast transformations by heat shock 
With exogenous DNA, yeast cells were grown overnight and 1 ml of the culture was pelleted in a table-
top centrifuge for 4 minutes at 3000 rpm. After the supernatant was removed, the cells were 
resuspended in 1 ml of TE buffer (pH 9), and then pelleted and the supernatant removed again. The 
cells were then re-suspended in 0.1 ml of 0.1 M lithium acetate (LiOAc) in TE. Next, 15 µl of carrier 
DNA was added (10 mg/ml single stranded DNA) followed by 1-2 µl of the transforming DNA and mixed 
gently. 700 µl of 40% PEG4000 (in 0.1 M LiOAc in TE) was added and the sample incubated with 
rotation for at least an hour on a roller. Next, the samples were incubated for 15 minutes at 42°C. 
After this time, the samples were centrifuged and the pellet resuspended in 200 µl of sterile H2O and 
plated on selective agar. These plates were left to grow at 30°C. 
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2.4.2 Generation of LoxP marker cassettes for yeast gene knock outs 
A gene disruption cassette can be used to delete a specific gene in budding yeast. This gene disruption 
cassette contains a selection marker gene (for example HIS3) which is flanked by two loxP sequences 
which are adjacent to the 45 bp of sequence flanking the gene you wish to delete. PCR can be used to 
amplify the cassette by using oligonucleotides that incorporate 19 or 22 3’ nucleotides complementary 
to the loxP sequence flanking the marker and to the sequences in the template flanking the disruption 
cassette and then 45 5’ nucleotides that anneal with sites upstream and downstream of the target 
sequence. Once this disruption cassette is ready, it is purified using the phenol/chloroform extraction 
method in section 2.5.4. This cassette was then transformed into the cells and checked using PCR for 
the correct integration of the disruption cassette. For this, primers are used that are complementary 
to the sequences in the cassette as well as one complementary to the sequence within the target 
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2.4.3 Generation of petite ρ0 (rho) yeast strains 
This method was undertaken to create yeast without mitochondrial DNA. The cells were grown in 
liquid YPD medium overnight containing sterile ethidium bromide (EtBr) at 25 µg/ml. These cells were 
taken from cells grown on YPD agar. The following day, a fresh culture was inoculated using the 
overnight cells in YPD containing EtBr at the same concentration as before. These cells were left to 
grow overnight until they have reached saturation. 10-20 µl was streaked out on YPD agar. 
 
2.5 Molecular biology techniques 
 
2.5.1 Miniprep purification of DNA 
This process used 1 ml of overnight cultures of bacterial strains containing the plasmid DNA required. 
The purification of plasmid DNA was achieved using the Quiagen Qiaprep® Miniprep kit where the cell 
lysate was placed in the silica spin column following the instructions provided by the manufacturer. A 
number of buffers with high salt concentrations were used so the DNA absorbs into the silica matrix 
but remaining contaminants in the lysate were passed through the column and removed. The DNA 
that was bound was washed with an ethanol mixture followed by elution of the DNA through the 
column (refer to Qiagen’s Qiaprep® Miniprep kit handbook for more information.) 
2.5.2 Polymerase Chain Reaction (PCR) 
PCR reactions are used to amplify specific DNA sequences such as the HIS deletion cassette. The 
essential components for this reaction include a DNA polymerase enzyme (such as Taq from Roche), 
nucleotides, a DNA template and oligonucleotides (these are all described in Tables 2.8). Using a 
Thermocycler, the reactions can take place at specific temperatures for exact periods of time. This 
reaction amplifies DNA by using DNA polymerase enzyme which will generate single stranded DNA 
from the 5’ to 3’ ends where the primers indicate the specific starting point. The changes in 
temperature lead to elongation, annealing and denaturation of the DNA. This produces templates 
which will then generate more fragments correlating to the primer nucleotides that were on the 
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Table 2.8 The reaction mixture contained the following reagents to make 25 ul reaction tube: 
Reagents Volume 
10x PCR buffer (Invitrogen) 2.5 µl 
10 mM primer 0.5 µl 
10 mM dNTPs (Invitrogen) 0.5 µl 
~1 µg template DNA variable volume 
Taq DNA polymerase (5units/µl) (Invitrogen) 0.125 µl 
nuclease free water Make up to 25 µl 
 
An example of the programme used for the thermocycler is shown in Table 2.9 below: 
Table 2.9 Temperatures and timing of each step in PCR. 
95°C for 3 minutes Initial Denaturation step of template 
95°C for 30 seconds 
54°C (varies depending on primers) for 1 min 
72°C for 2 minutes 
Short Denaturation              Repeat cycle 
Annealing                                       30x 
Elongation 
72°C for 10 min Final Elongation 
 
2.5.3 Agarose Gel electrophoresis Analysis of DNA 
 
Agarose gel electrophoresis was used to separate and analyse various DNA fragments and plasmids 
by size. The gel was made up of 1% (w/v) agarose (Melford) in TAE buffer. Reagents for TAE buffer 
include 40 mM tris, 1 mM EDTA and 20 mM Acetic acid, pH 8.5). 
The agarose-TAE mixture was placed in the microwave at full power for 1-2 minutes to dissolve the 
agarose. Once this has cooled, 0.5 µl of a 10 mg/ml ethidium bromide (EtBr) solution was added to 35 
ml of agarose solution and mixed. This mixture was then poured into a casting apparatus to form a gel 
with the comb. After the gel was set it was placed in an electrophoresis tank. The gel was submerged 
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in TAE making sure it covered the electrodes on each end of the tank; this was then ready for the 
samples to be loaded. Each sample was mixed with 5-7 µl of the concentrated DNA with 0.5-1 µl of 6x 
sample loading dye (Promega, G190A) and then pipetted into a well. A 1 kb DNA ladder (Promega, 
G571A) as a DNA standard was run alongside the samples. The samples were usually run for 20 
minutes at 120 volts or until the dye had migrated to the bottom of the gel. Once the gel was run, the 
fluorescence of the samples and ladder were observed on a short wave transilluminator (312 nm) and 
an image generated by a digital camera. 
 
2.5.4 Phenol chloroform purification of DNA 
A phenol/chloroform extraction method was used to purify the PCR product of the HIS knock out 
cassette. This method separates materials (i.e. proteins and DNA from generation of DNA cassettes 
through PCR) in an organic (i.e. phenol chloroform) and inorganic phase. First, equal volumes of buffer-
saturated phenol:chloroform (1:1) were added to the same volume of DNA and vortexed, followed by 
3 minutes in a table-top centrifuge at maximum speed. Next, the aqueous layer was carefully removed 
and transferred to a new microcentifuge tube (spin again if not all the aqueous layer is removed). An 
ethanol precipitation method was used to concentrate the DNA further by adding 3 volumes of 
ethanol (100%) to the DNA sample which was then incubated at -20°C overnight for full precipitation. 
To extract the precipitated DNA the tube was spun for 10 minutes in a table-top centrifuge at full 
speed. The supernatant was discarded, and the DNA pellet formed was washed with 70% ethanol 
solution and spun down again (10 minutes at full speed). After the pellet was left to air dry, it was re-
suspended in 20 µl of TE buffer at pH8. 
 
2.5.5 E.coli competent cells 
DH5α cells were grown overnight in 10 ml broth in a shake flask for aeration. The next day 8 µl of the 
culture was used to inoculate 28 ml of broth and growth with aeration at 37oC. After approximately 
4.5 hours, the culture reaches an OD600 of approximately 0.5. Five minutes before the culture reaches 
this cell density, 3.75 ml of sterile warm 100% glycerol was added slowly. The cells were then chilled 
on ice for 10 minutes and then pelleted at 4°C for 10 minutes at 4000 rpm. Next, the supernatant was 
poured off and the cells resuspended in an equal volume of ice-cold 0.1 M MgCl2 plus glycerol (0.1 M 
MgCl2 and 15% glycerol). The cells were then pelleted at 4°C for 8 minutes at 3800 rpm and the 
supernatant removed. The cells were then resuspended in 6.25 ml of ice-cold T-salts (0.075 M CaCl2, 
0.006 M MgCl2 and 15% glycerol) and incubated on ice for 20 minutes with occasional mixing. This 
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then centrifuged at 4°C for 6 minutes at 3600 rpm and resuspended in 1.25 ml of T-salts. This can be 
stored at -80°C. This must be left to freeze overnight before use. 
 
2.5.6 E.coli transformation 
50 µl of competent cells were first thawed on ice before adding 1 µg of DNA. This mixture was 
incubated for 30 minutes on ice followed by heat shock for 30 seconds at 42°C. 450 µl of YT media was 
added and incubated at 37°C with shaking. This was then plated onto YT agar plates. 10 µg/ml of 
Ampicilian was used for plasmid selection. 
 
2.6 Protein analysis techniques 
 
2.6.1 Polyacrylamide Gel Electrophoresis (PAGE) 
2.6.1.1 Preparation of protein samples 
2.6.1.1.1 Yeast whole cell extract method 
Cells were gown overnight in media. The next day samples were diluted to the same cell density. 200 
µl of the culture were pelleted at 4000 rpm for 3 minutes using a table-top centrifuge. After the 
supernatant was removed, about 100 µl of glass beads were added and mixed. 25 µl of 2x sample 
buffer (2.5 ml of 0.5 M Tris pH6.8, 2 ml 10% SDS, 2 ml ddH2O, 1 ml β-mercaptoethanol, 0.5 ml 
Bromophenol blue) were then added and vortexed for about 2 minutes. Next, the samples were boiled 
for 3 minutes after which 100 µl of 2x sample buffer was added once again and vortex. The samples 
can then be used immediately or stored at -20°C. 
2.6.1.1.2 Urea-TCA protein extraction for Sch9 analysis 
Due to the large size of the protein Sch9 (~100 kDa) and the presence of multiple phosphorylation 
sites, a separate protocol was used for the protein extraction using NTCB (2-nitro-5-
thiocyanatobenzoic acid) which selectively cyanylates cysteine residues allowing analysis of smaller 
fragments. This method was taken from Soulard et al., 2007. The method was used to extract protein 
from cells in log phase and post-diauxic shift. Cells were grown in overnight culture and the following 
morning 1 ml of the culture was re-inoculated into 10 ml of media; these cells grew into log phase 
after 3-5 hours. The remaining overnight culture was diluted to an OD600 of about 0.3 and left to grow 
for 24 hours before protein extraction.  
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For the protein extraction, 1 ml of the cells was used at an OD600 of 0.8-1 for each sample. Some 
samples were left to grow at 30°C in 200 ng/ml of rapamycin for 30 minutes. After this time, 66 µl of 
TCA (100%) was added and then put on ice for at least 10 minutes. The samples were then spun at 
13000 rpm and the supernatant discarded. The cells were washed in 200 ul of cold acetone, sonicated 
for 30 seconds and spun quickly in a tabletop centrifuge at high speed. After the supernatant was 
discarded, the cells were washed in acetone again, spun down, and dried in a speed vac for 5 minutes 
at about 60°C. The pellet was re-suspended using 10 µl of the urea buffer (50 mM Tris-HCL pH7.5, 5 
mM EDTA, 6 M urea, 1% (w/v) SDS, 1 mM PMSF, 10 mM Phosphatase inhibitors (Sodium flouride, β-
Glycerophosphate disodium salt hydrate, Sodium pyrophosphate and Sodium orthovanadate )) and 
glass beads added up to the liquid surface. However only add PMSF and PPi just before use. Cells were 
lysed in the bead beater for three rounds of 10 seconds in between 60 second pauses. Next, to remove 
the bubbles, the samples were spun in the table-top centrifuge for 5 minutes followed by 10 minute 
incubation at 65°C. 3 µl of 0.5 M CHES (N-cyclohexyl-2-aminoethansufonic acid) and 2 µl of 7.5 mM 
NTCB was added and each sample was vortexed. After the samples were left at room temperature 
overnight, 15 µl of 2x Laemmli Buffer (100 mM Tris-HCL pH 6.8, 4% SDS, 20% glycerol, 0.02% 
Bromophenol Blue, 200 mM DTT) was added and the samples boiled for 10 minutes at 65°C.  These 
samples were then run on a 7.5% acrylamide gel. 
2.6.1.1.3 Yeast whole cell quantitative method 
This method was taken from Von der Haar, 2007. Cells were grown overnight in minimal media and 
inoculated the following day in YPD and grown to a cell count of 1x107.  If supernatant was needed, 
500 µl of the sample was added to 500 µl of sample buffer and vortexed. Pellet samples were spun 
down for 2 minutes at high speed and harvested followed by re-suspension in 200 µl of Lysis Buffer 
(0.1 NaOH, 0.05 M EDTA, 2% SDA, 2% β-mercaptoethanol). The samples were then incubated for 10 
minutes at 90°C with 50 µl of loading buffer (0.25 M Tris-HCL pH 6.8, 50% glycerol, 0.05% Bromophenol 
Blue). Next the samples were centrifuged to clear the lysate and the extract loaded onto the gel or 
frozen at -20°C for future use.  
2.6.1.1.4 Mammalian cell lysis 
Cells are grown in 24 well plates (Greiner) to >70% confluence then the media removed. If the 
supernatant was needed, 1 ml was retained and 200 µl of lysis buffer added and placed immediately 
on ice. The cells were washed with PBS to wash off any excess media. 400 µl of 0.25% trypsin solution 
was then added and left at 37°C for up to 5 minutes until all the cells became dislodged from the 
surface. Next, 800 µl of media was added. 500 µl was put in a tube and spun down for 2 minutes at 
high speed and the supernatant removed. The pellet was resuspended in 200 µl of lysis buffer and left 
on ice for 5 minutes before stored at -80°C. 
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500ml of Lysis buffer contained 200 mM HEPES pH 7.2, 100 mM NaCl, 1% TX 100 and 10 mM Na β-
glycerophoshate. Phosphatase and protease inhibitors were added to an aliquot of lysis buffer when 
needed. For 10 ml Lysis Buffer with inhibitors, 50 mM NaF, 1 mMNa-Vanidate (New England Biolabs) 
and 1 EDTA-free protease inhibitor tablet (Roche) were added. 
2.6.1.1.5 Determination of protein concentration using the Bradford assay 
The concentration of proteins in soluble extracts was determined using the commercial Bradford 
reagent (Biorad). 2 µl of protein sample was added to 48 µl of dH2O and 1 ml of Bradford reagent 
added, vortexed, and left for 10 minutes. The sample was then read at A595 nm and the concentrations 
of samples determined with comparisons to known concentrations in a standard curve generated 
using known amounts of bovine serum albumin (BSA). 
2.6.1.2 Preparation of polyacrylamide gel 
The polyacrylamide gels used had a 5% acrylamide stacking gel on top (see makeup below) and a 
resolving gel on the bottom that can have varied concentrations between 7.5%-15% acrylamide. The 
resolving gel mixture was poured into the BioRad cast system and covered with isopropanol for the 
gel to polymerise correctly. When the gel was polymerised and the isopropanol poured out, the 
stacking gel was poured on top of the resolving cell and a comb placed on top for the sample wells to 
form as the gel sets. The reagents and solutions required are described in the table 2.10 below. 
Table 2.10 Reagents of acrylamide gels. Columns show varied percentage of acrylamide used, gel size 
9x9cm. 
Solution 7.5% 10% 12.5% 15% 5% (Stacking 
only) 
Acrylamide 40% 1.5 2.0 2.5 3.0 0.375 
1.5 M Tris (pH 8.8), 
containing 0.4% SDS 
2.0 2.0 2.0 2.0  
0.5 M Tris (pH 6.8), 
containing 0.4% SDS 
    0.75 
dH2O 4.5 4.0 3.5 3.0 1.875 
TEMED     (l) 5 5 5 5 3.5 
10% APS   (l) 35 35 35 35 35 
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2.6.1.3 Polyacrylamide gel electrophoresis protocol 
When the gel had polymerised, it was ready for electrophoresis. The gels were placed in the 
electrophoresis tank and immersed in Tris/Glycine/SDS buffer (TGS). After 5 µl of the protein ladder 
and 10-20 µl of samples where loaded the gels were run with a voltage at 90 V until the tracking dye 
had run through the stacking gel and entered the resolving gel, at this point the voltage was increased 
to 120 V. The samples took between 2 and 2.5 hours to run. The gels were stained with Coomassie 
Blue to visualise the proteins present on the gel or used for the next step of a western blot as described 
below. 
 
2.6.2 Western Blot 
The western blot procedure consisted of a semi-dry transfer onto a PVDF membrane and then the 
immunoblotting procedure for binding antibodies to the protein on the membrane which can then be 
detected using Chemiluminescence (ECL). 
2.6.2.1 Semi-dry protein transfer 
Initially the PVDF membrane was soaked thoroughly in methanol and then left to soak in transfer 
buffer (0.0029% w/v Glycine, 0.00004% w/v SDS, 0.0058% w/v Tris Base, 20% v/v methanol ) for 10-
15 minutes. On the bottom electrode of the Bio-Rad semi-transfer apparatus, a piece of thick blotting 
paper soaked in transfer buffer was placed first, taking care that any air bubbles were rolled out. Next 
the PVDF was placed neatly on top of the blotting paper, and then the gel on top of that. The next 
layer placed was again a piece of thick blotting paper soaked in transfer buffer. Once this was done 
then the top electrode can be placed on the apparatus and connected to the power supply. This was 
run at 25 V for 15-30 minutes per membrane. Once transferred the membrane was ready for the 
immunoblotting procedure. 
2.6.2.2 Immunoblotting 
Once the transfer was complete, the membrane was placed in blocking solution (5% w/v dried 
skimmed Milk in PBS/T containing Phosphate Buffered Saline with 0.2% Tween 20) and shaken for 45 
minutes at room temperature. Next the membrane was washed in PBS/T and placed in a 50 ml falcon 
tube with 3-20 ml blocking solution containing the desired concentration of primary antibody and left 
on a roller for an hour at room temperature (it can be left at 4°C overnight on the roller). The 
membrane was then rinsed twice in PBS/T, then left to wash in PBS/T for 15 minutes with gentle 
shaking, followed by two 5 minute washes. Next the membrane was left in blocking solution 
containing the secondary antibody in a falcon tube for 20-30 minutes. The secondary antibody was 
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conjugated to Horse-Radish Peroxidase. The membrane was then washed in PBS/T as before to 
remove unbound primary antibody. This was followed by an extra wash for 5 minutes before leaving 
in PBS (Phosphate Buffered Saline) and ready for detection (see section 2.5.2.3). 
2.6.2.3 Western blot detection – ECL method 
In the dark room, proteins were detected using the Chemiluminescent (ECL) method where the 
membrane was left in the developing agents (mixed at a 1:1 ratio) for 1 minute. Solution 1 contains 1 
ml luminol 250mM (3-aminophthalhydrazide for FLUKA No.09253), 0.44ml p-coumaric acid 90mM 
(Sigma), 10ml 1M Tris-HCL (pH8.5) with water to 100ml). Solution II contains 64µl 30% hydrogen 
peroxide, 10ml 1M Tris-HCL (pH8.5) and H2O made up to 100ml. 
The membrane was then dabbed on tissue to remove excess liquid and placed in a plastic wrap that is 
in a film development cassette. The ECL film was placed on top of Saran wrap containing the 
membrane and the cassette shut for the required time to be exposed. After the required time, the 
film was transferred to the development machine (XOgraph Compact X4).  
2.6.2.4 Antibodies used for protein detection 
The primary antibodies used for the detection of actin were raised in mouse and diluted 1:5000. This 
antibody was a gift from Prof. John Cooper (Department of Cell Biology & Physiology 
Washington University in St Louis). The GLuc antibodies (New England Biolabs) used were raised in 
rabbit and diluted 1:3000. Antibodies were diluted 1:5000 to detect PGK and raised in rabbit; this was 
purchased from York Biosciences. Anti-HA was developed in rabbit and diluted to 1:1000 for detecting 
Sch9 which was tagged (Sigma-Aldrich). The p38/Hog1 MAPK antibody was a gift from Prof. Nic Jones 
(Paterson Institute for Cancer Research, Manchester) and diluted 1:1000. In detecting phospho-p38 
MAPK, an antibody was purchased from Cell Signalling Technology which was raised in rabbit and 
diluted 1:1000. 
 
2.6.3 Gaussia luciferase assay 
This reporter assay uses the protein Gaussia luciferase (GLuc) from the organism Gaussia principe. The 
luciferase protein catalyses the oxidation of the substrate coelenterazine in a reaction emitting light. 
This technique used the commercially available kit from Invitrogen. Overnight cultures were grown in 
the appropriate minimal media and reinoculated to grow them into log phase. After 3-4 hours, 3x105 
cells were harvested and spun down at 3000 rpm for 4 minutes. 25 µl of supernatant was then placed 
in a 94 well plate. The BioLux Gluc substrate was mixed with the buffer (100X) diluting it by 100-fold 
and left on ice. 25 µl of this was delivered to each well using a multichannel pipette. Measurements 
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were promptly taken on the BMG Optima Fluostar mulitplate reader at 475 nm. More details on the 
settings of the plate reader are shown below in Table 2.11. 
 
Table 2.11 Optima settings used for Optima Fluostar mutiplate reader during the GLuc assay 
 
Optima settings 
No. of multichromatics =1 
Emmission filter = Lens 
Gain = 3600 
Optic = top optic 
Positioning delay = 0.2 
No. of kinetic windows = 1 
No. of cycles = 1 
Measurement start time = 0.0 sec 
Time to normalise the result = 0.00 sec 
Pass before cycle = 0.00 sec 
Shaking = orbital 500 rpm 
Additional shaking = before each cycle 
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2.7 RNA analysis technique 
 
2.7.1 Total RNA extraction  
2.7.1.1 Total RNA extraction from CHO  
Cells grown in 24 well plates had the media removed and were washed with 1 ml PBS, then 400 µl of 
trypsin(Invitrogen) was added and incubated at 37°C for up to 5 minutes until the cells had been  
dislodged. 800 µl of media were then added, the cells were spun down and the supernatant removed. 
The pellet was resuspended in RLT (Qiagen) (600 µl for 5x106 to 5x107 cells). The RLT lysate was then 
homogenised with QIAshredders (Qiagen). RNA was extracted according to the instructions from 
RNeasy mini kit and RNA levels measured using the Nanodrop spectrophotometer (Labtech). These 
RNA extracts were stored at -80°C. 
2.7.1.2 Total RNA extraction from yeast 
Cells were grown overnight in minimal media then inoculated into YPD and grown to the cell count 
1x107/ml. Cells were treated according to the RNeasy mini kit (Qiagen) using the mechanical disruption 
technique  where acid-washed glass beads are used to break open the cells.  
2.7.1.3 DNase treatment of RNA samples 
RNA samples were treated with the RQ1 RNase-free DNase kit from Promega to degrade any DNA 
contamination. See protocol for more details.   
 
2.7.2 qRT-PCR 
The method qRT-PCR was used to determine relative amounts of target mRNAs. -actin was used as 
the house keeping mRNA. qRT-PCR was carried out using the Quantifast SYBR Green PCR kit from 
Qiagen. The dye SYBR Green 1 was used binding to double stranded DNA so fluorescence is detected 
of amplification products. Below in table 2.12 is the reaction mixture needed per reaction. 96 well 
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Table 2.12 Reagents needed for qRT-PCR 
 
Reagents per well Volume Final concentration 
2X Quantifast SYBR Green PCR 
Master Mix 
12.5µl 1x 
Forward primer Variable 1 µM 
Reverse primer Variable 1 µM 
Template RNA Variable ≤100 ng/reaction 
RNase-free water Variable  
Total reaction volume 25 µl  
 
The resulting data was analysed using Opticon Monitor software. Melting curve analysis can be 
undertaken to analyse product homogeneity after a run. Normalised data was exported to Microsoft 
Excel for plotting graphs.  
 
Table 2.13 Temperature and time of each step in qRT-PCR.  
Step Temp/time 




98°C for 10 sec                           
Variable for 30 sec                   
72°C 30 sec/500 bp 
Extension final 72°C 5 -10 min 
 
 
Repeat cycle 35x 
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2.8 Phenotypic analysis techniques 
2.8.1 Multi-well plate growth assay 
To study the growth of cells, spectrophotometric growth readings were taken using the BMG LABTECH 
SPECTROstar Nano plate reader where optimal density (OD) measurements were taken through a 595 
nm(~600) visible light path. 5 ml culture was grown overnight and diluted with the starting OD600 of 
0.1-0.3 in bio-one well plates (Greiner). The cell density was determined by the Eppendorf 
BioPhotometer plus. The basic settings are described in Table 2.14 below: 
 












Data was exported from MARS data analysis software (BMG labtech) to Microsoft Excel and used to 
generate the growth curves from the readings. Data was corrected with the bank before logging the 
readings and calculating the maximal growth rate over a 3 hour period. The OD reading at the earliest 
point within a 3 hour time frame was subtracted by the final point and divided by 3. The doubling time 
was calculated by dividing 0.693 by the growth rate. 
Typical protocol settings 
Flashes per well: 3 
Cycle time (sec): 1800 
Excitation: 600 
Shaking frequency (rpm): 400 
Shaking mode: double orbital 
Additional shaking time: 30 s before each cycle 
Positioning delay: 0.5 
Target Temperature (°C): 30 
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2.8.2 β-galactosidase activity assay 
This method uses a LacZ expression vector which is a reporter construct used in this study to measure 
Ste12 activity. For this, cells were grown overnight in selective media. These cultures were then 
inoculated in YPD cultures at an OD600 of 0.3 and incubated at 30°C overnight. 200 µl of these cells at 
an OD600 of 5 were added to Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCL, 1 mM Mg2SO4, 
50 mM β-mercaptoethanol) to make up the volume to 600 µl. This mixture was incubated at 30°C for 
30 minutes. After this time, 150 µl of 4 µg/ml ONPG (2-nitrophenyl β-D-galactophyranoside) (Sigma) 
was added and gently shaken. The reaction was then stopped by adding 400 µl of 1.5 M Na2CO3 
(depending on the amount of protein used will depend on how long to wait before stopping the 
reaction). Samples were then centrifuged for 30 seconds at 13,000 rpm to remove cell debris before 
the absorbance was read through a spectrophotometer at 420 nm and 550 nm. 
The following equation was used to calculate the miller units of the protein in question: 
Miller unit = 1000 x    Absorbance at 420 – (1.75 x Absorbance at 550)  
                                                      t x v x Absorbance at 600 
t = the time left for the reaction to occur before stopped by Na2CO3  
v = the total volume of cells and Z buffer 
 
2.8.3 Spotting assay 
Cells were grown overnight in the appropriate media and diluted to an OD600 of 0.075 in 550 µl sterile 
water in a sterile autoclaved steel multi-well plate. Using flat-bottomed steel pins, cells were 
transferred to dried agar plates. This was left to grow at 30°C for 2-3 days.  
 
2.8.4 Killer Toxin assay 
This method uses a plasmid containing K1, a killer toxin naturally found in certain yeast isolates. Strains 
containing this plasmid are grown on a lawn of yeast cells sensitive to the toxin on agar plates forming 
a kill zone. These agar plates contain methylene blue, a dye which stains dead cells. This kill zone is 
then measured using the image processing programme Image J. 
Initially to prepare these plates the bottom layer of agar was set, followed by a top layer (lower pH to 
4.8) containing methylene blue and the sensitive strain S7 added after autoclaving. Table 2.15 below 
describes the makeup for each agar layer. The bottom layer can be made at an earlier time. All yeast 
strains are grown overnight in minimal media. The following morning, the sensitive strain was diluted 
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back to an OD600 0.05 and left to grow into early log phase with a cell count of about 2x106. The killer 
strains are then diluted to an OD600 of 0.2 and grown to a cell count of 1x107. While the strains are 
growing, the top agar was made and left to cool to 45°C. Once the sensitive strain had grown to the 
appropriate cell count, 500 µl was added per 10 ml of top layer media in a falcon tube. The plates were 
warmed containing the bottom layer before pouring over the top layer taking care to spread it evenly 
before it sets. Once the killer strains have grown to the correct cell count, cells were diluted in 2 ml 
with the cell count adjusted to 4x106 and further dilutions as required. Cells were spun down at 4000 
rpm for 4 minutes. The supernatant was removed and pellet resuspended in 60 µl sterile water. 10 µl 
of the cell suspension was then spotted onto small filter disks (0.5 cm diameter) on the top layer. The 
plates were then allowed to dry and incubated at 30°C. Plates were scanned after 2-3 days growth. 
Table 2.15 Reagents included in Top agar and Bottom agar used in the killer toxin assay. 
Reagents Top agar (100 ml) Bottom agar (100 ml) 
Yeast extract             0.5 g  0.5 g 
Bactopeptone 0.5 g 0.5 g 
Agar 1.5 g 0.5 g 
Glucose 5 ml 5 ml 




2.9.1 Gateway Entry cloning 
Gateway Technology by Invitogen was used to perform an LR recombination reaction between an attL-
containing entry clone at each end of the gene (see Figure 2.3). The attL sites are complementary to 
the sticky ends of the destination vector, attR. The attL sites on the entry clone are cut by the gateway 
recombination enzymes, leaving sticky ends which recombine with the attR sites of the destination 
vector creating the attB containing expression clone and attP by product. Reaction solutions are 
described in table 2.16 below:  
Table 2.16 Reaction solution in Gateway cloning.   
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Reagents Volume 
Entry clone (100-300 ng/reaction) 1-10 µl 
Destination vector (300 ng/reaction) 2 µl 
Reaction buffer 2 µl 
LR clonase II 4 µl 
TE buffer pH8 Make up to 16 µl 
 
The mixture was incubated at room temperature for 1 hour followed by 1 µl of proteinase K added 
and incubated for 10 minutes at 37°C. This stops the reaction by destroying the clonase enzyme. This 
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2.9.2 Hairpin cloning to knockdown genes 
To transiently repress CHO genes, the Hairpin Cloning system from Promega was used. In this system 
the siRNA are expressed as foldback stem-loop structure which act to suppress expression of a target 
sequence by stimulating specific degradation of the target mRNA (Zamore, 2001). This is achieved 
using a vector containing a U1 promoter which allows transcription of the hairpin target sequences. 
The hairpin insert is formed by two DNA oligonucleotides (see Figure 2.4) which anneal to form the 
insert; this contains the hairpin siRNA target sequence with sticky ends to facilitate ligation with the 
vector provided. This vector contains the gene for ampicillin resistance for screening of successful 
ligation once transformed into E.coli. More details on this method are provided in the manufacturers 
Hairpin cloning manual. Once the cloning is complete, the vectors containing the hairpin sequence 
were transiently transfected into the stable cell lines expressing GLuc, and GLuc levels determined by 







Figure 2.5 Example of oligonucleotide sequences for the hairpin cloning system. A forward and reverse 
oligonucleotide (which is complementary) is used to knock down ULK1. 
 
Oligonucleotide A is the template strand for cellular RNA polymerase II and should contain an 
overhang sequence which is complementary to the pGeneClip vectors, completing the U1 promoter 
sequence. The loop sequence provides flexibility for the RNA hairpin formation. The target sequence 
forms the double-stranded portion of the hairpin in combination with the reverse complement 
sequence. Oligonucleotide B is complementary except for the overhang sequence (GACGTC), which 
contains an additional nucleotide to form a PST I restriction site allowing for detection of successful 
clones. 
        Oligonucleotides for ULK1 (Atg1 in yeast) 
Overhang                 Target                Loop                  Reverse Complement 
5’ TCTC                                                                                                                                         CCT 3’ 
         TCTCGCCTGGTTATGGAGTACTGCAACCTTCCTGTCAGTTGCAGTACTCCATAACCAGGCCT  
                                                                             Complementary sequence 
             3’                               GACGTC 5’ 
                         CGGACCAATACCTCATGACGTTGGAAGGACAGTCAACGTCATGAGGTATTGGTCCGGACGTC 
Fwd oligo 
Rvrse oligo 
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2.9.3 DNA Quantification 
To measure DNA concentration, the BMG Labtech SPECTROstar Nano was used. Using an LVis Plate, 2 
µl of sample was loaded and a reading at OD260 was measured. 
2.9.4 Restriction digest 
This reaction uses restriction endonucleases which cut at specific sites on DNA plasmids. Below in 
Table 2.17 are the details of the method used for this process for one reaction. 
Table 2.17   Reagents used in restriction digest. This reaction mixture was incubated at 37°C for 1-2 
hours. 
Reagents Volume 
10x buffer 2 µl 
Restriction enzyme 1 µl 
DNA (1 µg in TE pH8) 1 µl 
BSA 0.2 µl 
Sterile H2O Up to 20 µl 
 
2.9.5 Sequencing 
To check cloning was correct, purified DNA samples (10 µl of 100 ng/µl) were sent to Source Bioscience 
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3.1 TOR signalling and recombinant protein production 
3.1.1 The industrial use of yeast for recombinant protein production 
 
The biopharmaceutical industry is continually growing in terms of the number of protein- based 
products in the clinic and in development, and now makes up a significant portion of total drug sales, 
indeed 8 of the top 10 drugs by sales are protein based drugs (Walsh, 2014). In line with the product 
requirements of recombinant biotherapeutic proteins, production is carried out using a number of 
different cell based expression systems ranging from micro-organisms to insect, plant and mammalian 
cell systems. Methods for recombinant protein production are continually developing and evolving, 
with modifications and optimising of current expression systems being addressed both in academia 
and industry. For example, investigating and altering biological pathways or processes that are 
involved in properties that contribute to recombinant protein production with the aim of increasing 
product quality and yield have been reported (Edros, McDonnell, & Al-Rubeai, 2014; Hamilton & 
Gerngross, 2007; Lee, Ha, Park, & Lee, 2013). More detail on such approaches is described in the 
introduction chapter of this thesis.  
The results presented in this chapter focus on the use of the budding yeast, Saccharomyces cerevisiae, 
which is one of the most robust and best-characterised experimental systems frequently used for 
expressing biotherapeutic recombinant proteins, (Hamilton and Gerngross, 2007) and development 
of a model reporter system of recombinant protein expression. Yeast can be grown to high cell 
densities in a basic cheap media, facilitating reliable recombinant protein expression and secretion by 
the cell (De Pourcq et al., 2010). This allows large volumes of heavily glycosylated recombinant protein 
to be produced. In addition, S.cerevisiae poses a very rigid cell wall compared to mammalian cells and 
can withstand higher levels of stress. They do however possess a disadvantage in that they produce 
high-mannose glycosylation which is not a suitable replacement for human glycoproteins required for 
medical products. However, there have been recent advances in this field of engineering which allows 
yeast to replicate the most essential glycosylation pathways found in mammals (De Pourcq et al., 
2010). 
In order to achieve the correct/required recombinant protein structure and function, post-
translational modifications occur within the secretory pathway. Proteins need to efficiently enter and 
transit the secretory pathway which requires a signal peptide for entry into and through the 
endoplasmic reticulum (ER) (Porro et al., 2005). Once in the lumen of the ER, correct folding of a 
secretory protein is necessary as failure results in its accumulation leading to the activation of the 
unfolded protein response (UPR) (see chapter 1.2.2 for more detail)(Bravo et al., 2012).  
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3.1.2 The use of a Gaussia luciferase construct as a model secreted recombinant protein 
system 
 
A vector was developed at Kent that expresses a secreted form of the Gaussia luciferase (GLuc) protein 
from the crustacean Gaussia princeps within S. cerevisiae. GLuc is a small, single chained polypeptide 
185 amino acids long which is naturally secreted (Ruecker et al., 2008). In, Gaussia princeps, after the 
synthesis of the luciferase protein, it is packed into secretory vesicles for storage. For the expression 
of GLuc in mammalian cells, the gene was cloned with a human signal peptide added at the N-terminal 
end (Knappskog et al., 2007). In yeast, an N-terminal hydrophobic signal peptide is required for 
efficient secretion of a heterologous protein. Many secretion vectors contain the yeast signal peptide 
prepro-α-factor from pheromone MFα1 which is secreted by Matα yeast strains during mating (Figure 
3.1). The pre-region is 22 amino acids long and is cleaved by the ER membrane-associated signal 
peptidase. The pro-region contains three N-linked glycosylation sites and is cleaved within the Golgi 
complex by the Kex2 enzyme at the Lys-Arg site to generate an authentic N-terminus on the secreted 
protein (Tuite, Clare & Romanos, 1999). This pre-pro peptide has been cloned at the N-terminal of the 





Figure 3.1 Organisation of the prepro-α-factor from S.cerevisiae showing cleavage sites by signal 
peptidase (SP) and Kex2p. The pre-pro region is taken from the yeast mating alpha factor containing 
a signal sequence. 
 
Like other reporter systems such as Renilla luciferase, Gluc uses the substrate coelenterazine and light 
for bioluminescence (Ruecker et al, 2008) and is reported to possess an increased bioluminescence 
signal over firefly and renilla luciferase (Tannous et al., 2005). This reaction with GLuc is shown 
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Figure 3.2 Reaction between GLuc and the substrate coelentrazine producing bioluminescence which 
is detected and quantified. The oxidation of the substrate produces coelenteramide, CO2 and light. 
A further advantage of Gluc as a reporter protein within an expression systems is that it does not 
require ATP for activity so it can report from cell surroundings as well as from the cell pellet (Tannous, 
Kim, Fernandez, Weissleder, & Breakefield, 2005). Here, we utilised plasmids containing GLuc to 




3.2 Towards optimisation of a model system for screening TOR mutants from 
the deletion library 
 
The ultimate aim of the work described in this thesis was to screen TOR and other mutants for the 
effect of these mutants on cell phenotypes, particularly the ability of the cell to secrete recombinant 
proteins. As such it was necessary to develop systems that could be used to screen for such effects. 
 
3.2.1 Using a Gaussia Luciferase assay as a screen to measure recombinant protein 
production  
3.2.1.1 GLuc bioluminescence and hence production throughout culture 
An initial GLuc assay was conducted to examine whether growth phase affected the bioluminescence 
output over a 25-hour period following inoculation of yeast cells at an OD600 nm of 0.3. This was 
performed using wild type cells grown in minimal media. Samples were analysed in duplicate and 
readings taken at 3.5, 6.5, 9.5 and 25 h after inoculation. This allowed investigation of bioluminescence 
at log phase (3.5, 6.5, 9.5 h) and stationary phase (25 h) of growth.  The highest readings observed 
  
+O2  
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were taken from cells within log phase growing at their maximal rate. Following this, a decline in 
bioluminescence was observed as the cells growth rate decreased as they entered the diauxic phase 
stage of growth. During this stage of growth the yeast had depleted glucose within the media and cells 
commence ethanol utilisation, a product of fermentation. With ethanol depletion, yeast cells enter 
stationary phase where the growth plateaus. At this point we observed almost an entire loss in GLuc 
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A) 
                         
B) 
                    
C) 






Figure 3.3 GLuc luminescence over a 25 h period as determined at the time points indicated when 
grown in minimal media. A) GLuc activity per 1000 cells. The highest levels of GLuc were detected 3.5 
h after cells were inoculated at an OD600 of 0.3 (n=6). B) Raw GLuc activity readings. C) Cell count/ml 
at each time point. Errors bars represent standard deviation. Statistical analysis was performed using 
an ANOVA test with significance annotated comparing samples at varied times to 3.5 hours (**p= 
<0.01). 
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Despite undertaking the time course analysis multiple times and undertaking replicate measurements 
at each time point, variation in GLuc activity was observed as shown by the large error bars (Figure 
3.3).  
Figure 3.3B shows how there is an accumulation of GLuc detected between 3.5 and 6.5 hrs, yet there 
is no further accumulation after 9.5 hrs followed by slightly further decrease in GLuc detected after 
25 hrs. This suggests that more GLuc was expressed earlier on in the time course; this was expected 
as the promoter is known to actively drive expression of GLuc protein during log phase. There is an 
increase in GLuc detected at 6.5 hrs compared to 3.5 hrs. However, the cell count at 6.5 hrs is more 
than 3 times higher than at 3.5 hours, yet it shows roughly less than 2 times the GLuc accumulation 
after 6.5 hrs. This is also seen in Figure 3.3A where GLuc activity per 1000 cells shows higher 
bioluminescence detected at 3.5 hrs compared to 6.5 hrs. The data from both graphs implies that 
there is degradation of the protein produced between 3.5 hrs and 6.5 hrs. This would also explain the 
loss of GLuc after 9.5 hrs where further degradation of the protein would also occur. However, due to 
inter-replicate error any data produced using this assay makes definitive conclusions challenging. Yet 
from the data shown here, this suggests that further assays measuring GLuc activity should be done 
at 3.5 hrs growth.  
To determine whether pH changes could lead to differences in luminescence output, cells were grown 
in media buffered to varying pH values and the growth and Gluc luminescence then assessed. The 
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Figure 3.4 Average growth of wild type BY4741 cells in minimal media (pH 5.1) and YPD at varied pH. 
A) Growth of the wild type expressing the plasmid lacking GLuc. B) Growth of the wild type with the 
GLuc expressing plasmid. Potassium phosphate buffers were used to get the media to the required 
pH.  Cells were inoculated at an OD600 of 0.1 and grown into stationary stage (n=2).  
 
Growth of the wild type with and without the expression plasmid was similar in media at pH 6 and 6.4. 
However, growth rate was affected in media lacking URA and YPD pH 7 with a longer lag phase (Figure 
3.4). As the data suggested that pH had an effect on growth, whether pH also led to differences in 
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Figure 3.5 GLuc activity at varied media and pH conditions. Cells were grown to an OD600 of 0.3 and 
readings taken after 3.5 hours (n=6). Errors bars represent standard deviation. Statistical analysis was 
performed using an ANOVA test comparing readings in –URA to YPD media (*P<0.05, ***P<0.001).  
 
Under increased pH media conditions the luminescence was higher suggesting that these conditions 
were better for secreting GLuc from the cells (Figure 3.5). Upon varying pH conditions, a change in 
both cell growth and the reproducibility of the Luciferase assay readings was observed. Suitable 
conditions for this assay were between pH 6.4 and pH 7, as pH 7 gave the highest activity in the Gluc 
assay but there was better growth at pH 6.4. Cultures were also grown to determine the viability of 
the cells under these different pH conditions and the results are shown in figure 3.6. 
            
Figure 3.6 Viability assay at pH 6.4 and pH 7 containing a plasmid with/without the GLuc gene. 300 
cells were plated and colonies counted after 2-3 days (n=3). Error bars represent standard deviation. 
ANOVA was used to determine statistical significance (*P<0.05, ***P<0.001).  
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The results of the viability investigations showed a statistically significant increase (***p<0.001) in 
viability at pH 6.4 compared to pH 7 expressing GLuc, which is the pH closer to the optimum of 
standard YPD cells are grown in. However, this particular assay is not entirely accurate with 
enumerating colony forming units. For example, cell counts may be inaccurate when performed 
before plating out 300 cells due to cells budding. The cells plated out can also be clumped forming 
what appears to be only one colony, instead of several.  
The GLuc assay was repeated with cells grown in YPD at pH 6.4 which was the optimal pH to 
encapsulate good cell viability together with sufficient GLuc activity. The results from this investigation 
are shown in figure 3.7 below. 
 
Figure 3.7 Reproducibility test of Gluc assay at pH 6.4 repeated on 4 different days. The bars show 
bioluminescence in the wild type (n=6). Cells were inoculated at an OD600 of 0.3 and grown for 3-4 
hours before the assay was performed. Errors bars represent standard deviation, and significance 
determined using an ANOVA test (*P<0.05, ***P<0.001). 
 
When cells were grown at pH 6.4, high variability was seen between individual days and within each 
day to a lesser degree (Figure 3.7). A potential source of variability could be where after re-
inocculation the following morning, the cells used are at varied phases of growth. If at varied phases 
of growth it could take some cells longer to get into log phase, thereby effecting GLuc produced as the 
promoter is switched on. If after the reinoculation the next morning, the cells were left to grow for a 
further 24hrs and then reinnoculated a second time, hopefully the cells would be in the same phase 
of growth.  
All of the luminescence data showed higher variability for samples than was ideal and therefore as an 
alternative to using the GLuc activity assay, GLuc protein expression was determined by western 
blotting with a monoclonal antibody against GLuc protein raised in rabbit. 
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3.2.2 Measuring the expression of Gaussia Luciferase by western blot 
 
GLuc expression in the yeast cells was evaluated by western blotting as an alternative to using the 
GLuc activity assay to determine if this gave results with less variability. Although this particular 
method is still only semi-quantitative as when the membrane containing the protein is exposed to the 
film, this is non-linear, in particular during short exposures. When the film containing is scanned into 
the computer and quantified using Image J, some of the quality of the autoradiograph may be lost.  
The levels of GLuc expression determined from these blots indicated whether strains were low or high 
recombinant protein producers. Cells were grown in standard YPD (pH 6.6) to a density of 1x107 
cells/ml and protein extracted. Both supernatant and cell pellet samples were taken to analyse how 
well the cell processes and secretes the GLuc protein and how much was maintained within the cell. 
GLuc expression detected from the resulting blots, and -actin from intracellular samples used to 
normalise data against the cell number, were processed by densitometry using the freeware software 
Image J. The resulting data is shown in figure 3.8 below. 
The expression of GLuc was detected in the pellet and supernatant of the wild type (Figure 3.8).  There 
was a more intense band of GLuc retained in the cell (58.5%) whilst a number of other unidentified 
bands were also observed. These unidentified bands of higher molecular weight could be due to 
incorrectly proccessed forms of GLuc with varied modifications causing a shift in size such as 
glycosylation or other post translational modifications. As these are only observed in the pellet, one 
of these at least could be due to unprocessed GLuc where the signal sequence has not been cleaved. 
Quantification of the blot images confirmed that these results were more reproducible than the GLuc 
activity assays previously described. Experiments were kept consistent to avoid any artefacts and a 
chemical lysis buffer used for extraction that has previously been shown to give the highest extraction 
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Figure 3.8 Expression of GLuc and -actin in the wild type. A) GLuc protein levels were analysed in 
biological triplicate. S represents supernatant, P represent pellet sample. B) Quantification of GLuc 
expression in the supernatant and pellet. Cells were grown overnight in minimal media and then 
inoculated at an OD600 of 0.3 in YPD and left to grow for 3-4 hours. Errors bars represent standard 
deviation and statistical analysis performed using a two-tailed t-test (p=0.0075). 
 
3.2.3 Testing Killer Toxin secretion 
 
3.2.3.1 Introduction to the Killer Toxin 
Another method that can be used to monitor protein secretion in yeast utilises the yeast killer toxin. 
In this assay, the cell secretes the toxin K1. Yeast which produce this toxin have an advantage over 
others during times of scarce nutrients. This toxin is conferred by a cytoplasmically inherited double-
stranded RNA (dsRNA) virus found in yeast and fungal species. However, the killer phenotype in some 
cases is due to the presence of dsDNA plasmids or the toxin is chromosomally encoded (Schmitt and 
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Breinig, 2006b). In yeast, killer strains have been classified into three major groups depending on the 
toxin secreted and the component that gives these cells immunity to their own toxin.  
The three killer strain groups are K1, K2 and K28 and are associated with the presence of the inherited 
dsRNA satellite virus (ScV-M1, ScV-M2 or ScV-M28 which are about 1.8 kb) which is stably maintained 
and replicated in the cytoplasm and relies on the presence of the L-A helper virus (4.6 kb)(Schmitt and 
Tipper, 1995; Schmitt and Breinig, 2002). Both these dsRNA genomes are separately encapsulated into 
virus-like particles (VLPs) and are spread via mating or heterokaryon formation (co-existence of two 
or more genetically different nuclei in the cytoplasm). The L-A virus contains two ORF’s, Gag, the major 
capsid protein for the encapsulation and viral particle structure and Pol, the RNA-dependent 
polymerase. Conversely, the genome for the M virus only contains the ORF coding for the preprotoxin 
(pptox) which is the unprocessed precursor of the mature secreted killer toxin. It is this ORF which is 
required for immunity though this is not currently well understood (Schmitt and Breinig, 2006b; Esser, 
2009).  
 
3.2.3.2 Processing of the toxin 
The preprotoxin (pptox) contains the N-terminal signal sequence which is the precursor required for 
the pptox import into the ER lumen which is followed by the subunits α and β of the mature toxin 
(Figure 3.9). These mature toxin subunits are separated by the γ subunit which is N-glycosylated. After 
the signal sequence is cleaved off, further processing is undertaken through the secretory pathway 
giving a biologically active α/β heterodimer. It is in the late Golgi where the γ subunit is removed by 
Kexp and the C terminal of β subunit is cleaved by Kex1p. The mature protein is then secreted as an 





Figure 3.9 Schematic of the four subunits forming the killer toxin gene, K1 with the promoter ADH1. 
The delta subunit acts as a signal sequence to the ER necessary for secretion. 
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3.2.3.3 Killer toxin action 
Different Killer toxins are capable of killing sensitive yeast strains through a range of receptor-
mediated two step processes The first is a fast and energy dependent binding to a toxin receptor in 
the cell wall. In K1, the receptor is β-1,6-D-glucan. Targeted strains can become toxin resistant by 
chromosomal mutations in any of the genes involved in structure and/or biosynthesis of the yeast cell 
wall components. Toxin resistant genes kre (killer resistant) have been found in K1. Another mode of 
action is toxin translocation and interaction with a secondary membrane receptor on the cytoplasmic 
membrane, Kre1p. After the toxin reaches the cytoplasmic membrane, it exerts its damaging effect by 
ion channel formation and disruption of cytoplasmic membrane function (Schmitt and Breinig, 2002).  
3.2.3.4 Toxin immunity 
In the K1 killer toxin, the mode of immunity is currently unknown but it is speculated that the toxin 
precursor can act as a competitive inhibitor of the mature toxin by saturation or by eliminating the 
plasma membrane receptor that normally mediates toxicity. Δkex2 mutants would lack the ability to 
process pptox becoming an immune non-killer yeast strain. Another possibility is that the γ subunit 
can not only act as an intramolecular chaperone ensuring proper secretory pptox processing but also 
provide a masking function by protecting the membranes of toxin producing cells against damage as 
the α subunit has hydrophobic components (Schmitt and Breinig, 2006b). 
3.2.3.5 Killer toxin assay 
In the killer toxin assay used in this study, K1 was used in a PVT100U plasmid and expressed with an 
AHD1 promoter. This was transformed into the wild type creating a killer strain, and the sensitive 
strain S7 was used. Cells were spotted onto a lawn of the sensitive strain in a series of dilutions. The 
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Figure 3.10 Strains expressing the toxin on agar plates containing methylene blue. Strains are spotted 
on filter paper in a dilution series and left to grow for 2 days killing the surrounding sensitive strain 
(1x105 cells were plated). This kill zone (indicated on the last spot) was measured in Image J for 
quantification with image contrast enhanced by 0.1%. Right to left dilutions were performed in the 
killer strain with a 5-fold, 2.5-fold and 2-fold dilution respectively.   
 
There was a clear kill zone surrounding the killer strain made visible through methylene blue when the 
assay was undertaken (Figure 3.10).  The top agar containing the sensitive strain had to be at a pH of 
4.8 for their cytotoxic activity to be achieved (Fink and Styles, 1972; Santos and Marquina, 2004).  
3.2.3.6 Low pH effects protein secretion 
As the killer toxin assay is conducted at a low pH, we were interested in testing how this condition 
affects the protein production of GLuc. GLuc expression was measured and compared between the 
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Figure 3.11 pH test on Gluc expression in wild type at pH 6.6 (standard YPD) and pH4.8. A) Western 
blots with GLuc and β-actin showing expression in supernatant (S) and pellet (P) (n=3). B) 
Quantification of the blots show lower pH has a negative impact on GLuc secretion. Cells were grown 
overnight in minimal media and then inoculated at an OD600 of 0.3 in YPD and left to grow for 3-4 
hours. Errors bars represent standard deviation. ANOVA was used ***P<0.001. Low pH has a 
statistically significant effect on secretion when comparing pH6.6 and pH4.8 p=0.0190 with the t-test). 
The results indicated that a reduction in pH of growth media led to a statistically significant decrease 
in total protein production but there was also a higher percentage of protein trapped within the cell 
(Figure 3.11).  
 
                                            Standard YPD pH 6.6                                YPD pH 4.8 
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This chapter describes the development of various assays and the techniques behind them used to 
find a suitable screen to investigate how changes in a yeast expression system affect recombinant 
protein production. This was important as the systems and assays developed were then to be used 
throughout the remainder of the study. 
 
3.3.1 The GLuc activity assay 
 
The GLuc activity assay proved difficult to work with, despite trying to retain consistency in 
preparation of cells and readings taken. The activity as determined by luminescence was variable, 
even for replicate measurements of the same sample making the use of the assay limited. An alternate 
option could have been to use an injector so the readings were taken immediately. The other issue 
was comparing average readings between days, presenting wide variation. During fermentation, yeast 
produce acetate while depleting nutrients in the media causing changes to the surrounding pH which 
appeared to have an effect on luminescence output. Cells were originally grown in minimal media for 
selection of the plasmid with a low pH. However, although the GLuc assay is functional over a broad 
pH, the minimal media is far from the optimal pH of 7.7  (Tannous et al., 2005). After 9.5 hours, where 
cells are no longer doubling, there was almost no GLuc detected (Figure 3.4). This was expected due 
to the high expression of the plasmid during log phase as a GPD promoter (glycolytic pathway) is used; 
yet could also be due to the accumulation of proteases later on in post diauxic shift. 
Growth analysis had shown that growth in minimal media at pH 5.1 increased lag phase time; the lack 
of nutrients explained this phenotype. Wiles et al. (2005) reported that GLuc bioluminescence is 
unaffected by exposure to low pH, despite this causing stress on cells. YPD at pH 7 demonstrated a 
growth defect similar to that of the minimal media, yet the highest GLuc activity was detected in this 
condition. pH 6.4 appeared to be the optimum pH for cell growth, as this had the second highest GLuc 
activity detected with a higher percent of viable cells compared to growth at pH 7. Perhaps proteases 
released are inactive at this pH, resulting in higher luciferase activity. GLuc is reported to be highly 
stable at a wide range of pH values so it is more likely to have been the substrate coelenterazine being 
affected.  
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3.3.2 Using western blotting to determine GLuc expression 
 
Regardless of finding the best pH conditions, results remained inconsistent and the GLuc activity assay 
could not be used as a screening method and as such western blots were utilised as an alternative. 
This method also gave information of how well the cell was secreting against the amount of material 
found intracellularly (Figure 3.8).  
Western blots still have some problems with variability however, such as incomplete protein 
extraction or inefficient transfer of the protein to the PVDF membrane. Due to large numbers of 
strains, membranes containing the protein extracts could not all be exposed at the same time, 
introducing more room for error.  Further, this analysis informs on the total amount of protein present 
but not on activity (as given by the assay) and hence it is possible that changes to the amount of 
protein made may not reflect changes in active protein produced. 
 
3.3.3 The killer toxin assay 
 
The pre-pro sequence helped increase protein production as the cells under stress try expressing the 
pheromone. As the data is specific to this construct we also wanted to use the Killer toxin assay as 
another screen. This viral model system has been used for a number of applications such as analysing 
specific aspects of yeast virology, used in food and fermentation industries but also in the field of 
recombinant DNA technology. The secretion and processing signal derived from ScV-M28 killer virus 
in S.cerevisiae has been used in S.pombe to target foreign proteins for secretion (Schmitt and Breinig, 
2002). The killer toxin assay is fast, cheap and highly reproducible, and was an ideal alternative 
screening method alongside the western blots for GLuc. As the Killer toxin used a different promoter 
and signal sequence, the protein was predicted to have different secretion compared to strains in the 
GLuc western blots.  
The killer toxin’s cytotoxic activity functions at pH 4.8, and therefore the assay was performed in this 
condition. As it is known that pH has no effect on the stability of GLuc (Tannous et al., 2005; Maguire 
et al., 2009), we looked at the effect of growing the cells at pH 4.8 and its consequence on protein 
expression detected by western blots of GLuc. We demonstrated the lower pH conditions caused a 
loss in GLuc expression (Figure 3.11). Our knowledge about the molecular basis for pH stress is limited 
and have no further data suggesting what is causing this result (Mattanovich et al., 2004).  
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3.3.4 Conclusion 
Given the results of the experiments presented here, it was decided to use western blotting as an 
alternative to the GLuc assay and the killer toxin assay as screening tools for investigations. To 
measure protein expression samples were collected when yeast cells were in log phase with growth 
in standard YPD at pH 6.6. The killer toxin assay meanwhile continued to be performed in a dilution 
series at pH 4.8. These assays were then used to investigated and identify novel ways of improving 
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4.1 Introduction to the Cofilin 
4.1.1 New roles for cofilin in stress response mechanisms 
 
Actin dynamics play an essential role in many processes such as cell motility and neural pathfinding, 
cell polarity, membrane dynamics, and cell polarity (Bernstein et al., 2006). Cofilin is an essential gene 
with a central role in regulating the actin cytoskeleton. Members of the cofilin family exhibit a high 
level of its structural and functional conservation in lower and higher eukaryotes (Yahara et al., 1996).  
Cofilin is an actin binding protein that associates with ADP-bound actin found at the minus, or pointed, 
end of actin filaments. Upon binding cofilin helps to stabilize a twisted form of the actin filament which 
promotes fragmentation and release of actin monomers (Bamburg and Wiggan, 2002) in a pH 
dependent manner. This pH-dependent function may be physiologically significant as cystolic 
alkalisation is induced by serum or growth factors, which at  a pH higher than 7.3, enhance  the ability 
of cofilin to depolymerise F-actin (Yahara et al., 1996). At a pH lower than 7.3, the ability of cofilin to 
bind and sever F-actin is reduced (Bernstein and Bamburg, 2010). In mammalian cells inactivation of 
cofilin is mediated by phosphorylation at serine3 by kinases LIMK or TESK then reactivated by the 
phosphatase slingshot (for more detail see figure 1.4 in chapter 1) (DesMarais et al., 2005). Alignment 
with cofilin in S.cerevisiae show serine 4 corresponding to serine 3 in vertebrates, however phospho-
regulation has not yet been shown in yeast (Mizuno, 2013).  Ser4 was replaced with alanine intended 
to encode constitutively unphosphorylated cofilin, however had very little effect. Mutation in this 
serine site to glutamine creates a lethal phenotype suggesting that phosphorylation would disrupt the 
interaction between cofilin and f-actin(Lappalainen et al., 1997).  
Besides its actin binding role, Cofilin is involved in the control of a number of signalling pathways and 
has been shown to contribute to the control of mitochondrial function when a cell is under stress 
(Bernstein et al., 2006). For example it has been shown that cofilin plays a role in apoptosis when 
active (dephosphorylated) and targets the mitochondria (Chua et al., 2003) . The oxidant, taurine 
chloromine (TnCL) generated by neutrophils cause cofilin to lose its affinity for actin and translocate 
to the mitochondria nucleus where upon it promotes the permeabilisation of the outer membrane 
and release of cytochrome C (Klamt et al., 2009).  Another example of how cofilin is involved in stress 
responses has been found in neurones, whereby ATP depletion induces cofilin to assemble into 
aggregates, termed rods. The formation of ADF/cofilin rods has been implicated in mitochondrial 
dysfunction and may play a role in neurological diseases such as Alzheimer’s disease (Davis et al., 
2011).  
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New functional surfaces of cofilin which lie outside of the actin binding regions and which link 
mitochondrial function and stress responses have been identified in S. cerevisiae (Kotiadis et al., 2012). 
Alterations to cofilin residues outside of the actin-binding region produced a dramatic increase in 
mitochondrial function causing increased resistance to drugs such as azoles due to the upregulation 
of a battery of ABC transporters from retrograde signalling (Kotiadis et al., 2012). Microarray analysis 
suggested that cofilin may control respiratory function post-transcriptionally (Kotiadis et al., 2012). 
Cofilin is also regulated by inhibition through binding to the phosphoinositides such as 
phosphatidylinosital 4,5-bisphosphate (PIP2) which are known to mediate cofilin-actin interactions 
(Ojala et al., 2001).  The Gourlay lab discovered that some of the residues mutated in their study which 
were implicated in PIP2 binding displayed elevated levels of respiration coming to the conclusion that 
PIP2 may be involved in influencing mitochondrial function via PIP2 interactions (Kotiadis et al., 2012).  
ER homeostasis is essential for cell function in protein folding but also in survival. ER stress is where 
the folding capacity of the organelle is overwhelmed due to increased protein load or disruption to its 
ability to fold proteins (Vannuvel et al., 2013).  Prolonged ER stress eventually leads to apoptosis, 
where the mitochondria releases cytochrome C and other apoptotic factors such as AIF1 (apoptotic 
inducing factor 1)(Franklin-Tong and Gourlay, 2008).  
In yeast, mitochondria have a mechanical link to the ER via a protein complex identified as the ERMES 
(ER-mitochondria encounter structure) junction. This junction allows  communication to occur 
between the organelles  controlling membrane biosynthesis, protein import, motility and genome 
replication (Kornmann and Walter, 2010). Communication between the ER and mitochondria also 
occurs via calcium signalling which plays an important role in ER quality control and proper folding of 
functional proteins as there are a number of calcium binding chaperones such as calreticulin (Bravo et 
al., 2012; Vannuvel et al., 2013). Examples where calcium exchanges between the two organelles is 
important include Krebs cycle dehydrogenases stimulation and calcium dependent ER chaperones 
(Bravo et al., 2012).  
Bravo et al (2011) found that during acute ER stress, there was an increase in ER-mitochondrial Ca2+ 
transfer as mitochondria redistributed to the perinuclear zone. This increased the metabolic state of 
mitochondria as Ca2+ increases its membrane potential stimulating oxidative phosphorylation and 
oxygen consumption, creating more ATP. This enhancement in mitochondrial metabolism is an 
adaptive response increasing the cell’s bioenergetics supply to ER damage by misfolded proteins 
(Bravo et al., 2011). It is not just ER stress leading to mitochondrial dysfunction and apoptosis, it has 
also been suggested that mitochondrial dysfunction due to free Ca2+ increases levels in the ER Ca2a 
disrupting homeostasis in the ER leading the ER stress(Lim et al., 2009). As it has been shown that this 
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ER-mitochondrial coupling is important during early ER stress, our rationale is that as cofilin mutant 
alleles have increased mitochondrial biogenesis, this may improve rP yields as these strains will be 
better adapted to increased stress of producing rP in cells with increased coupling between the 
mitochondria and ER. 
 
4.1.2 Characterisation of mutant cofilin alleles 
 
To determine whether cofilin may play a role in the ability of cells to produce RP we made use of a 
library of yeast strains expressing mutant alleles of COF1 as the sole source (Lappalainen et al., 1997). 
In this collection of strains surface charged residues of cofilin have been mutated to alanine, (Figure 
4.1) (Lappalainen et al., 1997). These subtle changes have been shown to have an effect on activity 
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A)                           B) 
                                                   
C)                         D) 
                                               
 
Figure 4.1 Space filling model of the cofilin crystal structure. A) and B) Residues involved in actin 
binding are indicated in red (essential), yellow (non-essential) and green (indicates residues which are 
not involved in actin binding) (Kotiadis et al., 2012). C) Positive charged residues are indicated by blue 
and D) negative charged residues are indicated purple. Crystal structure manipulated through Protein 
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Table 4.1 Table of altered cofilin alleles with growth and actin organisation phenotypes. Adapted 
from(Lappalainen et al., 1997). 
Mutant allele Amino acid substitution Growth Actin organisation 
cof1-4 S4A Wild type Wild type 
cof1-5 D10A,E11A Temperature sensitive Minor depolymerisation 
defects 
cof1-6 D18A,K20A Wild type Wild type 
cof1-7 C62A Wild type Wild type 
cof1-8 K23A, K24A, K26A Temperature sensitive Severely altered 
cof1-10 K42A,E43A Wild type Wild type 
cof1-11 D47A,D51A Wild type Wild type 
cof1-12 E55A,K56A Wild type Wild type 
cof1-13 E59A,D61A Wild type Wild type 
cof1-15 E77A,K79A Wild type Wild type 
cof1-18 K105A,D106A Wild type Wild type 
cof1-19 R109A,R110A Wild type Wild type 
cof1-21 D103A Wild type Wild type 
cof1-22 E134A,R135A,R138A Temperature sensitive F-actin binding and 
depolymerisation issues 
 
Previous studies from the Gourlay lab split all mutated cofilin alleles into three classes of yeast strains. 
Class I contains cof1-4, cof1-6, cof1-7, cof1-11, cof1-12, cof1-15, cof1-18, cof1-19 and cof1-21. Class I 
holds the majority of the cofilin mutant alleles whose expression leads to enhanced mitochondrial 
biogenesis, elevated levels of respiration and increased expression of integral membrane drug pump 
proteins (Kotiadis et al 2012), yet exhibit wild type growth rates and actin organisation (see table 4.1). 
Class II alleles include mutants expressing alleles cof1-10 and cof1-13. whcih display impaired actin 
regulatory function as these amino acid alterations fall within the actin regulatory region (Figure 4.1). 
In line with actin playing a role in mitochondria integrity in yeast cells expressing class II alleles fail to 
respire (Kotiadis et al., 2012). Cell expressing mutant alleles cof1-5 and cof1-22 from class III display 
temperature sensitive growth and exhibit an altered actin cytoskeletal morphology caused by a 
decrease in F-actin depolymerisation (more dramatic in cells expressing allele cof1-22). Expression of 
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alleles in classes II and III possess mitochondria which appear large and fragmented, and do not 
respond to signals that promote biogenesis during the diauxic shift phase of growth. Class II mutants 
display increased reactive oxygen species (ROS) levels that occur as a result of  the constitutive 
activation of Ras2 signalling  (CW Gourlay and Ayscough, 2005). The strain expressing allele cof1-8 has 
not had the mitochondrial morphology identified, but was temperature sensitive in growth and has 
severely altered actin organisation placing it in class III. 
Evidence from the lab of Campbell Gourlay suggested that Cofilin may also regulate aspects of signals 
within the Ras/cAMP/PKA (Kotiadis et al., 2012), TOR and MAP kinase transduction cascades 
(unpublished data). We sought to determine the extent of cofilin’s role in the control of cell signalling 
processes with a view to understanding how it may influence cell behaviour. Of particular interest 
with regards to RP production was the prospect that increased levels of mitochondrial biogenesis may 




4.2 The effect of Cofilin mutations on recombinant protein production 
 
 
It has been observed that many strains expressing cofilin mutant alleles have increased mitochondrial 
function and altered cell signalling (Kotiadis et al., 2012).  Initially, we sought to determine whether 
severe mitochondrial dysfunction had an impact upon rP production in yeast cells. To achieve this we 
used ethidium bromide to generate stains lacking mtDNA as this inhibits the replication and 
transcription of mtDNA  (Desjardins et al., 1985; Armand et al., 2004). mtDNA encodes for seven 
essential components of the electron transport chain needed for complex III (COB gene), complex IV 
(cytochrome oxidase gene COX1,COX2 and COX3) and complex V (ATP6,ATP8 and ATP9). Ethidium 
bromide treated cells , known as petites, or ρ0 cells therefore rely on growth by fermentation due to 
the deficiency of the respiratory chain  and  cannot grow on non-fermentable carbon sources (Deken, 
1966; King et al., 2014). Using the GLuc construct described in chapter 3, we tested recombinant 
protein production by using Western blotting to determine levels of protein secreted or trapped 
within the cell. Strains expressing cof1-4, cof1-18 and cof1-21 alleles from class I, the cof1-10 allele 
from class II and the cof1-22 allele from class III were selected with varied mitochondrial function 
(Figure 4.3).  
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Figure 4.3.1 Expression of GLuc in strains expressing cofilin mutant alleles cof1-4, cof1-10, cof1-21, 
cof1-22 and their respective petite strains (ρ0). A) Blots of GLuc expression in mutants and petite 
strains (no mitochondrial DNA) and actin expression as a loading control. Expression detected in 
supernatant (S) and pellet (P). Cells were grown overnight in selective media and re-inoculated in 
standard YPD at OD600 0.1 and grown to the cell count 1x107. Protein was extracted from the pellet 
using the yeast whole cell quantitative method and supernatant treated with 2x sample buffer (n=3). 
Actin was detected in these strains and used to normalise data. 
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Figure 4.3.2 Quantified expression of GLuc in strains expressing cofilin mutant alleles cof1-4, cof1-10, 
cof1-21, cof1-22 and their respective petite strains (ρ0). A) Quantification of wild type strain. B) GLuc 
detected in supernatant and pellet in the wild type relative to cofilin mutant alleles. C) Quantification 
of GLuc expression in all mutants relative to their respective petite strain using the free software 
Image J. Cells were grown overnight in selective media and re-inoculated in standard YPD at OD600 0.1 
and grown to the cell count 1x107. Protein was extracted from the pellet using the yeast whole cell 
quantitative method and supernatant treated with 2x sample buffer (n=3). Actin was detected in these 
strains and used to normalise data. Errors bars represent standard deviation. Statistical analysis was 
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When comparing GLuc protein found in the supernatant and pellet in the wild type, we observed that 
roughly a third of the protein was secreted (Figure 4.3.2A). In comparison to the wild type, the mutants 
expressing the alleles cof1-4, cof1-10, cof1-18 and cof1-22 demonstrated no significant change to rP 
production, however cof1-21 exhibited a large increase in secreted Gluc (Figure 4.3.2B).  
Another striking result was the outcome of removing mitochondrial DNA from wild type cells. In this 
case we found an almost total loss of GLuc production (Figure 4.3.1). In contrast, all petite strains 
expressing the mutant alleles cof1-4, cof1-10, cof1-21, cof1-22 exhibited higher GLuc expression when 
compared to the wild type petite strain (Figure 4.3.2C). In petite strains expressing cof1-4, cof1-21, 
and cof1-22 alleles compared to their respective control strains (with mtDNA), we found removal their 
mtDNA caused a 50% or more loss in secretion. However, only mutant allele cof1-21 petite showed a 
statistical loss (I believe this is because of the large error bars).  
In all cases (with the exception of mutant allele cof1-10) removal of mitochondrial DNA led to a 
reduction in rP secretion. However, all cofilin mutants displayed higher GLuc production when mtDNA 
was absent compared to the wild type petite strain.  
The Gluc construct contains the mating alpha factor signal sequence needed for secretion and mating 
is controlled by MAPK signalling. Therefore, strains with altered MAPK may have an effect on how 
GLuc is expressed and secreted when associated with the alpha factor signal sequence. We were 
interested in investigating how well the cofilin mutant strains secreted rP with a different signal 
sequence. Strains expressing Cofilin mutant alleles were therefore transformed with a plasmid 
containing the killer toxin gene encoding for the subunits involved in the killer toxin cytotoxicity and 
immunity (Schmitt and Breinig, 2006a). These strains were spotted onto agar plates with a top layer 
of ¼ YPD agar, containing a strain known to be sensitive to the effects of secreted killer toxin called 
S7. When the killer toxin is secreted in this assay it leads to inhibition of growth in the sensitive strain, 
creating a zone of clearance, or a kill zone (Figure 4.4). The kill zone can be measured and used as an 
assessment of killer toxin secretion levels (see chapter 3 figure 3.9 for more details). Using this assay, 
we compared the secretion capabilities of the wild type to strains lacking mtDNA (Figure 4.4A) and to 
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Figure 4.4 Killer toxin secretion in cofilin mutant alleles with mitochondrial DNA removed. A) Average 
results from quantification of the dilution series of COF1. Dilutions were performed in the killer strain 
with a 5-fold, 2.5- fold and 2-fold dilution (right to left) of the final spot with the cell count 1.3x106. 
(n=5).  B)  Quantification of the kill zone from all control strains relative to wild type of the final spot 
with the cell count 1.3x106. C) Quantification of the kill zone from all control strains relative to petite 
strains of the final spot with the cell count 1.3x106 .Note there is no data for petite strain for cells 
expressing cof1-18. The kill zone was measured in Image J for quantification.  Killer strains were grown 
overnight in selective media and reinoculated the following morning to a cell OD600 of 0.2 and grown 
to the cell count 1x107. Once spotted on, these plates where left to grow at 30°C for 2-3 days 
depending on how long the sensitive strain need to grow (n=3). Errors bars represent standard 
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We discovered that with increasing cell number, there was an increase in clearance in both wild type 
control and petite cells at varied cell counts, yet levels were consistently lower in petites (Figure 4.4A). 
We observed reduced secretion of the killer toxin in cof1-10, cof1-18 and cof1-22 when comparing 
these to the wild type (Figure 4.4B), yet when comparing secretion between the control strains and 
their petites only cof1-22 petite had an increase in killer toxin secretion. In conclusion, this data 
suggests cofilin and mitochondrial function can influence killer toxin secretion.  
  
4.3 Investigating Interactions between Cofilin and TORC1 signalling  
 
Given the role that Cofilin has in connecting signalling mechanisms to mitochondrial function we 
investigated whether the expression of cofilin mutant alleles led to changes in pathways known to 
affect mitochondrial biogenesis in yeast. Previous studies have identified that TORC1 signalling is 
involved in controlling mitochondrial metabolism and biogenesis as well as the control of protein 
synthesis (Laplante and Sabatini, 2009). We therefore investigated whether the expression of mutant 
alleles of cofilin that elevated mitochondrial biogenesis also exhibited changes indicative of TOR 
signalling. 
 
 4.3.1 Increased rapamycin resistance in strains expressing cofilin mutant allelles  
 
Alterations in TORC1 signalling can lead to changes in sensitivity to the inhibitory drug rapamycin. 
Rapamycin inhibits signalling through the TORC1 complex and induces a number of changes, for 
example its application leads to cell cycle arrest and entry into G0 (Rohde et al., 2001; Smets et al., 
2010). FKB12 (a TORC1 binding protein) has been shown to be the target of rapamycin and its presence 
is required for its actions upon the cell (Michnick et al., 1991; Fingar and Blenis, 2004).  
Rapamycin is an immunosuppressive drug that forms a protein-drug complex with FKBP12, interacting 
with the FRB (FKBP12-rapamycin binding) domain of TOR protein (Shertz et al., 2010). This may block 
interactions between FRB domain in TOR and other regulatory proteins downstream such as Sch9,  or 
alter the composition of the multiprotein TORC1 preventing function of this essential pathway (Fingar 
and Blenis, 2004).  
We therefore employed resistance to rapamycin treatment as an indicator of TORC1 signalling within 
strains expressing mutant alleles of cofilin in comparison to their wild type parental strain (Figure 4.5). 
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Cells expressing mutant cofilin alleles were grown on varying concentrations of rapamycin containing 
agar plates to test at their sensitivity relative to wild type (COF1).  
 









Figure 4.5 Rapamycin resistance of cofilin mutants. Cells were grown overnight in YPD and spotted at 
a cell OD600 of 0.075 and left to grow on YPD agar containing 5ng/ml rapamycin at 30°C for 3 days. 
 
Cells expressing cofilin mutant alleles from Class I showed rapamycin resistance at 5ng/ml in contrast 
to the wild type cells (Figure 4.5).  All mutants expressing cofilin alleles cof1-4, cof1-5, cof1-10, cof1-
8, cof1-13 and cof1-22 (all from classes II and III, with exception of cof1-4) were more sensitive to 
rapamycin when compared to the wild type. This data suggests that mutants from class I, which have 
elevated levels of mitochondria and respiratory function, may have elevated levels of TORC1 
signalling. However it may also be the case that rapamycin is recovered from these cells by the action 
of drug pumps, or that resistance is mediated by some other mechanism that sequesters the drug or 
prevents its entry into cells. The increased sensitivity of mutant strains from class II and III, which 
exhibit mitochondrial dysfunction, may reflect an inability to regulate TORC1 signalling, a reduced 
capacity to extrude the drug or an increased rate of uptake.   
 
Microarray data from previous work in the Gourlay lab has shown the upregulation of drug pump 
activity in a PDR1-dependent manner in cells expressing allele cof1-6 (Kotiadis et al., 2012). It is 
possible that an upregulation of drug pumps may explain the rapamycin resistance results observed 
in figure 4.5. To test if rapamycin is a substrate for drug pumps, we measured growth while treating 
the cells with rapamycin alone or in combination with FK506 which inhibits the major ABC transporter 
 -Rapamycin                                                      +Rapamycin 
5ng/ml 
COF1 Cof1-4 Cof1-5 Cof1-6 
Cof1-7 Cof1-10 Cof1-8 Cof1-11 
Cof1-12 Cof1-13 Cof1-15 Cof1-18 
Cof1-19 Cof1-21 Cof1-22 
COF1 Cof1-4 Cof1-5 Cof1-6 
Cof1-7 Cof1-10 Cof1-8 Cof1-11 
Cof1-12 Cof1-13 Cof1-15 Cof1-18 
Cof1-19 Cof1-21 Cof1-22 
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PDR5 in yeast (Egner et al., 1998; Hendrych et al., 2009). Strains expressing cofilin mutant alleles were 
selected for this experiment which had shown a slight increase (list strains e.g. cof1-4) and a significant 
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Figure 4.6.1 Drug pump substrate test. A-B) Examples of growth from various cofilin mutant alleles in 
YPD containing 4ng/ml rapamycin and 1ng/ml FK506. Cells were grown over night before being 
reinoculated to an OD600 of 0.3 with various drugs. A slightly lower concentration of rapamycin was 
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Figure 4.6.2 Drug pump substrate test. A comparison of doubling times with rapamycin and FK506 between mutant alleles. Errors bars represent 
standard deviation. Statistical analysis was performed using an ANOVA test comparing growth of each strain in each drug compared to control 
growth (*P<0.05, **P<0.01, ***P<0.001). A slightly lower concentration of rapamycin was used than in figure 4.5 as cells appeared more sensitive 
in liquid media. 
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Overall, no effect on growth was observed when all strains grown in the presence of FK506 (Figure 
4.6.2). It was observed that rapamycin treatment alone and in conjunction with FK506 slowed growth 
in all strains; yet the wild type, mutant allele cof1-4 and cof1-6 had less resistance to rapamycin with 
a significant increase in doubling time compared to growth without any drug (Figure 4.6.2). The growth 
curves seen in figure 4.4.1 show the same growth profile of mutant expressing alleles cof1-13, cof1-
15, cof1-18, cof1-19 and cof1-21 with the different treatments.  
In comparison to all other strains expressing cofilin mutant alleles, cells expressing allele cof1-4 and 
cof1-6 appeared more sensitive to rapamycin in liquid media than on agar media. In contrast to what 
we had observed on agar, mutant expressing allele cof1-13 has resistance to rapamycin in liquid media 
containing rapamycin. Our findings suggest that rapamycin is not a substrate for the major multi-drug 
pump Pdr5 which is inhibited by FK506 treatment. 
 
As a control to confirm that FK506 treatment was inhibiting the action of the drug pump Pdr5, we 
incubated cells with itraconazole, a known substrate of ABC transporters and of Pdr5 (Hendrych et al., 
2009).  Rapamycin resistant cofilin mutants cof1-6, cof1-12 and cof1-18 from class I were tested for 
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Figure 4.7 Resistance of cof1-6, cof1-12 and cof1-18 to itraconazole with FK506. A) Growth of cells 
expressing the cof1-6 allele in 6.6µM itraconazole and 1ng/ml FK506. B) Growth of cells expressing 
the allele cof1-12 and cof1-18 (C). Cells were grown overnight before being re-inoculated to an OD600 
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In all strains expressing cofilin mutant alleles we observed resistance to Itraconazole when compared 
to wild type cells (Figure 4.7). This resistance was either completely abolished, in the case of cof1-6 or 
cof 1-12, or significantly reduced, in the case of cof1-18, in the presence of FK506 (Figure 4.7) This 
suggests that cells expressing cofilin allele cof1-18 may have higher upregulation of drug pumps and 
may need higher concentrations of FK506 to see a loss of resistance to Itraconazole. 
For further confirmation that the rapamycin resistance observed in cofilin mutant alleles in class I are 
not due to the activity of drug pumps, we deleted PDR1 in COF1, cof1-11, cof1-12, cof1-15 and cof1-
18 resistant cofilin mutant alleles (all from class I) using a HIS3 gene disruption cassette. PDR1 is a 
transcription factor which controls the transcription of  many drug pumps such as PDR5 (Butow and 
Avadhani, 2004). The effects of pdr1 deletion in strains expressing cofilin mutant alleles was then 
tested by growing cells on agar containing rapamycin (Figure 4.8).  
 
 
                        
Figure 4.8 Rapamycin resistance test with PDR1 deletion mutants. Cells were grown overnight and 
spotted at a cell OD600 of 0.075 and left to grow on YPD agar containing 5ng/ml rapamycin at 30°C for 
2-3 days. A dilution series was done with a 10 fold decrease in concentration. 
 
No growth was observed in wild type (COF1) samples spotted onto DO His plates containing 5ng/ml 
of rapamycin (Figure 4.8). However in all cases, the deletion of PDR1 in strains expressing cofilin 
mutant alleles did not lead to a loss rapamycin resistance. On the contrary, when comparing growth 
of the cofilin mutant strains, the deletion of PDR1 led to an increase in resistance to rapamycin 
treatment. This data supports that hypothesis that the rapamycin resistance observed in strains 
expressing mutant cofilin alleles is not caused by an increase in drug pump gene transcription 
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controlled by PDR1. However this data does not discount the possibility that drug pumps not under 
the control of PDR1 are responsible for the rapamycin resistance observed. 
To further investigate this we identified the non-essential genes with a Gene Ontology assignment of 
Drug transporters using the Saccharomyces cerevisiae genome database. This list represents a small 
collection of transcription factors and drug pumps (table 1). We tested whether deletion of each of 
these genes led to changes in rapamycin or itraconazole sensitivity, to identify which, if any, are 
needed for resistance. Strains were acquired from the S. cerevisiae genome wide knock out collection 
which are derived from the wild type strain BY4741 (Winzeler et al., 1999).  
Table1 List of transcription factors for MDR (multi-drug resistance genes) and drug transporters which 
are non-essential in yeast. Saccharomyces genome database and UniProt was used to collect this 
information.  
 
Gene name Role Regulation 
PDR1 Transcription factor for MDR PDR10, PDR5, 
PDR3 Transcription factor for MDR PDR10, PDR5 
PDR5 drug transporter  
PDR8 Transcription factor for MDR PDR15, YOR1 
PDR10 drug transporter  
PDR11 drug transporter  
PDR12 drug transporter  
PDR15 drug transporter  
PDR18 drug transporter  
YRR1 Transcription factor for MDR  
YOR1 drug transporter  
SNQ2 drug transporter  
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Figure 4.9 Drug pump deletion screen with rapamycin (3.75ng/ml) and 6.6µM Itraconazole. Cells were 
picked form agar plates and grown overnight in YPD and spotted at a cell OD600 of 0.075 and left to 
grow on YPD agar at 30°C for 3 days. 
 
When compared to wild type, the deletion of multi-drug transporters PDR10 and PDR18 (Figure 4.9), 
as well as the TF PDR8 led to increased rapamycin sensitivity when compared to the wild type 
(BY4741). This may indicate that these genes are needed for rapamycin resistance. Interestingly, it 
was PDR10 which was upregulated in micro array analysis comparing cofilin mutant allele cof1-6 to 
the wild type (Kotiadis et al., 2012).  As expected Itraconazole treatment caused growth inhibition in 
strains Δpdr1, Δpdr5 and Δyor1 (another drug transporter). Our data may suggest that itraconazole 
and rapamycin are substrates for different drug pumps (Figure 4.9). Further analysis would be required 
to confirm whether rapamycin may be pumped out by PDR10 and PDR18 in response to the activity 
of which may have TF PDR8.  
 
4.3.2 Investigating altered Sch9 signalling with altered cofilin mutant alleles   
 
Although our data suggests that drug pump activity may play a role in resistance to rapamycin, another 
possibility is that TORC1 kinase activity is elevated in response to mutations in cofilin. To determine 
whether cofilin mutant strains exhibit changes in TORC1 signalling, we made use of an assay which 
assesses the phosphorylation status of Sch9, a major downstream target of TORC1 signalling.  Sch9 
phosporylation affects a number of processes in the cell, including growth and ribosomal biogenesis 
(Hands et al., 2009). Due to the large size of this protein (~100kDa) and the  presence of multiple 
           Control   Rapamycin 3.75ng/ml       Itraconazole 6.6µM 
 
PDR1 PDR3 PDR5 
PDR8 
BY4741 
PDR10 PDR11 PDR12 
PDR15 PDR18 YRR1 YOR1 
SNQ2 
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phosphorylation sites, NTCB (2-nitro-5-thiocyanatobenzoic acid) was used to induce chemical  
fragmentation as previously described (Urban et al., 2007). Treatment with NTCB selectively 
cyanylates cysteine thiol and under alkaline conditions cleaves on the N-terminal side of the residue, 
which in turn leads to protein fragmentation(Wu et al., 1996). Using this method, fragments of Sch9 
are generated and changes in phosphorylation can be detected by SDS-PAGE. C-terminally HA-tagged 
Sch9 was detected by western blotting using an anti-HA antibody following fragmentation as 
described (Urban et al., 2007). Sch9 phosphorylation was tested using this method in strains 
expressing the alleles cof1-11 and cof1-18, which both displayed elevated rapamycin resistance and 
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B)                                  Log Phase                                 Post-diauxic shift     
     
 
Figure 4.10a Chemical fragmentation analysis of Sch9 phosphorylation during log phase and post 
diauxic shift. A) blots showing phosphorylated and dephosphorylated C-terminal sch9. B) Percentage 
of Sch9 phosphorylated and dephosphorylated. Cells were grown in selection media overnight and re-
inoculated to OD600 0.3 and left to grow into log and post-diauxic shift. Sch9 was detected using an 
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A)                               
 
       B)                                                                           
         
Figure 4.10b Repeat of chemical fragmentation analysis of Sch9 phosphorylation during log phase and 
post diauxic shift. A) blots showing phosphorylated and dephosphorylated C-terminal sch9. B) 
Percentage of Sch9 phosphorylated and dephosphorylated. Cells were grown in selection media 
overnight and re-inoculated to OD600 0.3 and left to grow into log and post-diauxic shift. Sch9 was 
detected using an anti-HA antibody.  
 
When comparing the levels of Sch9, we observed higher phosphorylation during log phase compared 
to post diauxic shift phase across all strains from both repeats (Figure 4.10A/B). This is expected as 
TORC1 is active during rapid growth which should lead to Sch9 phosphorylation. Sch9 was not 
detectable in all strains tested as cells moved into post-diauxic shift suggesting a reduction in TORC1 
activity. This data suggested that TORC1 activity is comparable during log and stationary phase cells in 
wild type and cofilin mutant strains, however there were no significant differences between strains 
with varied rapamycin resistance. When comparing the repeats on separate days, (Figure 4.10A/B) 
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higher levels of phosphorylated sch9 where detected in Figure 4.10A. However, this does not alter our 
overall conclusion that there are similar levels of Sch9 active between the wild type and mutants.  
 
4.4 Roles of Cofilin in regulating MAPK signalling  
 
MAPK signalling is important for not only mating in yeast, but for environmental sensing and response 
to a range of stimuli (Brückner et al., 2011).  There are four clearly defined MAPK pathways involved 
controlling mating, filamentous growth, high osmolarity and cell wall integrity. The kinase Hog1 (High-
Osmolarity-Glycerol) is needed for survival under hyperosmotic conditions and can be activated via 
two pathways (Molina et al., 2010). The first is by phosphorylation of Pbs2 under iso-osmotic 
conditions and the second is via Ste11; activation of Hog1 causes it’s translocation from the cytoplasm 
to the nucleus where it affects the expression of genes in response to hyperosmotic shock (Chen and 
Thorner, 2007). Previous work has indicated that MAPK signalling can be affected by mutations in 
cofilin (C. Gourlay, unpublished work). We therefore sought to determine the extent to which cofilin 
interacts with MAPK signalling pathways in yeast.  
 
4.4.1 Cofilin and activation of the p38 stress linked MAPK HOG1 
 
Yeast adapt rapidly to adverse environmental conditions. Changes to the environment act as cues, 
signalling to specific MAPK pathways (Bardwell, 2006). When there is an increase in dissolved solute 
concentration of the external medium in comparison to the internal osmolarity of the cell it causes a 
drop in turgor pressure. To deal with this, the cell’s internal osmolyte concentration is altered by 
increasing their synthesis of glycerol. This mechanism is activated by the High Osmolarity Glycerol 
(HOG) MAPK pathway which requires activation of Hog1, which is a functional ortholog p38 family in 
mammalian cells (Westfall et al., 2004; Rodríguez‐Peña et al., 2010). Activated Hog1 MAPK induces 
cellular osmo-adaptive responses such as accumulation of the osmolyte glycerol, inhibition of protein 
synthesis and temporary arrest of the cell cycle in G1 phase. There are two branches of the HOG 
pathway. The SLN1 branch activates Ssk2 and Ssk22 compared to the SHO1 branch that activates Ste11 
(see figure 1.5). Both branches activate Pbs2 (MAPKK) and subsequently activate Hog1 (MAPK) 
(Molina et al., 2010; Saito, 2010). Hog1 influences the expression of a wide variety of TFs; those 
grouped together are sequence related. These include Hot1 and Msn1, Msn2 and 4, Sko1, as well as 
Smp1 (Alepuz et al., 2001; Capaldi et al., 2008). 
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HOG1 is the yeast homologue of the human stress activated kinase p38MAPK. Previous studies have 
determined that an antibody that detects phosphorylation of p38MAPK in human cells is also able to 
report phosphorylation of Hog1 in yeast (Widmann and Gibson, 1999; Martín et al., 2005). We 
therefore examined the total levels of Hog1 and its phosphorylation in wild type and cofilin mutant 
strains COF1, cof1-5, cof1-8, cof1-12, cof1-19 and cof1-21 as well as Δhog1 in response to salt stress 











Figure 4.11 Expression of phosphorylated and whole Hog1 in log phase with salt stress. Western blot 
showing Hog1 phosphoylation and total Hog1 expression levels. PGK was used as loading control. Cells 
were grown in selection media overnight and reinoculated to at OD600 of 0.3 and left to grow. Strains 
indicated were treated with 162mM NaCl for 5 minutes at room temperature before protein was 
extracted using the yeast whole cell quantitative method. 
 
As expected levels of Hog1 phosphorylation were undetectable using western blotting in wild type 
cells but rose dramatically upon salt stress (Figure 4.11). Strains expressing cofilin mutant allele’s cof1-
8, cof1-19 and cof1-21 appeared to display low levels of Hog1 phosphorylation under normal growth 
conditions suggesting a degree of aberrant signalling. Further work is required to assess the 
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4.4.2 Cofilin and activation of the mating /pseudohyphal MAPK pathway 
 
Ste12, the MAPK transcription factor, activates genes in the mating and filamentation pathway which 
is activated in response to nutrient deprivation(Brückner et al., 2011). For these responses to occur 
within the cell, Ste12 regulates a different set of genes by binding to specific promoter elements. For 
mating response genes it binds as a homodimer to the DNA motif PRE (pheromone-regulated genes). 
However, Ste12 binds as a heterodimer with Tec1 to induce genes for filamentous growth, known to 
contain FRE (filamentous response element) sequence(Wong Sak Hoi and Dumas, 2010). Previous data 
has suggested that Ste12 activity is upregulated in a strain expressing the allele cof1-6 as a potential 
candidate for upregulating some of the identified genes such as TEC1 and FUS3 (Kotiadis et al., 2012). 
To determine the extent to which cofilin surface charge alterations can influence Ste12 activity, we 
employed a Ste12 activity β-Galactosidase assay using a vector containing the FRE promoter with the 
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Figure 4.12 Ste12 activity in cofilin mutants strains. Cells were grown overnight in DO URA and re-
inoculated to an OD600 of 0.3 in minimal media before being left to grow overnight to grow to an O.D 
of 5 before treated with Z buffer and ONPG to start the reaction. Cells were left to incubate until 
sufficient colour change was seen and the reaction stopped and its absorbance measured. A) Shows 
miller units read in β-galactosidase assay B) resistance to rapamycin in strains expressing cofilin 
mutant alleles (from figure 4.5). Errors bars represent standard deviation. Statistical analysis was 
performed using an ANOVA test (*P<0.05, **P<0.01, ***P<0.001).  
 
Our results show that cofilin mutants in class I exhibited elevated levels of Ste12 activity when 
compared to the wild type (COF1) (Figure 4.12A). In particular, the mutants expressing alleles cof1-4, 
cof1-6, cof1-12, cof1-19 and cof1-21 displayed significant increases in Ste12 activity compared to the 
wild type (all from class I); in comparison, cells expressing mutant allele cof1-15 was the only mutant 
allele from this class to present very low levels. Reduced levels of Ste12 activity were detected in all 
mutant alleles from class II and III compared to wild type (except expression of allele cof1-22). A broad 
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B)                      
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correlation was therefore observed with high Ste12 activity and those that exhibited resistance to 
rapamycin (Figure 4.5B).  
 
4.4.3 Investigating whether STE12 activity is linked to rapamycin resistance 
 
To investigate whether changes in Ste12 activity were important in mediating resistance to rapamycin 
we deleted the gene STE12 in strains expressing cofilin mutant alleles (Figure 4.12). This method was 
achieved using a gene disruption cassette which replaced STE12 by homologous recombination with 
a HIS3 marker. These cofilin mutant ste12 deletion strains were spotted onto agar containing 
rapamycin to test for any changes to resistance (Figure 4.13).  










Figure 4.13 STE12 was deleted in cells expressing cofilin mutant alleles. A) Control agar plate B) shows 
agar containing 6.25ng/ml rapamycin.  Cells were grown overnight and spotted at a cell OD600 of 0.075 
and left to grow on YPD agar containing rapamycin at 30°C for 2-3 days. 
 
Our data demonstrates that in all strains tested the deletion of STE12 led to a dramatic increase in 
resistance to rapamycin (Figure 4.13). This suggests that the regulation of STE12 activity is important 
in mediating resistance to rapamycin, but that its elevation in strains expressing mutant cofilin alleles 
may not be a contributing factor.  
 
                                 -Rapamycin                    +Rapamycin  
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4.4.4 Effect of STE12 deletion on growth 
 
We considered that changes in rapamycin resistance observed when deleting STE12 may be may be 
linked to growth rate. As growth rate changes can sometimes be unclear on solid agar spotting assays 
we compared the growth of the wild type and selected mutant strains expressing cofilin alleles 
containing the GLuc expression plasmid grown in liquid growth. Some of the cofilin mutant expressing 
alleles with Δste12, cof1-4, cof1-18, cof1-21 and cof1-22 were selected (from all three classes) for 





Figure 4.14.1 Growth of cofilin mutants with STE12 deleted. Logged growth curves of cofilin mutant 
expressing A) alleles cof1-4 and B) allele cof1-18. Cells were grown overnight before re-inoculated to 
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Figure 4.14.2 Growth of cofilin mutants with STE12 deleted. Logged growth curves of cofilin mutant 
expressing A) alleles cof1-21 and B) allele cof1-22. Cells were grown overnight before re-inoculated to 
















































































































Chapter 4 – Results 
130 | P a g e  
 
A) 









Figure 4.14.3 Quantified growth of GLuc-transformed cofilin mutants with STE12 deleted. A) 
Calculated doubling times of the wild type with Δste12. B) Doubling time of each cofilin mutant allele 
relative to the wild type. C) Doubling time of strains with Δste12 relative to their control. Cells 
containing the GLuc expression plasmid were grown overnight before re-inoculated to an OD600 of 0.3 
in selection media (n=3). Errors bars represent standard deviation. Statistical analysis was performed 
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When comparing the doubling time of the wild type with and without the STE12 gene, we did not 
observe a significant change in growth rate (Figure 4.14.3A). We identified changes to growth of cells 
expressing the mutant allele cof1-18 (Figure 4.14.3B) where there was a decrease in doubling time 
(1.44hrs compared to the wild type at 2.4hrs). However in cofilin mutant allele cof1-18 Δste12 cells, 
the doubling time was further increased to levels similar to the wild type (Figure 4.14.3C).  In 
comparison, deletion of STE12 had no significant influence on the growth of strains expressing alleles 
cof1-4, cof1-21, and cof1-22. This data suggests that the cofilin mutant allele cof1-18 causes changes 
to growth through Ste12 signalling, as removing STE12 returns the mutant’s growth roughly to the 
wild type doubling time. 
 
4.4.5 Effects on GLuc expression with MAPK alterations 
 
Our data demonstrates an interaction between cofilin function and the regulation of STE12-MAPK 
activity. As we have established that cofilin plays a role in the regulation of rP production and 
secretion, we wished to establish whether STE12 activity was involved. Protein was extracted from 
cells expressing cofilin mutant allele’s cof1-18 and cof1-21 which exhibited high Ste12 activity and 
increased rapamycin resistance, and from the same strains in which STE12 had been deleted. GLuc 
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Figure 4.15.1 Expression of GLuc in STE12 deletions in cofilin strains.  Blots of selected cofilin mutant 
alleles showing GLuc expression. Expression detected in supernatant (s) and pellet (p). Cells were 
grown overnight in selective media and re-inoculated in standard YPD at OD600 0.1 and grown to the 
cell count 1x107. Protein was extracted from the pellet using the yeast whole cell quantitative method 
and supernatant treated with 2x sample buffer (n=3). Actin was detected in these strains and used to 
normalise data. 
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Figure 4.15.2 Quantified expression of GLuc in ste12 deletions in cofilin strains. Cells were grown 
overnight in selective media and re-inoculated in standard YPD at OD600 0.1 and grown to the cell 
count 1x107. Protein was extracted from the pellet using the yeast whole cell quantitative method and 
supernatant treated with 2x sample buffer (n=3). Actin was detected in these strains and used to 
normalise data. Quantification of these blots using the free software Image J. Errors bars represents 
standard deviation. Statistical analysis was performed using an ANOVA test comparing GLuc detected 
in the supernatant between the wild type and each strain as well as the pellet (*P<0.05, **P<0.01, 
***P<0.001). 
 
Deleting STE12 in wild type caused no significant change in the levels of GLuc detected (figure 4.15.2), 
as was also the case for mutant allele cof1-18. Although there was an increase in mutant allele cof1-
21Δste12 compared to the wild type, this was not statistically different to the mutant allele still 
containing the STE12 gene.  
 
We were interested in any changes caused to the incorrectly processed forms of GLuc also shown in 
4.15.1, where other heavier bands appear in western blot. Figure 4.16 shows quantified GLuc 




Chapter 4 – Results 
134 | P a g e  
 
















Figure 4.16 Quantified expression of all forms of GLuc in STE12 deletions relative to their control in 
cofilin strains found in the pellet. A) Quantified GLuc expression in the wild type COF1. B) Quantified 
GLuc expression in mutant allele cof1-4. C)  Quantified GLuc expression in mutant allele cof1-18 D) 
Quantified GLuc expression in mutant allele cof1-21. Errors bars represent standard deviation. 
Statistical analysis was performed using the unpaired t-test comparing change in protein production 
by Δste12 relative to the control (n=3). (*P<0.05, **P<0.01, ***P<0.001). 
 
Δste12 caused a significant increase when quantifying all forms of GLuc (all bands in pellet sample) in 
the wild type with a very similar change in mutant allele cof1-4, roughly doubling GLuc detected (figure 
4.16A/B). The native form of GLuc in cof1-4 was not shown in figure 4.15.1 due to problems with the 
transfer creating larger error bars making it difficult to quantify; although this may suggest Δste12 
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increase in GLuc production in the pellet; in contrast cof1-18 had shown no change (Figure 4.16C/D). 
There is strong evidence that Ste12 signalling is involved in recombinant protein production 
independent of the cofilin protein (Figure 4.16). 
 
To determine whether the loss of STE12 also led to changes in secretion in all secreted protein, we 
again made use of the killer toxin assay (Figure 4.17). Secretion of killer toxin was assessed in cofilin 
mutant alleles cof1-4, cof1-18, cof1-12 and cof1-22 during log phase, the same strains used to test 
GLuc expression.  







        
Figure 4.17 The effects of STE12 deletion upon secretion of killer toxin in cofilin mutant strains. A) 
Killer toxin secretion of cofilin mutant alleles relative to the wild type. B) Killer toxin secretion of each 
control strain relative to Δste12. Killer strains were grown overnight in selective media and re-
inoculated the following morning to a cell OD600 of 0.2 and grown to the cell count 1x107.. Once 
spotted on, these plates where left to grow at 30°C for 2-3 days (n=3). The kill zone diameter was 
measured in Image J for quantification. Quantification of the kill zone of all strains with the cell count 
1.3x106 Errors bars represents standard deviation. Statistical analysis was performed using an ANOVA 
test (***P<0.001).   
 
We observed a loss in killer toxin secretion in cofilin mutant allele’s cof1-18 and cof1-22 (Figure 4.17A) 
and when comparing secretion of Δste12 relative to their control, we found mutant allele cof1-4 had 
a significant loss in killer toxin secretion and cof1-22 had an increase in killer toxin secretion (Figure 
4.17B). Overall these results are in contrast to my findings with regards to GLuc production. 
  
Chapter 4 – Results 
136 | P a g e  
 
4.5 Discussion  
 
In this chapter we investigated interactions between cofilin and the control of cell signalling processes 
that are important for environmental sensing, growth and stress response. Using a library of mutant 
alleles in which surface charged residues were mutated to alanine, previous work in the Gourlay lab 
had identified alterations to mitochondrial function placing these alleles into three set groups. These 
were tested in an array of assays to investigate how these changes may affect rP production.  
4.5.1 Mitochondrial function and its importance in recombinant protein production  
 
It is possible that enhanced mitochondrial function could have effects on protein processing in the 
secretory pathway due to the relationship between the ER and mitochondria as discussed by Vannuvel 
et al, (2013). This group discussed how these two organelles are linked by the ERMES junction, where 
calcium is exchanged, activating apoptosis triggered by ER stress. ER stress also modifies the 
morphology and bioenergetics of mitochondria as early ER stress was found to be more physically 
connected to the mitochondria, to favour calcium exchange. This change in morphology promotes ATP 
production, oxygen consumption as well as an increase in mitochondrial membrane potential (Bravo 
et al., 2011). Therefore, mitochondrial function is necessary for dealing with ER stress; enhanced 
mitochondrial function may help the cell to be better adapted, having a positive impact on rP 
production. Other evidence linking this cross talk to rP production suggested that ER stress and 
mitochondrial dysfunction may cause metabolic disorders such as Type II diabetes, due to altered 
insulin secretion (Lim et al., 2009).  
As previous work from the Gourlay lab had shown that mutant cofilin allele’s exhibited altered 
mitochondrial function (Kotiadis et al., 2012), a GLuc expression construct was introduced into  cofilin 
mutant strains to determine whether such changes would lead to altered rP expression or secretion. 
We discovered that the mutation of cofilin led to variation in GLuc protein production and secretion, 
with the highest secretion levels obtained in the strain expressing allele cof1-21 (Figure 4.3.2B). These 
results suggest that removal of mtDNA (generation of so called petite strains), and so a complete loss 
of respiratory capacity, led to the shutdown of Gluc expression directed by the mating factor signal 
sequence (Figure 4.3.2A). This significant reduction in rP expression was not observed in petite strains 
in which cofilin had been mutated, yet when removing mitochondrial DNA in the wild type this caused 
a highly significant loss in almost all GLuc expression in contrast to what was observed in the cofilin 
mutant allele strains (Figure 4.3.2D). Mutant allele cof1-10 was the only mutant stain (already with 
low mitochondrial function) which had little change to GLuc secretion in the petite strain while mutant 
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strain cof1-4, cof1-21 and cof1-22 had shown a 50% loss or more in GLuc secretion with loss of mtDNA 
(figure 4.3.2C). Cof1-10 is part of class II with impaired mitochondrial function, therefore creating a 
petite had less repercussions for the cell compared to all other strains. This data strongly suggests 
signalling between cofilin and the mitochondria are effecting rP production due to striking result in 
wild type, yet no loss to this extent seen in mutant alleles. This evidence suggested that changes to 
cofilin are buffering the effects on protein production by the loss of mtDNA; this may involve 
alterations to the signalling of cofilin effecting rP production. Other data also suggests that the MAPK 
signalling TF, Ste12 may interact with cofilin due to altered Ste12 activity in strains with enhanced 
mitochondrial function (see section 4.5.3). 
We wanted to test rP production with the killer toxin assay in the same mutate allele’s as with the 
GLuc production, as another recombinant protein (Figure 4.4B). In this assay, we found a reduction of 
toxin in mutant allele’s cof1-10, cof1-18, and cof1-22 where mutant allele cof1-4 and cof1-21 had 
shown the same GLuc production as the wild type in comparison (Figure 4.3.2C). Generally, we found 
little difference between the control and petite strains in the killer toxin assay with the exception of 
mutant allele cof1-22 which showed an increase in secretion with mtDNA removed (Figure 4.4). These 
findings are in contrast to what was found using the GLuc expression construct, and suggest the use 
of different signal sequences have a profound effect upon the expression and secretion of different rP 
proteins. The most striking result was that the petite strain expressing COF1 still produced and 
secreted the killer toxin, while GLuc expression had been supressed in this strain. However, further 
experiments to confirm this would require that the signal sequences used for GLuc and Killer toxin be 
swapped. The expected result would be that Killer toxin production would be supressed in the 
presence of the mating factor signal sequence when mitochondrial function is lost and that GLuc 
expression would be similar to that of wild type when directed by the killer toxin pre-sequence.  
Ste12 controls the mating response when cells are under stress, such as lack of nutrients, where yeast 
sporulate in search for nutrients as these specialised cells are highly resistant to environmental stress 
(Mata et al., 2002; Neiman, 2011). Therefore, we believe that these change to Ste12 signalling, will 
alter protein expression/secretion as this is driven by the mating factor targeting sequence. This may 
explain why we see a difference in the killer toxin assay and GLuc expression. It would be interesting 
to repeat the killer toxin assay but using the alpha factor sequence for secretion. Through western 
blotting, this model has provided us a means of comparing expression between yeast strains of GLuc 
trapped in the cell and what was secreted. Nevertheless, due to altered Ste12 levels caused by 
mutations in cofilin, using the alpha factor signal sequence causes conflict in understanding the 
changes to GLuc expression. Therefore this signal sequence is not the most appropriate, an alternative 
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would be to use a signal sequence from another yeast protein which is secreted well and not affected 
by altered Ste12 signalling, such as invertase, used in breaking down sucrose. 
4.5.2 Resistance to rapamycin in cofilin mutant alleles 
 
Due to previous studies linking the control of mitochondrial biogenesis by TORC1 signalling through 
post-transcriptional control (Bonawitz et al., 2007), we tested rapamycin resistance in strains 
expressing mutant alleles of cofilin (Hardwick et al., 1999; Laplante and Sabatini, 2009). We identified 
that cofilin mutant strains with increased mitochondrial biogenesis have an increased resistance to 
rapamycin (Figure 4.5). This resistance may suggest altered TORC1 signalling, however we found no 
evidence that cofilin mutant strains led to changes in Sch9 phosphorylation that would suggest this. 
Micro array data from previous work in the Gourlay lab comparing strains expressing alleles COF1 to 
cof1-6 also revealed an upregulation of an array of ATP-binding cassette (ABC) transporters. This 
upregulation is believed to be caused by the dramatic increase in respiratory function triggering a 
retrograde signal (Hallstrom and Moye-Rowley, 2000; Kotiadis et al., 2012). To test if drug pump 
expression were responsible for resistance to rapamycin, we grew a selection of mutant alleles in 
rapamycin with FK506 which inhibits the major drug pump PDR5 (Egner et al., 1998; Hendrych et al., 
2009) (Figure 4.6.2). Our findings suggest that unlike the documented resistance to Itraconazole 
exhibited in cofilin mutant strains with elevated mitochondrial activity (Kotiadis et al., 2012) 
rapamycin resistance is not conferred by PDR5.  
For further confirmation that these drug pumps are not responsible for the rapamycin resistance, was 
obtained by deleting the transcription factor PDR1 which regulates the expression of a number of ABC 
transporter genes. Deletion of PDR1 did not lead to changes on resistance to rapamycin in cofilin 
mutant strains. However the possibility remained that the expression of other drug pumps may 
control rapamycin resistance. To identify the drug pumps for which rapamycin may be a substrate we 
tested an array of strains from our deletion collection with drug pumps or TF that control them 
removed. These data suggested that the ABC transporters PDR10 and PRD18, and the TF PDR8 may 
be involved in the regulation of rapamycin resistance. In support of this PDR10 levels were increased 
in cells expressing the cofilin mutant allele cof1-6, which displays resistance to rapamycin (Kotiadis et 
al., 2012). PDR10 transcription is known to be controlled by both PDR1 and PDR3. However, deletion 
of PDR1 in resistant cofilin mutant strains did not sensitise cells to rapamycin (Figure 4.9). In addition, 
the deletion of PDR3 did not lead to rapamycin sensitivity. One possibility is that PDR8 or another 
transcription factor controls PDR10 and PDR18 levels and that these modulate resistance to 
rapamycin. This would require further investigation.  
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4.5.3 Cofilin mutant alleles have altered MAPK signalling effecting rP production 
 
Microarray data from previous work in the Gourlay lab had also shown that MAPK signalling 
components were upregulated in strains expressing allele cof1-6. In particular the MAPK components 
that were upregulated were components of the Mating and filamentous growth pathways that 
activate STE12 and STE12/TEC1 signalling respectively  (Widmann and Gibson, 1999; Saito, 2010). 
Changes in MAPK signalling in cells expressing mutant cofilin alleles implicate Cofilin in a role to link 
environmental signals to physiological responses.  
There is considerable reported crosstalk within MAPK signalling pathways. Therefore, we investigated 
which MAPK pathways were altered when cofilin was mutated. The expression of phosphorylation of 
the stress activated MAPK, Hog1, were tested  (Alepuz et al., 2001; Engelberg et al., 2014). No 
significant differences were observed in Hog1 phosphorylation in cofilin mutant strains suggesting that 
this pathway is not promiscuously activated by cofilin mutation. Some phosphorylated Hog1 was 
detected in cof1-8 cells during log phase growth. This mutation changes a motif in cofilin that contains 
a putative MAPK docking site. The level of activation was low but may warrant further investigation.  
As microarray studies suggested a linked between cofilin and the mating/filamentous growth 
pathways we examined Ste12 activity using an established reporter system. Data revealed very high 
levels of Ste12 activity in mutants expressing allele’s cof1-4, cof1-12 and cof1-19 in class I suggesting 
increased mitochondrial function may have an effect on Ste12 activity (Figure 4.12). When comparing 
Ste12 activity in all cofilin mutant strains to rapamycin resistance we observed a positive correlation, 
suggesting a link between Ste12 levels and rapamycin resistance. To investigate the link between 
Ste12 and rapamycin resistance further we deleted STE12 in strains with high MAPK activity and test 
their rapamycin resistance. Our data had demonstrated that the loss of STE12 led to a further increase 
in rapamycin resistance across all strains. This suggests that targets of STE12 may play a role in the 
regulation of rapamycin resistance, or may regulate the cells TORC1 signalling properties. It would be 
interesting for example to assess the levels of PDR10 in cells lacking STE12. 
Due to high Ste12 activity which related to strains with high mitochondrial function, we also tested if 
removing this gene would affect GLuc expression in mutant alleles with varied Ste12 activity. Although 
there was no change to the native form of GLuc with STE12 deleted (Figure 4.15.2), an increase was 
observed in the incorrectly processed forms of GLuc that appear on western blots in the pellet 
suggesting that Ste12 signalling has a role in the processing of rP (Figure 4.16). It may be the case that 
by deleting STE12, there a loss of control in the MAPK mating pathway which translates to an increase 
in the signal to produce alpha factor and so in this case expression of GLuc. However as we observed 
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only a modest increase in secretion it seems likely that the general secretory pathway was unable to 
cope. It would be necessary to increase the capacity of the secretory system to allow the increase in 
protein produced to be correctly folded and secreted. Future work would involve increasing the 
capacity of the secretory pathway through the overexpression of chaperones to increase proper 
protein folding. For example, the overexpression PDI, an enzyme needed for disulphide formation 
which has been proven to benefit rP production  (Inan, Aryasomayajula, Sinha, & Meagher, 2006; 
Wittrup, 1995). In the yeast, P.pastoris, overexpression of PDI enhanced the secretion of the protein 
Necator americanus (Na-ASP1), a potential vaccine against hookworm infections (Inan et al., 2006).  
We observed a loss of killer toxin secretion in mutant allele cof1-4Δste12 compared to the control 
strain cof1-4 (Figure 4.17B). The cofilin mutant allele cof1-22 had an increase in killer toxin secreted 
with Δste12 compared to the control strain. These results vary compared to GLuc production, again 
confirming results of GLuc production are specific to that construct containing the mating pheromone 
signal sequence.  
4.5.4 Conclusion 
 
This chapter has highlighted the connections between the control of MAPK signalling and 
mitochondrial function by the actin binding protein Cofilin and rP secretion. This work strongly 
implicates the regulation of STE12 in the control of expression of rP protein that uses the mating factor 
signal sequence. Cofilin and mitochondrial function appear to be important for the regulation of MAPK 
signalling through STE12 and so can influence the expression of rP molecules that use the mating 
factor signal sequence. This work should be furthered by enhancing the capacity of the secretory 
pathway in cells lacking STE12, which led to a significant increase in expression of the rP Gluc. This 
may be achieved through the overexpression of the ER protein, PDI, improving the secretion of GLuc. 
It may be possible to significantly enhance rP signalling using this approach.  
STE12 expression also appears to be linked to resistance to the drug rapamycin. We suggest that the 
rapamcyin  resistance  was  not  due to hyper active TOR signalling even though previous micro array 
data from the Gourlay lab has pointed towards this pathway but due to the upregulated drug pumps 
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5.1 Introduction to the role of TOR signalling in recombinant protein 
production 
 
The improvement of recombinant protein production is a difficult task given the complexity of protein 
synthesis, protein processing and folding and secretion (Hou et al., 2012). Engineering a cell to over 
express a protein may not be straight forward, for example elevation of a particular rP may be toxic 
(Graf et al., 2009).  Environmental conditions or cell responses to stress, protein folding/aggregation 
and secretion can also contribute to the efficiency of rP production (Gasser et al., 2007). However, 
despite the complexities of cell biology, it may be possible to improve rP production by manipulation 
of central pathways that co-ordinate environmental signalling with growth, rather than just improving 
one particular cell trait (Dreesen and Fussenegger, 2011). 
The TORC1 (target of rapamycin) signalling network plays an important role in integrating 
environmental signals with growth. A brief description of this pathway and its control is provided in 
the introduction chapter of this thesis (see section 1.3.5). In view of TOR being a described as a master 
regulator of signalling, protein synthesis, ribosome biogenesis and proliferation within the cell, here it 
was investigated whether the manipulation of TORC1 signalling could be employed to enhance 
recombinant protein (rP) production in a yeast expression system. To achieve this, a screening 
approach was employed whereby Gaussia luciferase expression and secretion was assayed in a library 
of yeast strains deleted for individual genes within the TORC1 network.  The genes that were 
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Figure 5.1: The TORC1 network in yeast. Upstream and downstream regulators of TORC1, most of 
which are used in the initial screen discussed in this chapter (identifiable by red box).  The green P 
indicates phosphorylation. Key above shows arrows representing interactions. Adapted from Smets 
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Table 5.1: List of genes investigated and roles in TORC1, and grouped according to their roles.  
Gene Function 
SIT4 functions in the G1/S transition of the mitotic cycle 
TIP41 response to DNA replication stress 
PKH1 required for maintenance of cell wall integrity 
PKH2 required for maintenance of cell wall integrity 
SKO1 cytosolic and nuclear protein involved in osmotic and oxidative stress responses 
HOG1 MAPK involved in osmoregulation 
RTG1 Retrograde signalling 
RTG3 Retrograde signalling 
MSN2 TF that regulates the general stress response 
MSN4 TF that regulates the general stress response 
RIM15 Stress response protein kinase 
GIS1 Stress response  TF 
GTR1 Component of EGO complex in amino acid sensing, signals directly to TORC1 
GTR 2 Component of EGO complex in amino acid sensing, forms heterodimer with Gtr1 
EGO1 Component of EGO complex in amino acid sensing, acts as an anchor to the vacuole 
EGO3 Component of EGO complex in amino acid sensing, binds with Ego1 
VAM6 Vacuolar protein and GEF for GTR proteins, role in vacuolar membrane fusion 
ATG1 Autophagy gene, vesicle formation in autophagy, binds to Atg13 
ATG13 Autophagy gene, regulatory subunit of Atg1 signalling complex 
TOR1 subunit of TORC1 
TCO89 component of the TOR complex 1, role in cell wall integrity 
FRP1 Encodes FKBP12, rapamycin target in TORC1 
RPS6A Protein component of the small (40S) ribosomal subunit 
RPS6b Protein component of the small (40S) ribosomal subunit 
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CRF1 role in repression of RP genes 
SFP1 Regulates transcription of ribosomal protein and biogenesis genes 
GCN2 Protein kinase, phosphorylates alpha-subunit of eIF2 in response to starvation 
GCN4 transcriptional activator of amino acid biosynthetic genes 
GLN3 
TF involved in positively regulating genes subject to nitrogen catabolite repression 
(NCR) 
NPR1 Permease sorting and degradation, possibly involved in ribosome biogenesis 
MAF1 negative regulator of RNA polymerase III 
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TORC1 signalling provides the cell with a means of monitoring, responding to and controlling stress 
response genes that contribute to processes such as osmotic stress response, the retrograde 
response, loss of nutrition and energy depletion and DNA damage which leads to apoptosis (Proud, 
2007). Evidence supports the idea that manipulating expression levels of upstream and downstream 
TORC1 targets may affect rP production. For example CHO (Chinese hamster ovary) cells engineered 
to constitutively overexpress mTOR in one particular study found increased cell size, protein content, 
viability and proliferation. These cells exhibited reduced mortality due to the action of TOR in 
increasing cell robustness to sub-optimal culture conditions seen with oxygen and growth factor 
limitations (Dreesen and Fussenegger, 2011). In cells with the co-overexpression of Bcl-2 (inhibiting 
apoptosis) and pro-autophagy by Becinl-1 (Atg6/Vps30 yeast orthologue) a longer culture period 
allowing autophagy to remain within the homeostatic range was observed, reflecting the importance 
of regulating autophagy during rP production (Pattingre et al., 2008; Lee et al., 2013). This is further 
evidence of how controlling TORC1 improves key bioprocesses - relevant characteristics discussed 
above resulting in engineered CHO cells with improved secretion of therapeutic IgGs with a four-fold 
increase over the wild type expression levels (Dreesen and Fussenegger, 2011). 
External stresses such as temperature, nutrient limitation and pH, along with intrinsic stress from 
protein expression can limit rP production (Ferrer-Miralles et al., 2009). When P.pastoris was 
subjected to sub-optimal temperature (20°C), this resulted in a down regulation of stress response 
genes. This also led to an increase in secretion of a Fab antibody fragment due to enhanced 
transcription of components of secretory transport and the ER associated degradation  (Gasser et al., 
2007). In S.cerevisae, growth in low temperatures results in an TORC1 mediated upregulation of 
ribosome biogenesis genes increasing protein synthesis (Tai et al., 2008). Further evidence for the 
involvement of TORC1 in rP production was reported by Kitagawa et al. (2011) who identified that the 
transcription factor SFP1, which controls the TORC1 and PKA dependent expression of ribosomal 
biogenesis genes via the localisation of Sfp1, is involved in the enhancement of cellulose protein 
production (Marion et al., 2004; Kitagawa et al., 2011).  
Through TORC1 regulation, translational activity is increased when CHO cultures are continually fed 
nutrients leading to further growth and productivity (Huang et al., 2010; Edros et al., 2014). A recent 
paper which studied polysome profiling with rapamycin treatment in CHO culture found a shift in the 
proportion of polysomes (or polyribosomes) towards monosomes with a 30% decrease in maximal 
growth rate compared to the batch culture with a supply of nutrients activating the TOR pathway. 
Targeted quantification of the mRNA of heavy and light chain antibodies showed up to 5-fold higher 
specific translation due to the increase (up to 2-fold) in global translation and increased cellular growth 
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with nutrients supplied (Courtes et al., 2013). The examples given above are evidence supporting the 
hypothesis that TORC1 intervention may present a viable approach to manipulate rP production, and 
to identify new potential avenues outside stress and death control for manipulating the cell for 




5.2 A TOR screen to investigate alterations in recombinant protein 
production 
 
5.2.1 Effects of rapamycin on growth and GLuc expression 
 
Rapamycin binds to FKBP which in turn inhibits TORC1 signalling causing decreased protein synthesis 
and  ribosomal biogenesis with a reduction in growth (Dubouloz et al., 2005). We therefore tested 
how rapamycin treatment would affect rP expression in wild type yeast cells (BY4741). To achieve this 
we introduced a plasmid expressing the Gaussia luciferase gene (GLuc) from the organism Gaussia 
principes (described in chapter 3) and measured expression and secretion during log phase growth by 
western blotting (Tannous et al., 2005).   
To find the optimum rapamycin concentration, a range of concentrations were investigated and the 
effect on growth monitored by absorbance using an automated plate reader (see Figure 5.2a). This 
was undertaken to identify the lowest concentration at which rapamycin would measurably slow 
growth and rP production while maintaining cell viability so GLuc production could still be detected 
by western blot. From these experiments it was determined that a concentration between 2 and 5 
ng/ml was suitable for further use (Figure 5.2.1-5.2.2). 
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Figure 5.2.1 Effect of rapamycin treatment on GLuc expression in wild type cells. A) Investigating 
effects of varied rapamycin treatment on growth of wild type (BY4741) (n=1). B) Blot of GLuc and β-
actin expression as control with and without 3 ng/ml rapamycin (n=3). C) Quantification of GLuc and 
actin expression as a loading control in the supernatant and pellet using the free software Image J. D) 
Percent GLuc secreted with and without 3 ng/ml rapamycin treatment. Cells were grown overnight in 
YPD containing either DMSO or rapamycin, and reinoculated in media at the cell count 1x106 cells/ml 
with DMSO or rapamycin and grown to the cell count 1x107 cells/ml. Protein was extracted from the 
pellet using the yeast whole cell quantitative method. Errors bars represent standard deviation. 
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A) 
    
 
B) 
                                           
 
Figure 5.2.2 Effect of rapamycin treatment on growth in wild type cells with 3 ng/ml rapamycin. A) 
Growth of the wild type with and without 3 ng/ml rapamycin treatment. B) Calculated doubling time 
of wild type cells with and without rapamycin treatment. Cells were grown overnight in YPD containing 
either DMSO or rapamycin, and reinoculated in media at the cell count 1x106 cells/ml with DMSO or 
rapamycin and grown to the cell count 1x107 cells/ml. Protein was extracted from the pellet using the 
yeast whole cell quantitative method. Errors bars represent standard deviation. Statistical analysis was 
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Following the addition of more than 5 ng/ml rapamycin there was a strong effect on growth with 
continued growth inhibition as the concentration is doubled (Figure 5.2.1A). From this growth analysis 
we decided to use a concentration of 3 ng/ml so that there was still an effect on growth but the cells 
were still viable and produced rP. This concentration of rapamycin was used to test the effects of GLuc 
expression during log growth where we observed a decrease in GLuc protein production observed on 
the western blot (Figure 5.2.1C). However, after quantification we observed no significant change to 
secretion with 3 ng/ml rapamycin treatment (Figure 5.2.1D) but a decrease in GLuc trapped in the 
pellet (Figure 5.2.1C). When calculating the doubling time of the wild type with and without 3 ng/ml 
rapamycin treatment (Figure 5.2.2A), there was no significant change to growth (Figure 5.2.2B) 
suggesting rP production can be reduced by the inhibition of TORC1 signalling at this concentration 
without affecting cell growth. 
 
5.2.2 A TOR screen to identify genes that alter recombinant protein production in yeast 
 
To identify specific targets, both upstream and downstream of TORC1 which can modulate rP 
production, we screened all available yeast strains deleted for each non-essential gene that has been 
identified within the TOR signalling network.  GLuc expression and secretion was tested during log 
phase of growth by western blot. It should be noted that while strains did achieve log phase growth 
within four hours of sub-culture (determined by cell counting) there were some obvious differences 
in growth rate associated with the deletion. This represents a limitation of the strategy as in these 
cases samples were in early log or late log phase. Due to the large numbers of samples, it was not 
feasible to wait for strains to reach the same cell count. However, all results obtained were 
reproducible and this initial screen was used to identify putative candidate genes whose deletion 
resulted in altered rP production (Figure 5.3.1-5.3.6).  
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Figure 5.3.1 Results of GLuc expression in yeast cells deleted for components of the TOR signalling 
network. Cells were grown in selective media overnight and re-inoculated to an OD600 of 0.3 in YPD 
and left to grow into early log (roughly 4 hrs). A whole cell protein extraction method was used to test 
GLuc found in the supernatant and pellet (n=3). Blots showing GLuc expression in the supernatant (S) 
and pellet (P). Errors bars represent standard deviation. Statistical analysis was performed using one 
way ANOVA test with significance annotated comparing what was detected in the supernatant of each 










S      P       S        P       S       P 
 
WT Δsit4 




































Chapter 5 – Results 






















Figure 5.3.2 Results of GLuc expression in yeast cells deleted for components of the TOR signalling 
network. Cells were grown in selective media overnight and re-inoculated to an OD600 of 0.3 in YPD 
and left to grow into early log (roughly 4 hrs). A whole cell protein extraction method was used to test 
GLuc found in the supernatant and pellet (n=3). Blots showing GLuc expression in the supernatant (S) 
and pellet (P). Errors bars represent standard deviation. Statistical analysis was performed using one 
way ANOVA test with significance annotated comparing what was detected in the supernatant of each 
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Figure 5.3.3 Quantified results of GLuc expression in yeast cells deleted for components of the TOR 
signalling network. Cells were grown in selective media overnight and re-inoculated to an OD600 of 0.3 
in YPD and left to grow into early log (roughly 4 hrs). A whole cell protein extraction method was used 
to test GLuc found in the supernatant and pellet (n=3). A) Quantification of GLuc expression in the 
wild type using the software Image J. B-D) GLuc expression in TOR screen as a factor of the wild type. 
Errors bars represent standard deviation. Statistical analysis was performed using one way ANOVA 
test with significance annotated comparing what was detected in the supernatant of each strain to 
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Figure 5.3.4 Quantified results of GLuc expression in yeast cells deleted for components of the TOR 
signalling network. Cells were grown in selective media overnight and re-inoculated to an OD600 of 0.3 
in YPD and left to grow into early log (roughly 4 hrs). A whole cell protein extraction method was used 
to test GLuc found in the supernatant and pellet (n=3). A-D) GLuc expression in TOR screen as a factor 
of the wild type. Errors bars represent standard deviation. Statistical analysis was performed using 
one way ANOVA test with significance annotated comparing what was detected in the supernatant of 
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Figure 5.3.5 Quantified results of GLuc expression in yeast cells deleted for components of the TOR 
signalling network. Cells were grown in selective media overnight and re-inoculated to an OD600 of 0.3 
in YPD and left to grow into early log (roughly 4 hrs). A whole cell protein extraction method was used 
to test GLuc found in the supernatant and pellet (n=3). A-D) GLuc expression in TOR screen as a factor 
of the wild type. Errors bars represent standard deviation. Statistical analysis was performed using 
one way ANOVA test with significance annotated comparing what was detected in the supernatant of 
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Figure 5.3.6 Quantified results of GLuc expression in yeast cells deleted for components of the TOR 
signalling network. Cells were grown in selective media overnight and re-inoculated to an OD600 of 0.3 
in YPD and left to grow into early log (roughly 4 hrs). A whole cell protein extraction method was used 
to test GLuc found in the supernatant and pellet (n=3). A) GLuc expression in Δmaf1 screen as a factor 
of the wild type. B) Percentage GLuc secreted in screen from western blots shown in 5.3.1A.  Errors 
bars represent standard deviation. Statistical analysis was performed using one way ANOVA test with 
significance annotated comparing what was detected in the supernatant of each strain to the wild 
type, the same for pellet against the wild type (**P<0.05, **P<0.01 ***P<0.001). 
 
When testing this background strain of yeast, in the wild type we found that approximately 45% of 
GLuc product was secreted (see Figure 5.3.6B). From the pellet, a doublet was observed; at 19 kDa 
was the GLuc mature product with the lower band showing some possible degradation product. An 
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The deletion of a number of genes in the TOR signalling network lead to variation in GLuc expression 
with most showing a decrease in the protein detected. A summary of these results is provided below 
in Table 5.2 listing which were significantly higher or lower producers of GLuc when the specified gene 
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Table 5.2 High and low producers of GLuc detected in the supernatant and pellet with deleted 
components of the TORC1 pathway. This is a summary of data from figure 5.3.3B-5.3.6A above 
placing strains within their grouped roles. Stars represent their statistical significance (**P<0.05, 
**P<0.01 ***P<0.001) Gene names in bold had shown reduced secretion compared to the wild type 
as a percentage of total GLuc calculated. S (supernatant), P (pellet).  
Increase in rP production: 
Gene S P Role in TORC1 signalling 
TIP41  * response to DNA replication stress/subunit of complex signalling  
GIS1 * ** Stress response  TF 
Decrease in rP production: 
Gene S P Role in TORC1 signalling 















MSN4  * general stress response 



























NPR1 **  Permease sorting/degradation 
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With alterations in the expression to specific genes within the TORC1 pathway, varied alterations in 
GLuc production were observed, some resulting in a total loss in GLuc expression detected in the 
supernatant and pellet whilst in other cases there was an increase. In other cases a change to GLuc 
was detected in either the pellet or supernatant, but not both relative to the wild type. This data is 
summarised from figures 5.3.1/2/3/4 in table 5.2. These strains were placed into groups depending 
on their described role in the cell.  
The deleted genes causing an increase in observed GLuc production included TIP41, coding for the 
protein in the complex downstream of TORC1 which had an increase in GLuc trapped in the pellet in 
comparison to the wild type.  The stress response TF GIS1 when deleted caused an increase in total 
GLuc production detected in both the supernatant and pellet compared to the wild type. Surprisingly, 
compared to the wild type, the other component of the complex below TORC1 when the gene coding 
for SIT4 was deleted, a decrease in GLuc was detected in the pellet in contrast to the deletion of TIP41. 
Multiple components of the TORC1 complex were deleted and GLuc production determined, however, 
there was no significant change to quantified GLuc expression in either the supernatant or pellet 
compared to the wild type (Figure 5.3.1A). 
A reduction in GLuc detected was observed in the supernatant compared to the wild type in removal 
of the cell wall integrity and osmoregulation genes PKH2 (however no change with removal of PKH1), 
HOG1 and SKO1 which incidentally gave a significant loss in the percentage of GLuc secreted of the 
total GLuc quantified (all samples had the same cell number).  Other stress pathways effecting GLuc 
production with genes removed include the retrograde genes RTG1/3 causing a total loss in GLuc 
production as there was less GLuc detected in both the supernatant and pellet in comparison to the 
wild type. However, the stress responsive gene MSN4 when deleted caused a loss to GLuc expression 
detected in the pellet yet no change in Δmsn2 or Δrim15 deletions.  
Interestingly, the data suggest a role for the EGO complex (with a role in amino acid sensing) in rP 
production as deletion of EGO1, which is responsible for anchoring the EGO complex to the vacuole, 
caused a loss in total GLuc production as there was significantly less GLuc detected in both the 
supernatant and pellet compared to the wild type. However, when comparing the other strains Δgtr1, 
Δgtr2, Δego3 and Δvam6, also involved in this complex to the wild type, no significant changes to GLuc 
expression levels in the pellet or supernatant were observed. Yet when comparing GLuc expression in 
Δgtr1 to its heterodimer removed Δgtr2, a significant change in GLuc expression detected in the pellet 
was observed. Moreover, when comparing GLuc expression in Δego1 to Δego3, we discovered a 
significant increase in GLuc expression in both the supernatant and the pellet; all this data signifies 
the involvement and importance of the EGO complex. 
Chapter 5 – Results 
160 | P a g e  
 
We observed changes to GLuc expression in comparison to the wild type in autophagy deletion strains 
Δatg1 and Δatg13, where both deletions lead to a reduction in GLuc detected in the pellet yet a 
reduction in the supernatant in Δatg13 in comparison to the wild type. When comparing the 
percentage of the total GLuc detected that was secreted, we found that Δatg1 had a 14% increase 
(Figure 5.3.4B). 
TORC1 signalling controls components of the small ribosomal subunit (RPS6A/PRS6B) and regulation 
of ribosomal proteins and biogenesis (via CRF1 and SFP1) downstream. When these genes were 
deleted, a significant loss of GLuc detected in the supernatant and pellet was observed (bar SFP1 which 
just had a decrease in GLuc in the supernatant) in comparison to the wild type. Removal of the 
nitrogen discrimination gene (GLN3 and GCN4) and the removal of control of permeases Gap1 and 
Tat2 by deletion of NPR1 all had a negative effect on rP as there was a loss pf GLuc detected in the 
supernatant in comparison to the wild type (Smets et al., 2010). However, in comparison to the wild 
type, ΔGLN3 also exhibited a loss of GLuc expression detected in the pellet. 
In conclusion, a range of genes within the TORC1 signalling pathway appear to impact upon the 
production of GLuc. The roles of the genes that have been identified are varied, however in some 
cases more than one gene within the same process was identified, for example within the EGO 
complex or the process of autophagy.  
 
5.2.3 Overexpression of selected TOR targets 
From the initial screen we selected a small number of deletion strains for further examination. This 
was done to confirm reproducibility of the results obtained from the screening process and to 
determine whether observed changes in rP production or secretion were a result of the loss of the 
gene in question as opposed to strain background effects.  
Therefore we investigated further whether loss of the genes encoding GTR1 and GTR2, which are 
part of the EGO complex, and their GEF, VAM6, led to changes to rP production. The screen (Figure 
5.3) had shown differences in expression profile between the removal of the heterodimers Gtr1 and 
Gtr2. This is an interesting result as they are known to work together in signalling to TORC1 (Binda et 
al., 2009). Although we detected changes to rP production in EGO1 and EGO3 deletions (these 
proteins are so far only known to function as an anchor to the vacuole), we were interested in 
investigating the GTR component of the complex as this directly effects amino acid sensing (Zhang et 
al., 2012). Despite these changes to the EGO complex, we found no alteration to rP production when 
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deleting VAM6 where this is known to act as a GEF to Gtr1 and Gtr2. However, further studies were 
undertaken on this gene due to its role influencing the EGO complex and TORC1 downstream. 
In addition we further analysed TCO89 encoding the TORC1 component Tco89. Deletion of this gene 
reliably altered rP production where we found no change to GLuc expression compared to the wild 
type, but less degradation product suggesting Tco89 may affect stability of GLuc. Little is known about 
the role of this gene however recent data suggests that Tco89 directly interacts with Gtr1 in signalling 
to the TORC1 complex and so continued to investigate this gene (Sekiguchi et al., 2014).  
Deletion in autophagy genes, ATG1 and ATG13 resulted in the loss of rP production, with an increase 
in the ratio of GLuc found in supernatant to pellet in Δatg1 of 14% (Figure 5.3). Both proteins work 
together along with Atg17 (FIP200 in mammalian cells) in initiating autophagy, producing an 
interesting result when this was measured in log phase where there are still an abundance of 
nutrients. It has been reported that increased Atg1 alone leads to down regulation of TOR activity 
which illustrates the importance of the balance of autophagy (Scott et al., 2007). We chose to focus 
on Atg1 as this is the main coordinator of autophagosome formation with direct signalling to S6K (Sch9 
in yeast) in drosophila (Lee et al., 2007; Mizushima, 2010). 
To further investigate whether these deleted genes were responsible for the observed changes in rP 
production, an expression vector was created to re-express each protein in the deletion strains.  
5.2.3.1 Measuring mRNA levels with overexpression  
In order to check that the vectors generated for re-expression were functional we measured the mRNA 
levels during log phase growth. mRNA was extracted from deletion strains containing the plasmid 
overexpressing each gene and mRNA levels measured using qRT-PCR.  Measured mRNA levels are 
presented in figure 5.4 showing mRNA measured relative to the wild type with selected TOR strains 
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Figure 5.4 Relative mRNA levels of overexpressed VAM6, TCO89, GTR1, GTR2, and ATG1 relative to 
wild type. A-E) Mean-fold increase in mRNA expression of each gene. mRNA was extracted from strains 
grown overnight in selection media and re-inoculated in YPD to the cell count 1x106 and grown to the 
cell count 1x107 cells/ml. (n=3) Actin mRNA levels were measured and used to normalise the data. 
Errors bars represent standard deviation.  
The data obtained in figure 5.4 shows that mRNA of GTR1 and GTR2 produced from a plasmid source 
led to a significant increase in the mRNA level of each gene tested relative to the wild type. GTR1 
showed an exceptionally large increase, yet there was no significant change in mRNA with TCO89, 
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5.2.3.2 Overexpression of selected genes Δatg1, Δtco89, Δgtr1, Δgtr2 and Δvam6 
We wanted to further analyse the changes in rP production observed in Δatg1, Δtco89, Δgtr1, Δgtr2 
and Δvam6 strains. We also introduced expression vectors to re-express each protein into the 
appropriate gene knockout strains. These cells were grown into log phase and sampled for GLuc 















Figure 5.5.1 GLuc expression was assessed in Δatg1 and Δtco89, transformed with either an empty 
plasmid (marked +e) or with a vector re-expressing the deleted gene. a) GLuc and actin expression in 
the wild type as control. b) Blots of GLuc and actin expression of Δatg1 in the supernatant(s) and pellet 
(p). C) Blots of GLuc and actin expression of Δtco89 in the supernatant(s) and pellet (p). Cells were 
grown overnight in selective media and re-inoculated in YPD at the cell count 1x106 and grown to the 
cell count 1x107. Protein was extracted from the pellet using the yeast whole cell quantitative method 
(von der Haar, 2007) (n=3). Expression of GLuc and actin in the western blots were quantified using 
the software Image J. Errors bars represent standard deviation. Statistical analysis was performed 
using an ANOVA test with significance annotated comparing what was detected in the supernatant of 
each strain to the wild type, and what was detected in the pellet  of each strain to the wild type 
(*P<0.05, **P<0.01 ***P<0.001). 
 
 

















Δtco89 Δtco89 + Tco89^ WT + Tco89^ 
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Figure 5.5.2 GLuc expression was assessed in Δgtr1, Δgtr2 and Δvam6 transformed with either an 
empty plasmid (marked +e) or with a vector re-expressing the deleted gene. a) GLuc and actin 
expression in the wild type as control. B-D) Blots of GLuc and actin expression of Δgtr1, Δgtr2 and 
Δvam6 in the supernatant (s) and pellet (p). Cells were grown overnight in selective media and re-
inoculated in YPD at the cell count 1x106 and grown to the cell count 1x107. Protein was extracted 
from the pellet using the yeast whole cell quantitative method (von der Haar, 2007) (n=3). Expression 
of GLuc and actin in the western blots were quantified using the software Image J. Errors bars 
represent standard deviation. Statistical analysis was performed using an ANOVA test with significance 
annotated comparing what was detected in the supernatant of each strain to the wild type, and what 









Δgtr1 Δgtr1 + Gtr1^ WT + Gtr1^ 
Δgtr2 Δgtr2 + Gtr2^ WT + Gtr2^ 
Δvam6 Δvam6 + Vam6^ Δvam6 + Vam6^ 
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Figure 5.5.3 GLuc expression was assessed in Δgtr1, Δgtr2, Δvam6, Δatg1 and Δtco89 strains 
transformed with either an empty plasmid (marked +e) or with a vector re-expressing the deleted 
gene. A) Quantified GLuc expression of Δgtr1, Δgtr2, Δvam6, Δatg1 and Δtco89 from Figure 5.5.1-3. B) 
Quantified Gluc expression relative to the wild type of Δgtr1 transformed with an empty plasmid, and 
re-expression in the deletion stain and wild type (Western blot seen in Figure 5.5.1-3).  This is also 
shown in C) with Δgtr2. Cells were grown overnight in selective media and re-inoculated in YPD at the 
cell count 1x106 and grown to the cell count 1x107. Protein was extracted from the pellet using the 
yeast whole cell quantitative method (von der Haar, 2007) (n=3). Expression of GLuc and actin in the 
western blots were quantified using the software Image J. Errors bars represent standard deviation. 
Statistical analysis was performed using an ANOVA test with significance annotated comparing what 
was detected in the supernatant of each strain to the wild type, and what was detected in the pellet  
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Figure 5.5.4 GLuc expression was assessed in Δgtr1, Δgtr2, Δvam6, Δatg1 and Δtco89 strains 
transformed with either an empty plasmid (marked +e) or with a vector re-expressing the deleted 
gene. A) Quantified Gluc expression relative to the wild type, of Δvam6 transformed with an empty 
plasmid, and re-expression in the deletion stain and wild type (Western blot seen in Figure 5.5.1-3). 
This is also shown in B) with Δatg1, C) with Δtco89. Cells were grown overnight in selective media and 
re-inoculated in YPD at the cell count 1x106 and grown to the cell count 1x107. Protein was extracted 
from the pellet using the yeast whole cell quantitative method (von der Haar, 2007) (n=3). Expression 
of GLuc and actin in the western blots were quantified using the software Image J. Errors bars 
represent standard deviation. Statistical analysis was performed using an ANOVA test with significance 
annotated comparing what was detected in the supernatant of each strain to the wild type, and what 
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As observed in the wild type, Δgtr1, Δgtr2, Δvam6, Δatg1 and Δtco89 displayed less GLuc in the 
supernatant than what was detected in the pellet (Figure 5.5.3A). Deleting the EGO genes GTR1 and 
GTR2 led to a significant loss in secreted GLuc, with an increase in GLuc detected in the pellet of Δgtr1 
(P<0.01) but a loss to GLuc expression in the pellet of Δgtr2. Despite changes observed in Δgtr1 and 
Δgtr2 cells, there was no statistically significant alteration to GLuc production in cells lacking the GEF 
Vam6 in comparison to the wild type. Findings had shown that Δtco89, a component of the TORC1 
complex, had similar levels of expression of GLuc detected in the supernatant and pellet compared to 
the wild type. However, deletion of the autophagy gene ATG1 had a negative effect on rP production 
as we observed a loss of GLuc expression in the pellet in comparison to the wild type (Figure 5.5.3A).  
When comparing GLuc expression in the wild type to the Gtr1 deletion strains (Figure 5.5.3B) we 
discovered that overexpressing the GTR1 in Δgtr1 resulted in some rescue to the GLuc rP production 
observed in Δgtr1, however with overexpression of GTR1 in the wild type we found a significant 
increase in total GLuc production observed in both the supernatant and pellet.  Similarly, some rescue 
in GLuc expression was observed in Δgtr2 with GTR2 overexpression to wild type levels, with a further 
increase in rP expression in the supernatant when overexpressed in the wild type (Figure 5.5.3C). 
Interestingly, it is only when Δgtr1 and Δgtr2 were overexpressed in the wild type that a rescue in the 
ratio of GLuc detected in the supernatant and pellet was observed as expected yet this was not seen 
when restoring GTR1 and GTR2 levels back into Δgtr1 and Δgtr2 respectively. Despite the effects on 
rP production observed in GTR1 and GTR2 strains in comparison to the wild type, alterations to VAM6 
caused no changes to GLuc expression observed in the pellet and supernatant (Figure 5.5.4A). 
The overexpression of ATG1 in the Δatg1 deletion strain caused an increase in the expression of 
secreted GLuc although this was still not restored to wild type levels, however GLuc detected in the 
pellet was restored to wild type levels when ATG1 is overexpressed in Δatg1 (Figure 5.5.4B). However, 
when overexpressing ATG1 in the wild type there was an unexpected decrease in GLuc detected in 
the supernatant and pellet in comparison to the wild type with normal levels of ATG1. TCO89 
overexpression in Δtco89 appeared to reduce expression and secretion of GLuc compared to the 
Δtco89 which had little effect on GLuc expression detected compared to wild type. The percentage of 
GLuc that was secreted was found to be lower with TCO89 overexpressed in a wild type background 
(Figure 5.5.4C).  
The deletion of EGO complex genes Δgtr1 and Δgtr2 caused a reduction in secretion of GLuc yet not 
in Δvam6 (Figure 5.5.3A). Our data also suggests that this effect could be rescued when the 
corresponding gene was re-expressed (Figure 5.5.3B,C) yet this was not the case with ATG1 
overexpression. We found the most significant effects in Δgtr1 cells where overexpression of GTR1 
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which had a significant increase in secretion compared to the wild type. Overexpression of TCO89 
surprisingly had a negative effect on GLuc production compared to the wild type in both 
Δtco89+TCO89 and WT+TCO89 (Figure 5.5.4H). 
 
5.2.3.3 Growth analysis of overexpression in genes in the TOR pathway   
 
We wished to determine whether changes in growth rate associated with overexpression of genes 
within the TOR signalling pathway could account for variation in Gluc expression. The growth rate of 
strains deleted for VAM6, TCO89, GTR1, GTR2, and ATG1 transformed with either an empty vector or 
vector expressing the deleted gene was compared to that of wild type. An example of the growth 
curve data is presented in Fig 5.8A and doubling times of VAM6, ATG1, GTR1, GTR2 and TCO89 all 
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Figure 5.6 Growth of Δvam6, Δtco89, Δgtr1, Δgtr2 and Δatg1 with VAM6, TCO89, GTR2, and ATG1 gene 
overexpression. A) Growth curves of the wild type, Δgtr1, Δgtr1 with GTR1 overexpression and wild 
type with GTR1 overexpression. B) Doubling times were calculated in all selected TOR strains. Cells 
were grown overnight in minimal media before re-inoculated into YPD to an OD600 of 0.3 (n=3). Errors 
bars represent standard deviation. Statistical analysis was performed using an ANOVA test with 
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The data from our growth analysis in figure 5.6B shows that wild type cells exhibit a doubling time of 
approximately 2 hours. We observed a longer lag phase in Δgtr1 compared to the wild type (Figure 
5.6A), however once in log phase there was no significant change to doubling time displayed in figure 
5.6b when the doubling time was quantified. When comparing the growth of all deletion strains and 
when their gene is overexpressed has caused no change to growth compared to the wild type 
concluding we can rule out any changes to growth effecting changes to GLuc expression seen in figure 
5.5. 
 
5.2.2.4 Investigating growth analysis in GTR1 with rapamycin treatment 
Our results suggested that manipulation of the EGO complex, and in particular Gtr1, leads to a 
significant effect upon GLuc expression. We wished to determine whether TORC1 signalling was 
compromised within cells lacking or overexpressing Gtr1 by testing their sensitivity to rapamycin 
(Figure 5.7). 
 
Figure 5.7 Growth with rapamycin of GTR1 deletion and overexpression of GTR1 in the deletion strain 
and wild type. Cells were grown overnight in YPD media containing either DMSO as a control or 3 
ng/ml rapamycin before being re-inoculated in YPD to an OD600 of 0.1 (n=3) where either rapamycin 
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Compared to growth with DMSO, rapamycin treatment had no effect on growth in the wild type and 
WT+GTR1^. It was observed that only when GTR1 was deleted that the cells become sensitive to the 
effects of rapamycin, yet upon re-expression, the effects were reversed, although not fully to growth 
of the wild type (Figure 5.7). This test showed that deleting GTR1 made cells more sensitive to 
inhibition of TORC1 at this concentration of drug. Due to the additive effect of rapamycin to Δgtr1, 
this suggests that the TORC1 pathway is functional in cells lacking GTR1 and may imply that rP levels 
are altered in a manner that is independent of TOR signalling.  
5.2.4 Effects of deletion of genes involved in TOR signalling upon Killer toxin secretion  
 
We employed the killer toxin assay as another method to assess rP production in strains lacking the 
genes GTR1, GTR2, VAM6, TCO89 and ATG1. A plasmid containing the killer toxin plasmid was 
transformed into strains lacking the genes GTR1, GTR2, VAM6, TCO89 and ATG1 where these strains 
were grown into log phase and were spotted in a dilution series on to a lawn of yeast cells which are 
known to be sensitive to the toxin. As a result a zone of clearance is produced which represents the 
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Figure 5.8.1 Example of clearance zones created in killer toxin assay in the wild type, Δgtr1, Δgtr2, 
Δtco89, Δatg1 and Δvam6. Left spot contains strain without the killer toxin plasmid, spots to follow 
have increasing cell count.  Killer strains were grown overnight in selective media and re-inoculated 
the following morning to a cell OD600 of 0.2 in selective media and grown to the cell count 
1x107cells/ml.5-fold, 2.5- fold and 2-fold dilutions were performed and cells spotted onto plates with 
the final spot equal to a cell count of count 1.3x106. (n=3).Plates where left to grow at 30°C for 2-3 
days. Image J was used to quantify kill zone and image contrast enhanced by 0.1%. Statistical analysis 
was performed using an ANOVA test with significance annotated comparing each strain to wild type 
(*P<0.05, **P<0.01 ***P<0.001).Errors bars represent standard deviation. For more details on 
measuring the clearance zone, see chapter 3, figure 3.10. 
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Figure 5.8.2 Quantification of the clearance zone from killer toxin in the wild type, Δgtr1, Δgtr2, 
Δtco89, Δatg1 and Δvam6.  Clearance zone was measured using the software Image J.  Killer strains 
were grown overnight in selective media and re-inoculated the following morning to a cell OD600 of 
0.2 in selective media and grown to the cell count 1x107cells/ml.5-fold, 2.5- fold and 2-fold dilutions 
were performed and cells spotted onto plates with the final spot equal to a cell count of count 1.3x106. 
(n=3).Plates where left to grow at 30°C for 2-3 days. Statistical analysis was performed using an ANOVA 
test with significance annotated comparing each strain to wild type (*P<0.05, **P<0.01 
***P<0.001).Errors bars represent standard deviation. For more details on measuring the clearance 
zone, see chapter 3, figure 3.10. 
 
This data presented shows a steady increase in the clearance zone with increasing cell density in all 
strains tested (Figure 5.8.2). At all cell densities, we detected no significant change in secretion of the 
toxin in the strains Δgtr1, Δgtr2, Δtco89, Δatg1 and Δvam6 compared to that of wild type (Figure 
5.8.2). These data show that Δgtr1, Δgtr2, Δtco89, Δatg1 and Δvam6 had similar secretion to the wild 
type suggesting deletion of these genes had no effect on secretion of the toxin, as opposed to 
secretion of the GLuc protein (Figure 5.5.3A).  
We also assessed whether the secretion of killer toxin itself had an effect upon growth in the strains 
assessed. The doubling times were therefore calculated in wild type, Δtco89, Δvam6, Δgtr1, Δgtr2 and 
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A) 
 B)                    
              
Figure 5.9 Effects of Killer Toxin expression on growth of selected strains. a) Doubling time of strains 
deleted for TCO89, GTR1, GTR2, ATG1 and VAM6 without the killer toxin. Statistical analysis was 
performed using ANOVA test with significance annotated comparing each strain to wild type b) 
Growth of strains deleted for TCO89, GTR1, GTR2, ATG1 and VAM6 expressing killer toxin relative to 
strains without (n=2). Statistical analysis was performed using an ANOVA test with significance 
annotated comparing growth of each strain with the control plasmid to the killer toxin plasmid. Cells 
were grown overnight in selective media before re-inoculated to an OD600 of 0.3. (*P<0.05, **P<0.01 
***P<0.001).Errors bars represent standard deviation. 
The expression of killer toxin appeared to have no effect upon the doubling time of wild type, Δgtr1, 
Δgtr2, Δtco89, Δatg1 or Δvam6 cells.  
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5.3 Discussion 
The drug rapamycin, inhibits TORC1 signalling and is known to cause a decrease in protein synthesis 
and ribosomal biogenesis, thus mimicking responses to starvation (Dubouloz et al., 2005). Rapamycin 
treatment reduces cell size in both lower and higher eukaryotes and causes reduced antibody 
production in CHO cells (Fingar et al., 2002; Courtes et al., 2013). Due to our interest in rP production, 
we investigated GLuc expression on wild type cells with rapamycin treatment in yeast (Figure 5.2.1). 
A loss in expression of GLuc was observed in the supernatant when yeast cells were treated with a 
level of rapamycin that did not affect doubling time (Figure 5.2.2). This suggested TORC1 signalling 
may be manipulated to change rP production in yeast cells. To identify individual genes that may be 
useful targets for the development of enhanced rP production we screened a wide range of upstream 
and downstream regulators within the TORC1 network for their ability to influence the synthesis and 
secretion of a model protein, Gluc. 
 
5.3.1 Gaussia luciferase expression screen identifying genes in the TORC1 pathway that 
impact upon recombinant protein production   
 
Strains from the yeast knockout collection involved in variety of processes which hinder or facilitate 
protein synthesis through the TORC1 pathway were utilised in a screen to identify new targets that 
may alter rP production (Figure 5.3). By deleting the gene coding for the protein Tip41, which operates 
in the complex downstream of TORC1, we observed an increase in GLuc protein detected in the pellet 
suggesting there was an increase in protein synthesis but no change in secretion (Figure 5.3.3B).  The 
increase in GLuc expression in Δtip41 could be explained by the fact that this part of the pathway is 
inhibited by the TORC1 complex during cell growth and protein production (Rohde et al., 2008), yet 
we found deletion of SIT4 decreased GLuc production. Tip41 signals downstream to genes controlling 
the retrograde response (RTG1/3) and the nitrogen discrimination pathway (GLN3) which were found 
to decrease GLuc expression when deleted (Figure 5.3.3D), suggesting that deleting TIP41 improved 
GLuc expression due to another role other than downstream signalling in TORC1 (Smets et al., 2010). 
For cell growth and protein synthesis, the TOR pathway would repress transcription of starvation-
specific genes during favourable nutrient conditions by sequestering Msn2, Msn4, Gln3, Rtg1, Rtg3 in 
the cytoplasm. This suggests that deleting these stress TF should be favourable for rP production as 
was seen with Δgis1 (Figure 5.3.4A), yet we found a loss of GLuc production in Δmsn4, Δgln3 Δgcn4, 
Δrtg1 and Δrtg3 (Figure 5.3.4A, 5.3.5C, 5.3.3D) (Marion et al., 2004). The deletion of Δgln3, Δgcn4, 
Δrtg1 and Δrtg3, leaves the cells incapable of adapting as it cannot detect glutamine starvation, 
however this experiment was performed during log phase where there were still plenty of nutrients 
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in the media, nevertheless there was a loss in GLuc production when these genes were deleted 
compared to the wild type. In a similar way, it was surprising that deleting autophagy genes would 
have a negative impact on rP production. However it has been noted that some level of autophagy is 
still important during log phase, preventing the build-up of protein aggregates (Mizushima et al., 
2008). 
As expected, important genes involved in ribosomal proteins and biogenesis (RPS6A, RPS6B and SFP1) 
when deleted caused a loss in GLuc production as this will deter protein synthesis (Figure 5.5.5A), yet 
removing the repressor of translation CRF1 also had a negative impact on GLuc production (Figure 
5.3.5B). TOR1/2 in TORC1 is necessary for rP production, when deleting TOR1 there was no change to 
GLuc production as the gene TOR2 would still be available as a component of TORC1 (Figure 5.3.4D). 
Another component of the TORC1 when deleted had shown no significant change to GLuc production, 
Δtco89, yet a new model suggests that Tco89 may bind to Gtr1 in TORC1 activation during nutrient 
sensing (Sekiguchi et al., 2014). 
When deleting genes involved in stress response such as osmoregulation (Δpkh2, Δsko1 and Δhog1) 
(Figure 5.3.3), nutrient starvation such as nitrogen (Δnrp1)(Figure 5.3.5D) and amino acids 
(Δego1)(Figure 5.3.4B) we found a decrease in GLuc produced as when the cell is being pushed to 
produce rP production this puts mores stress on the cell. However, not all genes involved in amino 
acid sensing when deleted caused a loss in GLuc production. The EGO complex which comprises of 
Ego1 and Ego3, anchors the heterodimer Gtr1 and Gtr2 to the vacuole where this complex senses 
amino acid levels. Deletion of any of these components causes low TORC1 activity inhibiting protein 
synthesis and cell growth, essentially triggering starvation responses, even in nutrient rich media 
(Zhang et al., 2012). It would have been more feasible for a loss of GLuc production in Δego3 than 
Δego1 as Ego3 functions as a homodimer, mediating the interaction between Ego1 and the GTR 
proteins (Figure 5.4.3B) (Zhang et al., 2012). However, more recent literature suggests a model where 
deleting the protein Ego1 may cause a loss of interaction between Ego3 and the GTR proteins, and 
that it may be the Ego1-Ego3 complex acting as a GEF to the GTR proteins (Sekiguchi et al., 2014). This 
contradicts previous literature which suggests that Vam6 is the protein which regulates the GTP-GDP 
exchange on both GTR proteins needed for signalling to TORC1 (Valbuena et al., 2012). Additionally, 
it is the GTR proteins which interact directly with TORC1 yet there was no significant change to GLuc 
production when GTR1 or GTR2 were removed. 
We discovered that 15 of the 30 genes investigated, which were grouped together according to their 
role in TORC1, caused a loss in GLuc expression when deleted reiterating the importance of TORC1 
signalling in rP production. This is particularly interesting as strains expressing low GLuc are linked to 
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stress response and protein synthesis, vital for the correct homeostasis of the cell and rP production. 
Overexpression of GLuc, a heterologous protein at high levels, would be connected to different 
stresses as this may limit other cellular processes by competing for substrates (Mattanovich et al., 
2004). 
 
5.3.2 The effects of overexpression of VAM6, ATG1, GTR1, GTR2 and TCO89 upon rP 
production 
 
For further analyses of the selected genes VAM6, ATG1, GTR1, GTR2 and TCO89, we used an 
expression vector to re-express in the appropriate knockout strains as well as to overexpress in a wild 
type background. We observed no significant change to growth when comparing the doubling time of 
Δvam6, Δatg1, Δgtr1, Δgtr2 and Δtco89 to the wild type. A similar result was observed when these 
genes were overexpressed in the corresponding deletion strain, (Figure 5.6). This data implies that 
changes to growth rate were not responsible for differences in GLuc expression or secretion.  
5.3.2.1 Effects of Δatg1 on recombinant protein production 
A great deal of research has been undertaken to understand the process of autophagy. TORC1 
negatively regulates autophagy by the hyperphosphorylation of Atg13, thus preventing the formation 
of the Atg13-Atg1 complex. Autophagy is also regulated by the nutrient sensing pathways PKA and the 
energy sensing AMPK pathway (Scott et al., 2007). When investigating the role of ATG1 in GLuc 
expression we discovered that its deletion led to reduced levels of GLuc in both the supernatant and 
pellet suggesting it affects overall protein synthesis (Figure 5.5.4B). As protein extracts were taken 
during log phase, when cells have sufficient available nutrients in their growth media, it was surprising 
to find Δatg1 had any effect. However, it has been noted that autophagy is utilised during active 
growth as part of the protein homeostasis system to prevent a build-up of protein aggregates. 
Therefore a basal level of autophagy during growth is important for maintaining normal cellular 
homeostasis (Mizushima et al., 2008).  Misfolded protein accumulation in the ER can send stress 
signals that induce autophagy as an alternative pathway for ER quality control. This is also verified by 
the induction of autophagy with rapamycin treatment where the cells were found to be more resistant 
to ER stress (Yorimitsu and Klionsky, 2007). Although our data shows that Atg1 expression impacts 
upon rP production, we were only able to partially rescue the reduction in Gluc expression observed 
in ATG1 null cells when re-expressing the gene compared to the wild type (Figure 5.5.4B). This shows 
that ATG1 is important in rP production yet we observed a loss to GLuc when overexpressed in the 
wild type.    
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However, in this study as we did not determine protein levels. A future validation of the results here 
would be to use an antibody to investigate ATG1 overexpression as it did not appear as if the mRNA 
levels were any higher than the control in the wild type suggesting this plasmid may not be working 
(Figure 5.3C). Yet, we found that overexpression caused a reduction to GLuc detected in the 
supernatant and pellet in the wild type suggesting the plasmid is working and that subtle changes in 
the amounts may have a detrimental effect on protein synthesis. High ATG1 levels may increase 
autophagy in the cell to a level too high reducing protein synthesis (also reported in the literature); 
autophagy has a negative feedback on S6 (Sch9 in yeast) to reduce growth of cells in an environment 
lacking nutrients or under stress (Scott et al., 2007; Lee et al., 2007). Discrepancies between mRNA 
levels and the effects of the plasmid on rP production may reflect how mRNA levels don’t always 
correlate to expected protein levels as many biological factors can influence this effecting translation 
rates. Conversely, even if translation rates were all the same, this does not take into any differences 
with, or account for changes in protein stability (Maier et al., 2009). 
5.3.2.2 Effects of Δtco89 on recombinant protein production 
Tco89 has been identified as part of the TORC1 complex and found to localise to the vacuole as well 
as Kog1 (another TORC1 complex subunit), yet was originally discovered due to its role in cell integrity 
(Reinke et al., 2004; Binda et al., 2009). It was suggested by Sekiguchi et al. (2014) that the C-terminal 
of the GTPase Gtr1 (part of the EGO complex) interacts with Tco89 when Gtr1 is GTP bound (Sekiguchi 
et al., 2014) having a direct effect on amino acid sensing. Upon deletion of TCO89 we found no 
significant change to GLuc expression (Figure 5.5.4C). However, overexpression led to a loss in Gluc 
expression in the supernatant and pellet when overexpressed in the wild type suggesting this causes 
a negative effect on protein synthesis. Little is known about the role(s) of TCO89 in the cell and 
understanding the mechanism behind this phenotype; therefore it is not known if Tco89 has any 
inhibitory effects on processes in the cell that may be important for protein synthesis. Being directly 
part of TORC1, any changes may affect downstream signalling to proteins involved in protein synthesis 
such as Sch9 or by perturbing the balance of stress signalling important in growth control (C De Virgilio 
and Loewith, 2006b). Overexpression of TCO89 causes increased protein-protein interactions between 
Tco89 and other known associating proteins in TORC1 and perhaps other unknown interactions, 
inhibiting protein functions linked to downstream protein synthesis. However, it was recently 
suggested that within the EGO complex, the component Gtr1 may directly bind to TCO89, increasing 
TORC1 signalling through nutrient sensing. However, overexpression of protein can overload the cell 
becoming detrimental by increasing a number of intracellular stresses such as protein aggregation 
although the plasmid used for this study had a low copy number (Naidoo, 2009). Overexpression of 
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TCO89 in the wild type caused a loss in GLuc in the supernatant impacting the secretory pathway of 
the cell. This could be due to a build-up of proteins aggregating as the quality control was not sufficient 
for successful increased secretion which would lead to ER stress (Yorimitsu et al., 2006). There may 
have been an increase in ER stress markers such as phospho-PERK or Bip which could be investigated 
in future work (Vannuvel et al., 2013). 
In conclusion the data presented here provides evidence that Tco89 may have a negative effect on 
recombinant protein production although at this time we do not understand the mechanisms behind 
this due to the limited knowledge on its role in TOR signalling. 






    
 
 
Figure 5.10 The EGO complex in yeast and mammalian systems needed for amino acid sensing in the 
TORC1 pathway. The complex in yeast consists of the heterodimer Gtr1 and Gtr2 binding to Gse1/Ego3 
and Gse2/Ego1. Figure taken from Kogan et al., (2010). 
 
The EGO complex contains Ego1 and Ego3 involved in anchoring the complex to the vacuole, and Gtr1 
and Gtr2 which are known to activate TORC1 via a still elusive mechanism (Binda et al., 2009) (Figure 
1.8). The human homologue of Gtr1 is RagA and RagB, and binds to the Gtr2 homologue of RagC and 
RagD to form a heterodimer. This regulates TORC1 protein kinase activity through amino acid 
signalling by controlling its intracellular localisation (Sekiguchi et al., 2014). Both Gtr1 and Gtr2 are 
involved in the regulation of Gap1 amino acid permease which is controlled by nitrogen source (Binda 
et al., 2009). 
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If cells can’t sense nutrients due to mutations in the EGO complex this has a knock on effect where 
cell growth slows, entering quiescence and starvation state where transcription factors such as Gcn4 
activate transcription of genes needed for amino acid biosynthesis; this is due to TOR depletion or 
rapamycin treatment (Dubouloz et al., 2005; Smets et al., 2010). Partial inactivation of TORC1 also 
leads to loss of sorting Gap1 from the late endosome to the plasma membrane leading to loss of amino 
acids and nitrogen starvation (Inoki et al., 2005). Deletion of any of the EGO genes leading to loss of 
rP production suggests that the cells were starving even when grown in nutrient rich media leading to 
down regulation of protein synthesis through the TORC1 pathway due to changes in nutrient 
signalling. Studying the metabolomics of these EGO strains would tell us more about how the cell is 
surviving when amino acid sensing is lost in GTR1/GTR2 and what nutrient source is being used. 
Although the transition from quiescence back to proliferation from loss of TORC1 signalling is poorly 
understood, it is believe that EGO complex ensures proper exit from rapamycin-induced growth arrest 
by regulating microautophagy (in response to glutamine levels) to counter-balance the 
macroautophagy-mediated membrane influx toward the vacuolar membrane (Dubouloz et al., 2005; 
Li et al., 2012). Therefore, as overproduction of the EGO complex is known to induce microautophagy 
and in this study we found that overproduction of GTR1 in the wild type caused an increase in GLuc 
production, suggesting that by increasing microautophagy through the EGO complex this improved rP 
production enables the cell to direct uptake and degradation of the vacuolar boundary membrane 
(shrinking the vacuole), increasing nutrient concentration and making these available for cellular 
processes (Uttenweiler and Mayer, 2008; Li et al., 2012) (Figure 5.5.3B). Overexpression of the 
autophagy gene ATG1 did not cause the same effect which could be due to the importance in the 
balance between autophagy and TOR signalling is important in cell aging and fitness (Hands et al., 
2009) (Figure 5.4G).  
Removal of GTR1 caused a loss in GLuc in the supernatant with an increase of GLuc in the pellet 
suggesting this mutation impacts negatively on secretion of the rP (Figure 5.5.3A). This in in contrast 
to deletion of GTR2 which impacted negatively on total recombinant protein production as there was 
a loss of GLuc detected in both the supernatant and pellet. With overexpression of GTR1 in its deletion 
strain, we found some rescue of GLuc expression to wild type levels in the pellet. However, when 
overexpressed in the wild type, this caused an increase in GLuc production, roughly 3 times what was 
detected without overexpression of GTR1 (Figure 5.5.3B). This data suggests that GTR1 impacts upon 
rP production with enhanced production when GTR1 is overexpressed. We observed the highest 
mRNA levels in the GTR1 overexpression plasmid compared to other plasmids which may add to the 
explanation for the large increase in GLuc production when GTR1 was overexpressed in the wild type. 
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However, as the protein levels of Gtr1 were not confirmed, it would be beneficial to check Gtr1 levels 
when using the overexpression plasmid in the wild type and measure GLuc production to confirm this 
is due to GTR1 over-expression. 
Results from investigating GLuc production in GTR2 strains show some rescue of GLuc expression with 
GTR2 overexpressed in Δgtr2 to wild type levels detected in the supernatant yet with full rescue of 
GLuc detected in the pellet (Figure 5.5.3C). Although the loss of GTR2 has a negative impact on rP 
production, we also found that when overexpressing this gene in the wild type, this too has negative 
implications suggesting there is a delicate balance between overabundance of Gtr2 and loss of its 
function by removal.  
This difference between the heterodimers is interesting, signifying differences in other roles which are 
currently not well understood (Sekiguchi et al., 2014). A new model as to how the EGO complex 
interacts with TORC1 has been proposed where Tco89 binds to Gtr1 (GTP bound) and Kog1 bins to 
Gtr2 in order to signal to TORC1 (Sekiguchi et al., 2014).  It was also discovered that Gtr1 can also form 
a homodimer as well as a heterodimer with Gtr2, which may explain why overexpression of GTR1 has 
a stronger effect on rP production (Valbuena et al., 2012). The interactions of Gtr1 with nuclear and 
cytoplasmic proteins Rpc19p (RNA polymerase subunit), Nop8 (nucleolar protein) and Yrb2 
(controlling nuclear protein export) as well as the deletion of Gtr1 reducing RNA pol I and III activity 
suggests a role for Gtr1 in RNA synthesis and ribosome maturation effecting rP production (Wang et 
al., 2005; Todaka et al., 2005; Wang et al., 2009). These are examples of roles outside of amino acid 
signalling that might influence rP production through the overexpression of GTR1.  If a polysome 
profile of the GTR1 strains were tested in the future, this could give us more information on how 
changes to GTR1 expression levels are affecting GLuc production and if there are reduced polysomes. 
Sekiguchi et al have discovered that both proteins interact with the chromatin remodelling factor 
INO80 complex. GTR1 is also believed to interact with INO80 and Gtr2 interacts with Rvb1 and Rvb2 
(also involved in the INO80 complex) (Sekiguchi et al., 2008). 
In the initial screen we found that Δego1 caused a significant decrease to GLuc production, however 
this was not repeated or taken any further as we wanted to investigate the GTR proteins which directly 
activate TORC1 (Figure 5.3.3B). As we know the EGO complex is important in activating TORC1, 
another experiment would be to repeat this test alongside determining any changes to GLuc 
production with EGO1 overexpression in the deletion strain and the wild type.  
When quantifying the western blot of GLuc expression the Vam6 strains through statistical analyses 
we found that Vam6 strains caused no change to GLuc expression suggesting this deletion caused no 
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change to amino acid sensing through the EGO complex (Figure 5.5.4A). Valbuena et al (2012) reported 
that in S.pombe, the Δvam6 orthologue still had partial response to amino acids, indicating another 
unknown protein involved in a similar role to Vam6 or there was a problem with the deletion strain. 
It has been suggested that Ego1 and Ego3 may play a role in TORC1 activation as the regulatory 
complex which has structural conservation with the Ego proteins in mammalian cells has GEF activity 
towards the Rag proteins (equivalent of GTR proteins) (Zhang et al., 2012). Vam6 mutants present 
with fragmented vacuolar morphology which can be seen using GFP-Vam6 so it would be worth 
checking that this deletion strain has this characteristic to confirm this gene was deleted correctly. 
Vam6 is paralogous to Vam2 but has not been linked as a controller of guanine nucleotide exchanger 
factor for GTR proteins (Ostrowicz et al., 2010). When overexpressing VAM6 in Δvam6 and the wild 
type there was no change to GLuc which is expected as deleting VAM6 showed no change, however 
when measuring mRNA levels in the wild type with the overexpression plasmid we found levels to be 
similar to the wild type suggesting the plasmid may have not been working (Figure 5.4A). As 
mentioned before when discussing ATG1 overexpression, this may be because mRNA levels aren’t 
depicting protein levels accurately. 
 
5.3.3 TOR inhibition in Gtr1 strains  
 
As GTR1 overexpression exhibited the largest increase in rP production when overexpressed in the 
wild type we had chosen to test the effects of rapamycin on the growth of these strains. 3 ng/ml of 
rapamycin was added to YPD media to the wild type and all Gtr1 strains (Figure 5.7). This concentration 
of rapamycin had little or no effect on growth of almost all strains except Δgtr1 which showed 
sensitivity to the drug. When treating cells with rapamycin, transcription factors are triggered for 
nuclear entry which stimulates gene expression of products required for the synthesis of nutrient 
storage reserves, for the uptake and assimilation of suboptimal nitrogen sources, synthesis of amino 
acids and cell survival under stress conditions (Claudio De Virgilio and Loewith, 2006). We found that 
Δgtr1 had repressed growth implicating that it is involved in curating some of these processes. 
However, Δgtr1 sensitivity to rapamycin suggests TORC1 signalling in not completely inhibited by the 
removal of the amino acid sensing gene which may indicate that GTR1 plays other roles in the cell 
parallel to TORC1 signalling. When GTR1 was overexpressed in Δgtr1, this decrease in doubling time 
was rescued (Figure 5.7).  
The data presented in this chapter was not consistent throughout. The loss of genes GTR1, GTR2 and 
ATG1 in the screen showed no change in GLuc production (Figure 5.3), in contrast when this was 
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repeated with the selected strains (Figure 5.5); there was a loss in GLuc production in triplicate 
analyses. However, due to the lack of a loading control in the screen performed, the data seen may 
not be a true representation even though all samples were diluted to the same cell count. The selected 
strains from the screen were then tested using an alternative method which is believed to be a more 
quantitative protocol of releasing the protein from cells (through chemical disruption rather than 
mechanical), however the supernatant was treated the same way yet results were varied. When using 
this second method, cells where grown for longer (to 1x107cells) as a much smaller number of samples 
were tested making the experiment more manageable compared to the screen where all cells were 
grown for the same amount of time which may cause slight variation to phase of growth, perhaps to 
early log phase.  
There has also been evidence that there are some knockouts possessing background mutation(s) or 
perhaps epigenetics which may explain why we don’t see full rescue of GLuc production to what was 
detected in the wild type in Δgtr1, Δgtr2 and Δatg1 when their respective genes are overexpressed 
(Figure 5.5.3B,C and 5.5.4B). As TORC1 signalling is involved in a number of processes such as protein 
synthesis, responses to stress and nutrient sensing, as such trying to pull apart this complex is difficult 
as it also cross talks with a number of other sensor pathways. However, there is much work into 
investigating the GTR proteins in the EGO complex, and the GTR1 data from this chapter is more 
reproducible.  
 
5.3.4 Killer Toxin secretion in Δgtr1, Δgtr2, Δvam6, Δatg1 and Δtco89 
 
To test the recombinant protein production of these strains with another protein other than GLuc, we 
used the killer toxin assay by measuring the secretion of the toxin by the size of the kill zone over a 
lawn of sensitive cells (Figure 5.8.2). When comparing secretion by the cells with the highest cell count 
we found no statistical difference to secretion, which was not in agreement with the secretion of GLuc 
reported in figures 5.5.3A, where Δgtr1, Δgtr2 and Δatg1 show a decrease. However, due to these 
proteins containing different signal sequences, they should not be directly compared. The doubling 
times of these strains with and without the killer toxin assay exhibited no change to growth (Figure 
5.9). Generally we did not find these deletions causing the same effects on toxin secretion as what 
was found with GLuc secretion.  
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In this chapter we performed a GLuc expression screen to select for new targets within the TORC1 
pathways which alter rP production. Due to some discrepancies in data replicates, we cannot draw 
absolute conclusions in all deletions, however the data does imply the EGO complex, specifically GTR1 
and GTR2, when using the GLuc expression plasmid with the alpha factor signal sequence are 
important determinants of GLuc expression. Recent data points towards emerging roles of GTR1 and 
GTR2 in chromatin regulation and ribosomal regulation connecting EGO nutrient signalling to 
epigenetics, yet only overexpression of GTR1 in the wild type caused an increase in rP production 
reflecting differences in the role of the GTR proteins. We also found with Δgtr1 that TORC1 signalling 
can be uncoupled from growth rate when treated with rapamycin suggesting roles in GTR1 
independent of TORC1 signalling are causing altered rP production. However, as the expression of 
GLuc was driven by the alpha factor promoter, this may have an unknown impact on TORC1 signalling. 
Variation in data means the observed results would need to be further verified, nevertheless, the data 
does imply and identify certain target genes as being worthy of further investigation as to their 
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6.1 Major constituents of the TOR signalling pathway are conserved from 
yeast to higher eukaryotes 
 
TOR is a key signalling pathway as described in the introduction chapter to this thesis; therefore it is 
not surprising that the key components of TOR signalling are well conserved across eukaryotes where 
the tight control/regulation of growth and nutrient sensing is fundamental for survival. Indeed, the 
main regulators in the TOR pathway transcend from yeast to higher eukaryotes, although some 
features are not entirely identical. For example, the protein TCO89, is a component of TORC1 that is 
only conserved among fungi (Reinke et al., 2004; Sekiguchi et al., 2014). Although yeast are considered 
one of the lower eukaryotes, S.cerevisiae is an important model eukaryotic system for investigations 
into the functions of TOR, with only one of the two TOR complexes being sensitive to rapamycin 
(Claudio De Virgilio and Loewith, 2006). Unlike yeast, mammalian cells contain only one gene for TOR, 
termed mTOR, where the protein from this gene is found in both the TORC1 and TORC2 complex, 
where activity is blocked by rapamycin which binds to FKBP12 preventing the ability of mTORC1 to 
phosphorylate downstream substrates (Michnick et al., 1991; Dann and Thomas, 2006). The main 
components of TOR signalling in yeast and mammalian cells and the relationship/comparison between 
these are described in Table 6.1 below. 
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Figure 6.1 A schematic showing the basics of the mTORC1 pathway in mammals. Environmental inputs 
and signals such as energy availability, growth factors, stress and amino acid availability are sensed 
and act upstream of TORC1. TORC1 is regulated by amino acids via the regulatory complex containing 
RAG GTPases which is controlled by GEF activity. AMPK phosphorylates RAPTOR and TSC2 inhibiting 
mTORC1 signalling. Activation leads to cell growth, tumour development  and inhibition of autophagy 
(Jewell et al., 2013).   
 
Through biochemical purification TOR was found to be associated with a high-molecular weight 
complex (Loewith et al., 2002) (see mTORC1 figure 6.1). In mammalian cells, mTORC1 contains the 
protein Raptor that is believed to function as a scaffold coupling mTOR to substrates (regulatory 
associated protein of mTOR), which was discovered to be important for phosphorylation of S6K and 
4EBP1 (involved in regulating protein synthesis by binding and sequestering the translation initiation 
factor eIF4E) (Inoki et al., 2005; C De Virgilio and Loewith, 2006a; Sancak et al., 2008). The complex 
also contains the protein mLST8 whose function is not well elucidated but has been implicated in 
negatively regulating amino acid biosynthesis (Chen and Kaiser, 2003; Wang and Proud, 2011). AMPK 
(AMP-activated protein kinase) inhibits mTORC1 when cells are energy deprived by phosphorylating 
raptor (Dunlop and Tee, 2013). This kinase is believed to be a primary physiological sensor of the 
intracellular AMP/ATP ratio, important for maintaining the energy requirements in the cell (Inoki et 
al., 2005). In yeast the homologue of AMPK is SNF1, a glucose sensory protein kinase which promotes 
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GLN3 and the expression of nitrogen-catabolite repression sensitive genes, which allows cells to 
import and utilise poor nitrogen sources(Bertram et al., 2002; Engelberg et al., 2014).  
Tuberous sclerosis (TSC) is a disorder causing benign tumours in a variety of organs, and the TSC1 and 
TSC2 proteins have been shown to negatively regulate TOR (Inoki et al., 2002; Han et al., 2012). AMPK 
inhibits mTORC1 through phosphorylation of TSC2. TSC2 forms a complex with TSC1 which negatively 
regulates TOR signalling as overexpression of TSC1 and TSC2 suppresses S6K and 4EBP1 
phosphorylation (Inoki et al., 2002). TSC2 phosphorylation activates its GAP (GTPase activating 
protein) activity which in turn converts Rheb into an inactive state (GDP-bound). This removes 
mitogenic stimulation. Rheb drives ribosome biosynthesis and hence global protein synthesis and is a 
key control point in both protein synthesis and cell proliferation rates (Dunlop and Tee, 2013). This is 
through Rheb binding to activating mTORC1 directly, associating with mLST8 and raptor, which is 
strongly inhibited by withdrawal of extracellular amino acids (Hara et al., 2002; Long et al., 
2005)(Yadav et al., 2013). Interestingly, this part of the TOR signalling pathway is conserved in S.pombe 
but not in S.cerevisiae although it has a Rheb protein it is not known to be involved in the TOR signalling 
pathway, therefore S.Pombe is used as a model organism to investigate this part of the TOR pathway 
(Aspuria et al., 2007).  
Peterson et al. (2009) discovered the protein DEPTOR (DEP domain-containing mTOR-interacting 
protein), a homologue of which has not yet been identified in yeast, that negatively regulates mTORC1. 
In 2007, Akt substrate 40 (PRAS40) was also discovered to inhibit mTORC1 kinase activity which 
depends on PRAS40 associating with raptor. When the expression of PRAS40 was reduced by short 
hairpin RNA it was found to result in an enhancement of 4E-BP1 binding to raptor.  PRAS40 competes 
with 4E-BP1 binding to raptor, another mTORC1 component not found in yeast (Wang et al., 2007).  
 
6.1.1 TOR and amino acid sensing 
 
TORC1 plays a major role in sensing amino acid availability in the environment, particularly leucine, as 
first discovered by Hall and colleagues (1996) and the absence of nutrients causes cells to enter 
stationary phase of growth (Barbet et al., 1996). Just as in yeast, amino acid signalling and sensing is 
achieved in mammalian cells through a complex which interacts with the TORC1 complex which 
contains Rag proteins (Schurmann et al., 1995; Sancak et al., 2010). The Rag proteins are known as 
RagA and RagB (with 97.8% amino acid sequence identity) and are highly conserved (both are 
orthologues of Gtr1 in yeast). RagC and RagD (with 81.1% amino acid sequence identity) are also 
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similar (and have orthologue Gtr2 in yeast) and can pair with either partners forming a heterodimer 
(Schurmann et al., 1995; Sekiguchi et al., 2001; Kim et al., 2008). RagC and RagD are related but it was 
found that as for Gtr1 in yeast, only RagA/B (GTP bound) is needed to maintain mTORC1 activity in an 
amino acid deprived environment and that amino acids regulate its nucleotide-bound state. RagA/B 
(GTP bound) may be the primary determinant for TORC1 signalling, however RagC and RagD are also 
essential for mTORC1 activation due to the instability of these dimers (Kim, Buel, & Blenis, 2013). Rag 
proteins may be unstable when not in the heterodimer complex as depletion of RagA and RagB causes 
a loss of RagC and RagD and vice versa (Sancak et al., 2008). Unlike in yeast where Gtr1 can form a 
homodimer, this is not the case for RagA which is likely to be due to structural differences between 
the proteins (Sekiguchi et al., 2001; Sancak et al., 2008). Further, in contrast to mammalian cells where 
GTP-locked RagB uncouples mTORC1 from leucine signalling, GTP-locked Gtr1 only has a partial effect 
in yeast suggesting there may be other signalling routes involved (Binda et al., 2009). 
It has also been reported that RagC co-purifies with raptor, and that Rag GTPases binding to raptor is 
necessary to mediate amino acid signalling to mTORC1 causing the relocalisation to a membrane 
bound compartment containing Rheb (Sancak et al., 2010). In starved HEK cells it was found that mTOR 
was in tiny punta throughout the cell, however upon addition of amino acids mTOR localises to the 
perinuclear region and large vesicular structures of the cell (Sancak et al., 2008). It has been suggested 
that mTOR may interact with Rheb within the nucleus where several upstream regulators have been 
reported to be expressed (as well as the cytoplasm) regulating translation (Yadav et al., 2013). 
 
6.1.1.1 Regulation of Rag proteins 
It is thought that the nuclear bound state of Gtr1 in yeast or RagA/B in mammalian cells is regulated 
by amino acid signalling, although the mechanism by which this is achieved is unclear (Kim et al., 2013). 
In yeast Vam6 acts as a GEF controlling TORC1 activity by acting as a nucleotide exchange factor for 
Gtr1 and this is believed to be a homologue of Vps39. Δvam6 mutants show fragmented vacuolar 
morphology with defective protein processing suggesting this protein is required for the assembly of 
mature large vesicles(Nakamura et al., 1997; Binda et al., 2009). However, more recently Bar-Peled et 
al. (2012) demonstrated that Vps39 failed to interact with RagA, nor did it stimulate GDP or GTP 
dissociation from RagB. It was suggested this could be due to amino acid sensing mechanisms having 
diverged between yeast and higher eukaryotes.  
In yeast Gtr1 and Gtr2 form part of the EGO complex for nutrient sensing involving Ego1 and Ego3 
which tethers the Rag proteins to the vacuole. Subsequently it was discovered that these components 
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in TOR signalling were structurally conserved where Ego1 was similar to MP1 (mitogen-activated 
protein kinase scaffold protein1) and p14 (Kogan et al., 2010). This complex was termed Ragulator by 
Sabatini and colleagues who later discovered it to be a pentameric complex with C7orf59 and XBXIP 
(hepatitis B X interacting protein), MP1, p14 and p18 which together controlled Rag lysosomal 
localisation in response to amino acids (Bar-Peled et al., 2012). Although the Ragulator complex may 
be structurally similar to the EGO complex, Ragulator is also responsible for guanine nuclear exchange 
in RagA/B when amino acids are rich in the environment, activating RagA/B GTPases (Zoncu et al., 




Cell growth and autophagy are important in the response to cellular nutrition status. During 
starvation, autophagy is important for recovering carbon source material to maintain cellular 
processes through a lysosome-mediated process in bulk degradation, breaking down old proteins, 
organelles and other components of the cytoplasm. This process is achieved through autophagosomes 
which engulf these components using special double membrane vesicles supplying the cell with an 
internal source of nutrients (Levine and Klionsky, 2004). The coordination of this process is through 
multiple ATG proteins first identified in yeast (summarized by Klionsky et al., 2013; Huang & Klionsky, 
2002) as described in Chapter 5.  In yeast Atg1 (ULK1 in mammals) plays a central role in autophagy, 
which is inhibited by TOR. When Atg1 is overexpressed, it induces high levels of autophagy, but Atg1 
can also cause a negative feedback on the activity of TOR itself as cells with an autophagy defect had 
a growth advantage over wild type cells resulting in further activation of Atg1 promoting autophagy 
and reduced cell growth. However, S6K is also required for autophagy but is inactive when TOR 
signalling is lost (Scott et al., 2007). Thus, processes are balanced with proper control through positive 
and negative feedback loops. Atg1 forms a complex with Atg13 (which is phosphorylated by TORC1) 
and during starvation Atg13 is partially dephosphorylated (Klionsky et al., 2010).  
Yan et al. (1999) identified and characterised ULK2 in mice, which has a 52% amino acid identity to 
ULK1, and suggested this is part of the TOR signalling pathway in mammals. It has been suggested that 
ULK1 and ULK2 may have originated by gene duplication during evolution. The role of ULK2 is less 
clearly defined at present, but ULK1 silencing is sufficient to inhibit autophagy (Chan et al., 2007). A 
screen for ULK binding proteins discovered focal adhesion kinase family interacting protein of 200 kDA 
(FIP200) interacts with ULK1, this protein having a role in regulating cell size, proliferation and 
migration (Hara et al., 2008). During starvation where TOR is no longer phosphorylating Atg13, Atg13 
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ULK1/2 and FIP200 complex recruits proteins to the phagophore including Beclin 1 which starts the 
induction of autophagy. Beclin 1 is important as it interacts with several enhancing or inhibitory factors 
which moderate its binding to Vps34 which is needed for vesicle nucleation/autophagosome 
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Table 6.1 List of TOR related proteins in budding yeast and mammalian cells discussed in this chapter. 
Not all pathways in TOR are as well conserved. * indicates yeast or mammalian protein with similar 
function but not involved in the TOR pathway. 
 
Budding Yeast Mammalian Function 
TORC1 mTORC1 TOR complex 1 involved in protein synthesis and ribosome biogenesis 
TORC2 mTORC2 regulate the special aspects of growth including actin polarisation 
TOR1,2 mTOR1,2 TORC1 component  
Lst8 mLST8 Binds to TOR kinase domain required for TORC1/2 activity 
KOG1 Raptor TORC1 component, possibly couples TOR to substrates 
Tco89 - Involved in glycerol uptake under osmotic stress. Component of TORC1 
- Deptor mTORC1 component, negatively regulates mTORC1 
- PRAS40 mTORC1 component, possibly associating with raptor 
Atg1 ULK1,ULK2 Induce autophagy  
Vam6 Vps39* Assembly of large vesicles. In yeast, acts as GEF for Gtr proteins 
Gtr1 RagA,B GTP-binding protein involved in amino acid sensing 
Gtr2 RagC,D GTP-binding protein involved in amino acid sensing 
Sch9 S6K Major TOR protein kinase directly regulates protein synthesis 
- 4E-BP1 Controls eIF4E in translation initiation 
- TSC1,2 Signalled via energy and growth factors, directly acting controlling Rheb 
downstream 
RHB1* Rheb Rheb activates TORC1. Both Rheb and RHB1 regulate arginine uptake 
Snf1 AMPK glucose sensory protein kinase 
Ego1,Ego3 Regulator Tethers Rag proteins to lysosome/vacuole. Ragulator may also act as GEF for the 




Chapter 6 – Results 
193 | P a g e  
 
6.1.3 CHO cells as a model mammalian cell system and for the production of biotherapeutic 
recombinant proteins 
 
A variety of organisms including yeast and E.coli, and cultured cell systems, are used to produce 
recombinant proteins for clinical applications, however proper folding, assembly and human-like post-
translational modifications are important for correct protein function in humans and this is superior 
in mammalian cells (particularly human-like glycosylation) (Wurm, 2004) as outlined in the 
introduction chapter of this thesis. Chinese hamster ovary (CHO) cells in particular are used for 
producing recombinant therapeutic proteins as they can be genetically manipulated producing 
complex therapeutics with manufacturing adaptability, delivering up to several grams per litre of 
products with a highly optimised production process (Xu et al., 2011). However, with the continued 
development of new protein based biopharmaceutical target drugs, there is a continual need to 
further improve titre and particularly quality (correct folding and post-translational modifications) of 
biotherapeutic proteins from mammalian cells (Walsh, 2010a).  TOR signalling in particular has been 
shown to improve antibody titre by four-fold by ectopic expression of the global metabolic sensor 
mTOR, improving cell size, proliferation, viability, and robustness of the cell (Dreesen and 
Fussenegger, 2011). As TOR is conserved in yeast and higher eukaryotes such as CHO cells, here we 
investigated how disrupting TOR signalling via the specific TOR targets investigated in the yeast system 
described in Chapter 5 of this thesis translated into CHO cell phenotypes was investigated, particularly 
the effects on recombinant protein production using the Guassia luciferase reporter protein as a 




6.2 Investigation and manipulation of TOR signalling in CHO cells and its 
effect on recombinant protein production 
 
From the results described in chapter 5, the yeast genes from the EGO complex Gtr2, and Vam6 which 
acts as a GEF for the GTPase were selected for further study in CHO cells, this complex being 
responsible for amino acid sensing in TOR. Although the heterodimer to Gtr2, Gtr1, is also part of the 
complex, due to time constraint, this gene was not investigated. Deletion of GTR2 caused a loss of rP 
production, although the deletion of VAM6 had no effect we chose to test this in the mammalian 
system due to the lack of knowledge of the protein in this role. The mammalian orthologues for these 
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genes Vps39 (Vam6), and RagC and RagD (Gtr2) were investigated in the CHO system (Schurmann et 
al., 1995; Sancak et al., 2010).  
From the yeast screen data, Atg1 caused a loss in rP production and has two mammalian homologues; 
ULK1 and ULK2, however it was previously reported that the silencing of ULK1 was sufficient to inhibit 
autophagy, therefore it was decided to knockdown the gene for ULK1 in CHO cells (Yan et al., 1999; 
Chan et al., 2007).  
6.2.1 Effects of the knockdown of selected TOR targets in CHO in an initial screen 
 
To test if similar effects on GLuc expression from CHO cells were observed as to that observed in yeast 
in chapter 5 when manipulating TOR gene expression, an adherent CHOK1 cell line which expressed 
Gaussia luciferase (GLuc) previously generated at The University of Kent was utilised. GLuc is a 
naturally secreted protein from the organism Gaussia principes which is used as a molecular tool to 
study gene expression (Ruecker et al., 2008). Here, how alterations to TOR signalling effect GLuc 
secretion in the model CHO system was investigated. The GeneClip U1 Hairpin Cloning System from 
Promega was used to develop tools for the specific knockdown of target genes, thus achieve silencing 
of these TOR genes, as described in the methods chapter. This approach uses a foldback stem-loop 
structure which suppresses the expression of the target TOR gene sequence. This structure stimulates 
specific degradation of the target mRNA (Zamore, 2001; Wu, 2009).  
Oligonucleotide design was undertaken to produce two hairpin oligonucleotides which anneal to form 
a double-stranded DNA fragment containing a target sequence specific to each selected TOR gene. 
After the annealing reaction, the double-stranded DNA fragment containing a Pst1 site was inserted 
into the pGeneClip vector by the overhang sequence which was complementary to the vector 
overhang. These vectors containing the hairpin were transformed into competent E.coli cells, with the 
DNA extracted and sequenced to identify correct clones. CHOK1-GLuc cells were then transfected with 
the vectors for transient expression/knockdown and GLuc expression measured after 24 and 48 hours 
of knockdown by western blotting. This approach allowed for the determination of the ‘best’ 
conditions for knockdown of mRNA of the selected TOR genes as optimal conditions can vary. The 
amounts of mRNA knockdown were verified using qRT-PCR where mRNA levels were compared in the 
control to TOR knockdowns. For optimisation initial data is reported in Figure 6.2. Note that no 
housekeeping genes were used for normalisation in this experiment.  
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 Figure 6.2 mRNA levels of TOR knockdowns relative to the control. In 6 well plates 5x105 viable cells 
were seeded the day before transfection with the vector (n=1). Control contains scrambled sequence 
in the vector transfected.  Half the cells grown were re-suspended in 350 µl RLT and RNA extracted. 
This was then DNAse treated before used for qRT-PCR. A) mRNA levels after knock down relative to 
the control in cell lines after 24 hours with 1 µg and 2 µg DNA. B) mRNA levels after knock down 
relative to the control in cell lines after 48 hours with 1 µg and 2 µg DNA. (n=2, technical replicates). 
Note cells taken for each time point were from different wells. qRT-PCR was measured using 
Quantifast SYBR Green PCR kit and run using MiniOpticon System (BioRad). Note that no housekeeping 
genes were used for normalisation in this experiment. 
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Levels of mRNA detected in knockdown transfected cells were compared to that in the control with 
transient expression of the hairpin containing vector. After 24 hours the knockdown in some straing 
were 20% or less; however there was an increase in the knockdown observed after 48 hours except 
for the knockdown of ULK1, which was still low. The level of knockdown at the mRNA level was not 
considered high (>70%) for any of the genes with the knockdown of Vps39 mRNA showing the greatest 
knockdown of about 40% 48 h after transfection of the shRNA plasmid. Surprisingly, after 24 hours 
with 2 µg DNA added, an increase in RagD mRNA levels was observed, with a knockdown only 
observed after 48 hours. The general trend observed was that after 48 hours there was an improved 
knockdown of all mRNA from the shRNA with 1 µg DNA and this may be due to the time required to 
synthesise the shRNA and then subsequently for the mRNA to be targeted and degraded. Regardless, 
although the level of knockdown was not optimal (considered to be >70%), due to time limitations 
further work was undertaken to determine if this modest knockdown at the mRNA level resulted in 
any changes to recombinant protein expression. As antibodies to the proteins coded by these mRNAs 
were not available it was not possible to determine if the modest mRNA knockdown subsequently 
resulted in reduced protein levels at the time points investigated. 
Protein cell lysates were extracted and prepared from the same wells as those where mRNA levels 
were determined after knockdown to measure GLuc expression at the same time points. GLuc and 
actin antibodies were then used to assess recombinant protein production in the intracellular samples 
with selected TOR genes knocked down by western blot analysis and for GLuc in the supernatant 
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B)   24 hrs      48 hrs 
      
Figure 6.3 Initial screen of GLuc and actin expression in CHO cells and of GLuc in the cell culture 
supernatant with selected TOR knockdowns. In 6 well plates 5x105 viable cells were seeded the day 
before transfection with the vector. Control samples contained scrambled sequence in the vector 
transfected.  1 ml supernatant was removed with 200 µl lysis buffer added. Half the cells grown in 
each plate were collected by centrifugation and treated with 200 µl of lysis buffer. (n=1)  The Bradford 
assay was performed to measure protein levels. A) GLuc expression time course at 24 hours and 48 
hours using 1 µg and 2 µg control DNA in the supernatant (s) and pellet (P). B) Quantification using 
Image J of GLuc expression in supernatant and pellet after 24 h and 48 h using 1 µg and 2 µg DNA for 
TOR knockdowns. (n=1). Quantification was undertaken using the software Image J. 
 
GLuc expression detected in the supernatant and pellet following targeted knockdown is reported in 
figure 6.3a where expression was determined 24 and 48 hours after transfection with the scrambled 
sequence as a control. This data illustrated that there was more GLuc expressed from CHO cells 
           Control 
     S         P         S          P         S          P         S          P 
                  24 hr                                     48 hr           __      
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compared to yeast (chapter 5) with more found in the supernatant at both 24 and 48 hours. As 
expected, more GLuc was detected after 48 hours than 24 hours of culture and the control DNA 
amount transfected made little difference to secretion. 
The amount of GLuc in the various knockdowns 24 hours after transfection with 1 µg DNA is reported 
in figure 6.3B. An increase in GLuc expression was observed in RagC, RagD and Vps39 knockdowns at 
24 h, yet with 2 µg generally a decrease in expression was observed. In the knockdown of both Rag 
proteins higher GLuc expression with 1 µg DNA and greater knockdown was observed suggesting that 
knockdown of these mRNA may result in an increase in GLuc protein production.  Knockdown of RagD 
with 1 µg in particular resulted in an approximate 3-fold increase in GLuc expression in the pellet and 
slightly less in the supernatant.  Although the level of mRNA knockdown of RagD and in RagC was 
comparable at 24 hours, RagD knockdowns had more apparent effects on the GLuc expression levels. 
This could be due to a smaller level of mRNA knockdown producing a bigger change in protein 
expression in RagD although this was not investigated here as antibodies to Rag D were unfortunately 
unavailable. Transfection of the hairpin for RagD could ultimately result in a different effect in the cells 
compared to the hairpin for ULK1. ULK1, showed a higher percentage knockdown of mRNA with 2 µg 
DNA, yet showed only marginally higher levels of GLuc secretion in the supernatant. This was the only 
mRNA targeted which had more knockdown with 2 µg of DNA. 
Vps39 knockdown showed little change to GLuc expression after 24 hours and there was also little 
change to mRNA levels which suggests the knockdown was not efficient in this transfection or that the 
sequence designed for the knockdown did not result in the desired knockdown. When comparing GLuc 
expression with the varied amounts of DNA little change to mRNA levels was observed yet a reduction 
in GLuc expression with 2 µg DNA after 24 hours was detected suggesting this amount of DNA was 
negatively influencing the cell’s ability to produce recombinant protein.  
We discovered 48 hours after transfection, there was a general decrease in GLuc expression across all 
knockdowns with both amounts of DNA investigated in the pellet and supernatant suggesting the cells 
responded differently after 24 hours and 48 hours to the transfection (figure 6.3C). As there was a 
drastic change to GLuc expression in RagC after transfection with both 1 µg and 2 µg of DNA and in 
RagD with 1 µg DNA, this amount was used in future experiments and GLuc expression monitored 
after 48 hours transfection/knockdown.  
From these initial studies, knockdown from transfecting the shRNA was achieved but only at modest 
amounts of 30-40% mRNA knockdown and there was a higher degree of knockdown after 48 hours 
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with 1 µg DNA (see figure 6.2). Knockdown of all the targets except ULK1 mRNA caused an increase in 
GLuc expression after 24 hours then a decrease in all knockdowns after 48 hours (figure 6.3).  
 
6.2.2 Effects on recombinant protein production of Rag protein knockdowns 
 
The data presented in figure 4.2 and 4.3 illustrate knockdown, albeit very modestly, using 1 µg of the 
vector containing the hairpin after 48 hours achieves the highest knockdown. As knockdown of these 
selected TOR genes reduced rp production at 48 h, we wanted to confirm this by repeating the 
transfection of the vector silencing RagC and RagD as one of the main components of nutrient sensing. 
This test would also confirm if perturbing nutrient sensing in yeast via the GTPases in the EGO complex 
gives the same effect in CHO cells when analysed by monitoring GLuc expression. In addition, a double 
knockdown of RagC and RagD was also performed, as only the knockdown/silencing of both would 
compare to deletion of Gtr2 in yeast. Figure 6.4 below reports the mRNA levels detected after 48 hours 
post transfection with the shRNA using 1 µg of DNA. As described earlier, qRT-PCR was undertaken to 
determine target gene mRNA levels, and hence knockdown, from cells grown in 6 well plates. 
 
                                        
Figure 6.4 mRNA levels of Rag knockdowns after 48 hours. Percentage of mRNA levels in cell lines 
relative to the wild type after 48 hours knockdown with 1 µg DNA. In 6 well plates 5x105 viable cells 
were seeded the day before transfection with the vector. Control contains scrambled sequence in the 
vector transfected.  Half the cells grown were resuspended in 350 µl RLT and RNA extracted. This was 
then DNAse treated before used for qRT-PCR. qRT-PCR was measured using Quantifast SYBR Green 
PCR kit and run using MiniOpticon System (BioRad). Statistical analysis was performed using one-way 
ANOVA test (*P<0.05, **P<0.01, ***P<0.001). (n=4) Errors bars represent standard deviation. 
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mRNA levels were measured after 48 hours of transient knockdown of selected TOR mRNA. However 
it was revealed that little/no changes to mRNA levels suggesting there was no knockdown of the target 
genes in this experiment at 48 h post-transfection (figure 6.4). Despite this, GLuc expression was still 
measured to determine if the transfection itself of the different knockdown plasmids had influenced 




Chapter 6 – Results 
201 | P a g e  
 
A) 
            
            
            
            
            
            
            
            
            
            
            
            





                                   
Figure 6.5 GLuc expression in cell lines 48 hours after knockdown. Actin expression was also detected 
for normalising data. In 6 well plates 5x105 were seeded the day before transfection with the vector. 
Control contains scrambled sequence in the vector transfected (KD-knockdown). 1ml supernatant was 
removed with 200µl lysis buffer added. Half the cells grown in each plate were spun down and treated 
with 200µl of lysis buffer. (n=1) The Bradford assay was performed to measure protein levels. a) Gluc 
expression in control and Rag knockdowns after 48 hours using 1 µg DNA in supernatant(S) and pellet 
(P). b) Quantification of GLuc expression in knockdowns after 48 hours using 1 ug DNA (n=4). 
Quantification was done using the software Image J. Statistical analysis was performed using the 
ANOVA test (*P<0.05, **P<0.01) which compares GLuc in the supernatant of each strain to the control 
as well as GLuc detected in the pellet to the control. Errors bars represent standard deviation. 
Gaussia luc. 
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It was revealed that GLuc is secreted in higher amounts in the control than in the knockdown 
transfected samples (figure 6.5A), as observed before in figure 6.3A.  Quantification of these blots in 
figure 6.5b showed that transfection with the knockdown plasmids caused a statistical decrease in 
secretion in RagC (P<0.05), RagD (P<0.01) and knockdown of both combined (P<0.01).  This was a 
surprising result as there was little/no knockdown detected at the mRNA level as reported in figure 
6.4. Either there was a subtle but non-detectable knockdown, knockdown had occurred earlier and 
then recovered or the transfections were influencing the cells in some other, unknown manner 
causing a reduction in GLuc protein synthesis within the cell. We also observed a reduction in GLuc 
trapped in the pellet when comparing all knockdowns to the control with the transfection of the 
plasmid for knockdown of RagC caused a significant loss of expression (P<0.01), in addition a loss with 
the knockdown of RagD (P<0.01). When comparing transfection of the plasmids for the knockdown of 
RagC and RagD, there was little difference between these when measuring GLuc expression.  With the 
double knockdown transfection we saw a similar reduction to GLuc expression suggesting that 
transfection of both plasmids caused no further perturbation to rP production.   
In conclusion, the data here is inconclusive as to whether Rag proteins are important in rp production 
in CHO cells as determined from GLuc expression as insufficient knockdown of the target mRNAs was 
achieved. The fact that GLuc expression decreased upon transfection does agree with the data earlier 
in this chapter but the lack of knockdown precludes any conclusions being drawn with respect to the 
effect of reducing amino acid sensing and rP production as reported in the yeast with the deletion of 
Gtr2. Of course, amino acid sensing may not be relevant at 48 h after transfection when sufficient 
nutrients are still available in the media and longer time points may have been more interesting if 
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6.3 Discussion 
                                 
In this chapter we investigated TOR signalling in the CHO expression system in relation to rp 
production using CHOK1 cell line expressing the secreted protein GLuc. We previously identified TOR 
proteins in yeast from a screen which caused a loss to GLuc expression when these genes were 
deleted; as CHO cells are predominantly used in the biopharmaceutical industry we wanted to test if 
we detected the same effects to GLuc protein synthesis when the mammalian counterpart is silenced.  
An attempt at silencing of these selected mTOR mRNA was performed using shRNA which targets the 
mRNA for degradation. In the initial test (figure 6.2) we detected a higher percentage knockdown in 
general after 48 hours with 1 µg DNA as this gives more time for the vector containing the shRNA to 
be expressed and target the specific gene by the shRNA for degradation by the enzyme Dicer (Zamore, 
2001; Wu, 2009). A vector containing a scrambled sequence was used as a control and its GLuc 
expression measured where we observed more GLuc secreted versus that in the cytoplasm (figure 
6.3A). Compared to what was detected in yeast, CHO are much better secretors of GLuc, however the 
activity of the protein secreted was not tested in both systems.  
With GLuc expression quantified, we observed a loss in GLuc expression detected in the pellet and 
supernatant across all knockdowns (figure 6.3C). Unfortunately it was not possible to confirm if the 
modest knockdowns at the mRNA level had resulted in a knockdown, and to what extent, at the 
protein level due to a lack of available antibodies. 
 
6.3.1 Loss of autophagy in CHO cells 
 
Autophagy is inhibited downstream of TORC1 through ULK1/2 which forms a complex with ULK13 and 
FIP200 (Hara et al., 2008). ULK1/Atg1 is a major coordinator of autophagy which is essential for 
recycling old or damaged components in the cell increasing intracellular nutrients during starvation or 
other forms of environmental stress and so is necessary for efficient protein synthesis in both yeast 
and CHO cells (Levine and Klionsky, 2004; Ganley et al., 2009). To test the role of ULK1 in GLuc 
production, its gene was knocked down using shRNA. A low percent knockdown of ULK1 mRNA using 
shRNA was achieved (figure 6.2), yet we observed a similar loss of GLuc expression after 48 hours 
transfection (figure 6.3C). This suggested that the sequence targeting ULK1 worked in the shRNA, and 
a loss of ULK1 (although not fully knocked out) resulted in an impact upon rp production.  
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Of all the autophagy genes, some regulate development in other pathways in higher eukaryotes 
including Beclin 1 (Atg6 in yeast) which interacts with anti-apoptotic members of the Bcl-2 family 
(Levine and Klionsky, 2004; Lee et al., 2013). CHO cell phenotypes grown in industry in large batches 
to produce rP can be improved with cellular engineering, for example ectopic expression of mTOR 
which increased antibody production (Dreesen and Fussenegger, 2011). Kroemer et al., (2010), discuss 
how autophagy integrates stress responses which would accumulate during cell growth such as ROS, 
DNA damage, damaged organelles and protein aggregates.   
As CHO cells are engineered to produce rP in high volumes, there is added stress such as ER stress 
leading to misfolded protein and mitochondrial dysfunction which can result in cell death by apoptosis 
(Bravo et al., 2011). Autophagy can however be harnessed as an anti-cell death target in conjunction 
with controlling apoptosis during stressful culture conditions. For more efficient protection of cells, 
apoptosis and autophagy are both being targeted in CHO cells. For example, Bcl-2, an anti-apoptotic 
protein and Beclin-1, a key regulator of autophagy were co-overexpressed causing a synergistic effect 
by enhancing anti-cell death during growth (Lee et al., 2013). One of ULK1’s role is in phosphorylating 
Beclin-1 to initiate autophagosome formation, which supports the phenotypic response found here 
from silencing ULK1(Russell et al., 2013).  
 
 
6.3.2 Inhibition of amino acid sensing     
 
RagC/D (Gtr2) form a heterodimer with RagA/B (Gtr1) which form part of the EGO complex which 
needs the GEF Vps39 (vam6), important for activating TORC1 and controls growth and protein 
synthesis (Kim et al., 2008). rP production places additional energy demands upon the cell and 
therefore nutrition sensing is important in optimising recombinant protein synthesis. It is known that 
glucose and energy sensing is undertaken via AMPK, yet amino acid sensing is poorly understood. 
Amino acids are essential for mTOR activation because even growth factors and other stimuli are not 
efficient in activating mTOR when amino acids are limited (Jewell and Guan, 2013).  
The knockdown using shRNA confirmed a loss of GLuc expression (figure 6.3) in RagC and RagD (Gtr2 
in yeast) and Vps39 (Vam6 in yeast), confirming their importance in rP production. We reported a loss 
of GLuc expression (figure 6.3) when only limited silencing of Vps39 was achieved (figure 6.2). 
Although Vps39 was previously believed to be the GEF for the Rag proteins, it was recently 
demonstrated that Vps39 does not interact with RagA suggesting that the effects of silencing Vps39 
are not due to the loss of amino acid sensing but only due to its role in the assembly of vacuoles, a 
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function already known (Nakamura et al., 1997; Binda et al., 2009; Bar-Peled et al., 2012). In yeast it 
was discovered that Vam6 has a function in the vacuolar assembly and deletion of this gene causes 
vacuole-related structures smaller than normal vacuoles(Nakamura et al., 1997; Binda et al., 2009). 
The loss of this function in CHO cells may have been what was causing loss of GLuc expression. 
Vps39/Vam6 is known to co-localise with Vps41/Vam2 (also involved in vacuolar assembly) and form 
part of the HOPS complex which is required for several fusion events at the late endosome and the 
vacuole including the fusion of autophagosomes and golgi vesicles (Bröcker et al., 2010). Quality 
control is important in the secretory pathway where substrates targeted for degradation can be 
targeted for the endosomal system for lysosomal degradation, this is important for normal protein 
trafficking and stability in the secretory pathway (Arvan et al., 2002; Brodsky and Skach, 2011).  
The attempted silencing of RagC and RagD was repeated but with more replicates, and again a loss to 
GLuc expression was observed when they were knocked down separately or together (figure 6.5). It 
was not unsurprising that the knockdown of each caused similar alterations to GLuc production as 
they are functionally redundant (Schurmann et al., 1995; Sancak et al., 2010). Unfortunately the 
knockdown of these mRNA proved difficult to achieve, the reasons for this are not clear at this stage 
(figure 6.4). When transfecting with shRNA for both RagC and RagD a further decrease to GLuc 
expression was observed, yet not all function is lost. Although there was little/no change to mRNA 
levels observed, the system was perturbed causing a loss in GLuc expression detected in both the 
supernatant and the pellet. The reason for this is unclear but may be the result of either off target 
effects, recovery of mRNA levels at 48h after knockdown or the DNA itself may have been toxic to the 
cell and generally slowed protein synthesis (although this was not seen in the initial knockdown, figure 
6.3). A future experiment would be to check the protein levels of RagC/D, Vps39 and Ulk1 as we did 
not have the antibodies available. It would be interesting to see if knockdown of RagA/B shows the 
same effect on GLuc production, and even further the combination knockdown of RagB/C. It was 
found that RagB-GTP/RagC-GDP was the most effective in signalling to mTORC1 (Sancak et al., 2010). 
Interestingly, GLuc expression investigated in RagC, RagD and Vps39 knockdowns had shown an 
increase in GLuc expression from RagD knockdown in particular (figure 6.3b). There are a number of 
possible reasons to explain this increase after 24 hours of transfection before a reduction in GLuc at 
48 hours. The transfection process itself may have caused an effect resulting in either stress or some 
form of cellular response causing a transient increase in expression before the knockdown at 48 hours. 
There is literature discussing how lipofectamine used for siRNA transfections can cause an increase of 
autophagasomes (Mo et al., 2012).  Any stresses can cause cellular changes, however knockdown of 
these three mRNAs in this particular part of the TOR pathway may be more sensitive. Another reason 
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could simply be due to the initial response of the knockdown resulting in the GLuc increase but after 
a longer time period TOR signalling is shutdown reducing rP production. Further experiments would 
need to be undertaken to confirm whether any of these mechanisms were responsible for the 




In summary, the control of TOR signalling through various upstream and downstream processes is 
paramount for cellular homeostasis during growth. The nutrient status of the cell is carefully 
monitored by the Rag complex in communication with mTORC1 via raptor which is necessary for 
efficient rP production. However, this process along with other control mechanisms in the cell works 
together to correctly sense and react to the appropriate cues from intracellular and extracellular 
senses. This chapter investigated how both amino acid sensing as well as autophagy, which promote 
and inhibit TOR signalling (via feedback mechanisms) respectively, reduces GLuc expression when 
silenced in CHO cells (Dunlop and Tee, 2013). Unfortunately the hairpin approach to knockdown target 
gene expression was largely unsuccessful. The reason for this are unclear as this system has been used 
successfully to knockdown other target genes within our research group. Further investigation is 
needed to determine if manipulating these selected components of mTOR signalling by 
overexpression could potentially enhance rP production which would be beneficial to industry. 
Improved knockdown and protein levels detected for further confirmation of the effects of the 
manipulation of these genes needs to be undertaken to allow a full assessment of the effects of 
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Since the advent of recombinant DNA technology and the approval of the first rP for use in humans 
by the FDA around 30 years ago, heterologous protein production has been possible in a variety of 
systems including plants and cultured yeast, bacteria, insect and animal cells. Advances in 
recombinant DNA technology alongside an ever improving knowledge of the mechanisms involved in 
controlling protein synthesis, quality control, responses to environmental conditions, coupled with 
genetic manipulation of host expression systems have been instrumental in boosting rP productivity 
(Ferrer-Miralles et al., 2009). Through the genetic engineering of various organisms and cell systems, 
it is possible to improve production rates by harnessing improved cellular functions. Examples include 
altering protein processing through the secretory pathway (such as the overexpression of the PDI 
folding protein), metabolic engineering for improving growth and viability, and use of anti-apoptotic 
strategies to prevent cell death in the bioreactor (Davis et al., 2000; Fussenegger et al., 2000; 
Palomares et al., 2004; Dinnis and James, 2005).  
Due to the relative ease of genetic manipulation and fast growth, yeast are common manufacturing 
systems in rP expression of biotherapeutics (16.5% of approved products are expressed in yeast), 
including the use of S.cerevisiae and P.pastoris (Walsh, 2014). In this study we harnessed S.cerevisiae, 
one of the most well-studied lower eukaryotic microbial systems, as a model for the expression of 
recombinant reporter molecules. In addition, we used this to probe cell signalling pathways and the 
influence on rP production. Yeast are able to adapt to stresses such as low oxygen levels, high 
osmolarity and temperature by adapting to new conditions through transient responses of gene 
expression changes (Mattanovich et al., 2004; Porro et al., 2005; Rodríguez‐Peña et al., 2010; Çelik 
and Çalık, 2012).  
Specifically, S.cerevisiae was utilised in this project to investigate how modifications to various 
nutrient sensors in the cell may affect rP production, as cell growth is controlled by the cellular 
responses to nutrient availability and stress through various signalling pathways. However, due to the 
complex nature of the mechanisms involved through cell signalling, cross talk between pathways does 
occur. For example, there is considerable cross-talk between Target of Rapaymcin (TOR) and the PKA 
pathway in controlling autophagy when nutrients are scarce (Stephan et al., 2014). As the TOR 
pathway is well conserved among eukaryotes, the aim here was to investigate the yeast system and 
then establish how these findings could be related to the mammalian expression system, Chinese 
hamster ovary (CHO) cells. This is a robust system most commonly used in expressing rP due to their 
ease of manipulation, robust performance in the bioreactor, ability to be cloned to deliver cell lines 
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with different phenotypes, regulatory approval and ability to fold and assemble complex proteins with 
human-like post-translational modifications, particularly glycosylation (Fan et al., 2012; Walsh, 2014). 
In this thesis, a reporter construct for expressing the heterologous protein Gaussia luciferase (GLuc) 
from the organisms Gaussia princeps was used as a model recombinant expression molecule and the 
signal sequence from the yeast pheromone gene MFα was used for the secretion of the model 
recombinant protein (Lin-Cereghino et al., 2013). The advantage of using this construct in yeast is that 
it allows the user to rapidly screen a variety of mutants with altered nutrient and stress signalling to 
determine their influence on rP production. However, before undertaking the screen, it was necessary 
to identify and optimise the screening process using the GLuc construct. The results from this process 
are reported in Chapter 3, and a discussion of the results is presented below. 
 
7.2 Optimisation of the yeast model system using the GLuc construct 
 
The aim of the work described in Chapter 3 was to find a suitable screening method for identifying 
genes/proteins that may influence recombinant protein expression, as determined using a GLuc 
reporter construct developed specifically for yeast. The GLuc assay, involving measuring varying 
luminescence between strains depending on their ability to produce rP, was investigated; the pH of 
the media and GLuc expression (through a time course) were determined. Although luminescence was 
assumed to be stable under varied pH conditions, low or high pH may influence the yeast mutants, 
modifying/inactivating enzymes involved in processes along the secretory pathway (Figure 3.5) (Wiles 
et al., 2005; Tannous et al., 2005). There was significant variation in GLuc activity detected from day 
to day, despite following a defined methodology (Figure 3.7). This work suggested that the GLuc 
activity assay was not robust under the conditions investigated and could not be used for reliable 
comparisons across experiments and different days to determine effects of gene manipulation on 
expression (Figure 3.7). An option could have been to use an injector so the readings were taken 
immediately after the substrate is added, as the timing may have been introducing this error when 
signal is lost. However, an alternative method of assessing protein expression was investigated. 
As an alternate method, western blotting using a GLuc antibody for determining expression levels was 
investigated, allowing determination of the recombinant GLuc protein levels in the pellet and the 
supernatant. This provided additional information as to how mutations may affect protein processing 
as well as secretion (Figure 3.8). The disadvantage of this approach is that the method determines 
protein amounts, not activity, and as such manipulation of a specific target gene/protein may 
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increase/decrease total protein expressed but influence the amount of active protein present in a 
different manner (e.g. more protein might be expressed but at the expense of folding and as such the 
change in the amount of active protein may not reflect the change in the amount of total protein). 
Taken together, this suggests that the system used has variable quality output, since measuring 
protein production in this way gives accurate results but variable activity measurements. One 
improvement to overcome this issue may be to investigate activity levels in yeast with a different 
genetic background which may more accurately produce a functional product. Mutations in the 
protein cofilin for example, causes alterations to the protein’s role as a homeostatic regulator, 
therefore these genetically altered cells may be causing unstable activity of the protein. 
In addition, an alternative rP system was also established to ensure that any changes observed were 
not specific to the GLuc construct. The signal sequence from the yeast mating pheromone is commonly 
used for secretion (Lin-Cereghino et al., 2013). As an alternative screen, the Killer Toxin assay was 
utilised which is a viral model system also used previously to target foreign proteins for secretion 
(Schmitt and Breinig, 2002). We predicted that as the rP is driven by a different signal sequence, the 
secretion profile of the wild type and mutants investigated may be different under varied conditions. 
As this protein assay is inexpensive and rapid, the assay has proven to be a good tool for screening. 
Nonetheless, this assay relies on a low pH media for the toxin to function and therefore the observed 
results may be influenced as altered strains may adapt to the environment differently as pH stress will 
alter signalling activity differently with mutated components. As such, both CHO and yeast systems 
were selected to screen for gene/proteins whose manipulation changes rP production through 
alterations to stress sensing through genetic mutations. As TOR signalling is so well conserved 
between the two systems, we discovered similar results in chapter 5 (yeast cells) and chapter 6 (CHO 
cells) in investigating altered amino acid sensing and its importance in rP production (see section 7.4.1 
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7.3 The actin binding protein Cofilin plays a role as an environmental sensor 
revealing the importance of mitochondria in rP production and stress 
signalling in yeast.  
 
7.3.1 Linking mitochondria and cofilin in rP production 
 
Unpublished data from the Gourlay lab at the start of this project highlighted the importance of 
mitochondrial function for rP production. When comparing a high and low rP producer of albumin and 
transferrin, Gourlay et al found the higher producer had greater mitochondrial damage, as determined 
by respirometry studies (unpublished data). It is well established that mitochondria are important in 
sensing and regulating ER stress, controlling apoptosis through the unfolded protein response (UPR), 
as well as supplying the energy required during protein synthesis. These organelles communicate 
through  mechanisms of calcium transfer via the ERMES (endoplasmic reticulum(ER)-mitochondrial 
encounter structure) junction,  which is important in modulating mitochondrial bioenergetics for the 
cell to adapt during stress (such as that encountered during rP production) (Bravo et al., 2012). 
Although this is only true in yeast, mammalian cells have a functional equivalent (described in chapter 
1 section 1.3.2.5) (Kornmann and Walter, 2010). 
Cofilin, the actin binding protein, is known to translocate to the mitochondria during oxidative stress 
and initiate the release of cytochrome C leading to apoptosis (Liu et al., 1996; Chua et al., 2003). It 
was recently reported that specific mutations outside of cofilin’s actin binding region leads to 
increased mitochondrial function in yeast (Kotiadis et al., 2012). We hypothesised that such cofilin 
mutations may be beneficial in terms of subsequent effects upon rP production yield.  As ER stress 
causes mitochondrial dysfunction leading to cell death (Lim et al., 2009), enhanced mitochondrial 
function may buffer against this. In CHO cells, the key signalling pathway TOR (which controls growth 
and protein synthesis through the TORC1 complex), is also involved in regulating mitochondrial 
biogenesis. This is achieved via PGC1a, a transcriptional activator of genes encoding proteins in 
mitochondrial function in mammalian cells. Although there is no known orthologue in yeast cells, this 
increase in mitochondrial biogenesis may be advantageous for rP production.  
As enhanced mitochondrial biogenesis may be beneficial to rP production, we sought to investigate if 
recombinant GLuc expression could be effected by changes to cofilin that altered mitochondrial 
function. In order to address this, a library of cofilin mutant alleles were expressed to determine if 
modification of specific residues outside of the actin binding region with alanine mutations, 
removed/changed the function of the protein and therefore rP production (Lappalainen et al., 1997). 
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These mutant alleles were split into three groups depending on effects upon mitochondrial biogenesis 
or actin organisation (Kotiadis et al., 2012). Class I contained cof1-4, cof1-6, cof1-7, cof1-11, cof1-12, 
cof1-15, cof1-18, cof1-19, cof1-21 expressing strains which all demonstrate an increase in 
mitochondrial respiration (Kotiadis et al., 2012). Class II included cof1-10 and cof1-13 which possessed 
slow growth, decreased respiration and impaired actin regulatory function; compared to Class III (cof1-
5, cof1-8 and cof1-22) with severely altered actin organisation as well as temperature sensitive growth 
(Lappalainen et al., 1997).  
When expressing GLuc in a selection of these strains with varied mitochondrial function (class I that 
have enhanced mitochondrial function), cells expressing the cofilin mutant allele cof1-21 showed an 
increase in GLuc secretion compared to all other strains. This suggests that the mutated protein 
positively impacts upon rP production (Figure 4.3). We found that the loss of mtDNA in the wild type 
cells led to an almost complete loss of GLuc expression. However, GLuc expression was apparent in 
cells expressing cofilin mutant alleles. This data suggested that signalling between cofilin and the 
mitochondria is important in determining rP production. When position 103 containing an aspartic 
acid is mutated to alanine an advantageous response in rP production is observed, although the 
mechanism by which this results in this phenotype is unknown. As already discussed, mitochondria 
are important in regulating the metabolism of the cell especially during rP production, where the cell 
is forced to use more energy and nutrients. With the loss of mitochondrial function and metabolic 
insufficiency, the ER may become stressed leading to cell death (Bravo et al., 2012). mtDNA is needed 
for glutamate biosynthesis and respiration, as cells without mtDNA do not have enough glutamate to 
convert to glutamine, a precursor for nucleotides and amino acids (Durán et al., 2012). In turn, loss of 
these precursors would negatively influence protein synthesis. There is also proof that mitochondria 
are needed in the rejuvenation of the cellular environment, as it tethers to toxic protein which form 
aggregates in yeast, preventing aggregated protein being passed on to the daughter cell (Zhou et al., 
2014; Mogk and Bukau, 2014). Due to their enhanced mitochondrial function and/or their alterations 
to stress signalling through cofilin, mutant strains with loss of mtDNA produced more GLuc compared 
to the wild type. This data provides further evidence of signalling between the mitochondria and 
cofilin. 
When comparing GLuc expression in these strains to results obtained from the killer toxin assay, there 
was some loss in killer toxin secretion with mtDNA removed, however this loss in rP production was 
less significant compared to GLuc expression. An increase in killer toxin secretion in cofilin mutant 
cof1-21 (as seen with GLuc expression) was not observed, confirming that the GLuc results may be 
specific to the construct used. Two different signal sequences were utilised between constructs, the 
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K1 signal sequence for the killer toxin and the MFα1 signal sequence for producing GLuc in yeast. The 
results acquired using the GLuc construct may be influenced by the MFα1 signal sequence used. The 
findings may be specific to producing GLuc (or any other recombinant protein) with this signal 
sequence. It would be interesting to exchange the GLuc and Killer toxin signal sequences to confirm if 
the results are specific to the signal sequence used.  
As there was an increase in the respiration of mutants with alterations outside of the actin binding 
region, this suggests other roles of cofilin as a stress sensor to the mitochondria. Microarray data from 
previous work in the Gourlay lab proposed that this change to mitochondria must be controlled post-
translationally as levels of mitochondrial biogenesis were not apparent within the mRNA population 
(Kotiadis et al., 2012). In light of these observations, we investigated TOR signalling by growing the 
strains expressing the mutant alleles of cofilin in the presence of rapamycin. We observed that strains 
with elevated respiration tended to show rapamycin resistance in the majority of strains (Figure 4.5). 
Previous microarray data of the mutant expressing allele cof1-6 revealed upregulation of ABC 
transporters through ABC transporters PDR5, PDR10, PDR15 and SNQ2. This is a result of the elevation 
in respiratory function from the cofilin mutation, triggering a retrograde response, inducing PDR1-
dependent multidrug resistance (Kotiadis et al., 2012). As PDR10 along with the PDR18 and TF PDR8 
were discovered to be a drug pump for rapamycin (Figure 4.9), we were able to rule out hyper-TOR 
signalling in strains with rapamycin resistance. This data, along with the finding that the mutant strains 
showed no changes in phosphorylation of Sch9 (a key target of TORC1 signalling), suggests that there 
was no alteration to TOR signalling (Figure 4.10). 
 
7.3.2. MAPK signalling plays a role in the secretory pathway  
 
Previous microarray data of cofilin mutant allele cof1-6 from the Gourlay lab found increased levels of 
TEC1 and FUS3 mRNA compared to wild type cells (unpublished data). Both TEC1 and FUS3 are part of 
the MAPK pathway controlling filamentous growth response, yet only Fus3 in mating pheromone 
response (see chapter 1 section 1.3.4 for more detail), suggesting an increase in STE12 as this is the 
common TF in both MAPK pathways (Bao et al., 2004; Molina et al., 2010). This signalling pathway 
causes an upregulation of genes involved in regulating the cell cycle, budding pattern, enhancing 
cellular adhesion as well as regulatory genes in elongating the cells morphology. During the 
filamentous response when nitrogen is limited, Ste12 binds to the filamentation response elements 
(FREs) as a heterodimer with Tec1 which is bound to the motif TEA/ATTS consensus sequence (TCS) 
(Wong Sak Hoi and Dumas, 2010) activating genes for filamentation. Conversely, during mating Ste12 
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binds solely to pheromone response elements (PREs), controlling the genes for proteins involved in 
the cell cycle, causing G1 arrest and the morphological changes needed during mating (Su et al., 
2010b). However, as these cells are not undergoing mating or filamentous growth, an increase in Ste12 
indicates a loss of fidelity in the control of MAPK signalling. As there is no mating factor signal or 
nitrogen limitation, this tells us that the response is only partial as we don’t see changes in cell shape. 
This may be due to cofilin interacting with common proteins in the pathways effecting Ste12, for 
example, Ras, Cdc42 or perhaps other MAPK’s. Previous evidence shows that mutated cofilin leads to 
hyperactive Ras (Kotiadis et al., 2012). 
As an extension of this we tested a number of cofilin mutant alleles, and found a strong correlation 
between Ste12 activity, rapamycin resistance and increased mitochondrial respiration (Figure 4.12). 
This suggests that cofilin is involved in co-ordinating environmental sensing with mitochondrial activity 
and stress response. This data lead us to investigate how the removal of STE12 would influence rP 
production in cofilin mutant alleles. This deletion led to an accumulation of non-native GLuc detected 
in both the wild type and the mutants, suggesting that loss of this TF led to changes in rP processing 
through the secretory pathway, which is likely to be due to an increased load on chaperones in folding 
GLuc (Figure 5.16). These changes could be an effect of the removal of STE12 on MAPK signalling. The 
signal sequence used here was different to what was used to express the killer toxin, giving a possible 
explain as to why we don’t see the same results in both assays (Figure 4.17). 
However, as we only detected moderate changes to the expression of GLuc, it is more likely that 
deleting STE12 prevents proper processing of GLuc within the secretory pathway. This result suggests 
that the control of stress response factors through Ste12 is important for the appropriate responses 
during rP production. Loss of this control may alter levels of proteins needed for correct folding and 
secretion. Future work could be undertaken to identify which Ste12 binding genes are responsible for 
these observed changes to rP production outside their role in regulating mating or filamentation. An 
interesting experiment would be to test if overexpressing protein folding chaperone would improve 
secretion in cells with Δste12. This would confirm our hypothesis of how removing Ste12 effects rP 
production. An example would be to overexpress the chaperone PDI, which has been shown by others 
to  enhance rP production (Wittrup, 1995).  
Figure 7.1 below portrays the interactions investigated between cofilin, Ste12 signalling and the 
mitochondria in stress signalling and recombinant protein production in this study with other known 
links.  
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Figure 7.1 Components involved in stress signalling and its effect on recombinant protein production 
studied using a library of Cofilin mutant alleles. Arrows depict interactions between components 
investigated in stress signalling and rP production through the secretory pathway.  (1) Previous data 
has shown that mutations to cofilin outside of its actin binding region led to alterations in 
mitochondrial function suggesting there is stress signalling between cofilin and the mitochondria 
(Kotiadis et al., 2012). (2) Cofilin mutant allele cof1-21 was the highest producer of GLuc with a 
significant increase in GLuc secreted. This strain and others from Class I had enhanced mitochondrial 
function which triggered an upregulation of drug pump activity, giving these cells resistance to 
rapamycin. (3) Ste12 activity across most strains also had rapamycin resistance, linking Ste12 signalling 
to the mitochondria during stress. It was also discovered that deleting STE12 influences protein 
processing in the secretory pathway, as its deletion led to an increase in non-native GLuc. Ste12 is part 
of the MAPK signalling pathway in mating, therefore we believe that changes to Ste12 activity will 
influence GLuc expression as the signal sequence from mating alpha factor gene (MFα1) is utilised. (4) 
Removing mitochondrial DNA from the wild type caused an almost complete loss of GLuc produced, 
confirming the importance of the mitochondria in rP production. As the cross talk between the ER and 
the mitochondria through the ERMES junction is important in calcium signalling, this effects ER stress 
and mitochondrial bioenergetics possibly influencing rP production if perturbed (Kornmann and 
Walter, 2010). (5) rP production is heavily effected by protein processing through the secretory 
pathway such as PTM’s and protein folding by chaperones (Walsh, 2010a; Brodsky and Skach, 2011). 
(6) It has been previously documented that cofilin is involved in the induction of apoptosis in the cell 
as it translocates to the mitochondria during oxidative stress, also linking Cofilin to stress (Chua et al., 
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7.4 Nutrient signalling through TOR, and its impact on rP production  
 
7.4.1 Importance of the EGO complex in rP production 
 
TOR signalling controls many processes linked to growth and stress response and so can be described 
as acting as a homeostasis sensor (Laplante and Sabatini, 2012). TOR signalling is controlled by two 
multi-protein complexes: TORC1, which is sensitive to rapamycin controls many processes important 
to rP production, and the rapamycin-insensitive complex TORC2, which is best characterised for its 
function in cell polarity and control of the actin cytoskeleton (C De Virgilio and Loewith, 2006a; 
Laplante and Sabatini, 2012).  Due to its role as a growth regulator, TORC1 has been identified as an 
important target for manipulation or control for improving rP production in higher eukaryotes (Kim et 
al., 2012; Walsh, 2014). There is evidence that manipulation of TORC1 signalling can help improve 
antibody production in CHO cells when mTOR is overexpressed (Dreesen and Fussenegger, 2011).  
The aim of the work described in Chapter 5 was to identify targets in TORC1 signalling by using the 
budding yeast S.cerevisiae, and screening strains from a TOR gene knockout library collection. The 
screening process involved expressing GLuc in the reporter construct as a recombinant protein. We 
identified Gtr1 and Gtr2 (which are part of the EGO complex in sensing amino acids) in influencing rP 
production. The deletion of GTR1 and GTR2 led to reduction in GLuc expression, implying that their 
function is important in rP production (Figure 5.5). Amino acid sensing in particular has been proven 
to control TORC1 signalling through the Rag proteins in higher eukaryotes and (homologous) Gtr 
proteins in yeast. This signalling controls cell growth and protein synthesis in response to amino acids 
available. 
 In line with the deletion of GTR1 in yeast, previous research has shown that this loss perturbs TORC1 
signalling (Valbuena et al., 2012). In yeast, when amino acids are added to starved cells, TOR 
translocates to the vacuole where the GEF Vam6 activates the GTPases Gtr1 (GTP bound) and Gtr2 
(GDP bound) in a heterodimer formation (Sancak et al., 2008; Oshiro et al., 2014). Gtr1 signals to KOG1 
(raptor in mammalian cells) directly, a component of TORC1; yet new evidence also suggests that Gtr1 
may also interact directly with another TORC1 component, Tco89 (found in yeast only) (Sekiguchi et 
al., 2014). This activates downstream processes in TOR such as ribosomal biogenesis and protein 
synthesis through Sch9, and other processes such as cell proliferation, mitochondrial biogenesis and 
stress response genes (Aronova et al., 2007; Binda et al., 2009; Sekiguchi et al., 2014).  It may be the 
case that by inhibiting amino acid sensing through deletion of components of the EGO complex, cells 
dampen TOR signalling and protein synthesis leading to a loss of GLuc expression. During starvation, 
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cells go into quiescent phase and autophagy is upregulated as it is no longer inhibited by TOR, recycling 
old proteins and organelles while sequestering nutrients for the cell to survive the starvation period 
(Lee et al., 2007; Galdieri et al., 2010; Meijer and Codogno, 2011).  
Although TORC1 has a significant role in cytoplasmic signalling, it also plays a role in nuclear function 
such as in the regulation of the transcription of ribosomal protein gene expression through TF Fhl1, as 
well as mitotic cell cycle progression through Sch9 (Fingar and Blenis, 2004; Smets et al., 2010). Recent 
evidence has also linked environmental status with the expression of pro-growth genes through 
modifications to histones controlling epigenetic processes (Cai et al., 2011; Workman et al., 2014). It 
has been reported that as well as an being amino acid sensor, Gtr1 and Gtr2 also play a role in 
negatively regulating the nuclear protein Gsp1-GTPase activity, functioning in the nucleocytoplasmic 
transport of proteins and nucleic acids across the membrane of the nucleus, through the nuclear 
protein Yrb2 (Nakashima et al., 1999; Avruch and Long, 2009; Sekiguchi et al., 2014). Another role for 
Gtr1 and Gtr2 are in their genetic interaction with INO80, a chromatin regulatory complex, proving 
their involvement with chromatin silencing (Sekiguchi et al., 2008). Other evidence from a yeast two-
hybrid assay discovered that active (GTP bound) Gtr1 interacts with the Rpc19 subunit (mammalian 
RPA16) of RNA polymerases I and III. Gtr1 was also found to interact with Nop8 (Nop132 in mammalian 
cells shares a similar sequence), suggesting a role for Gtr1 in ribosome RNA processing (Sekiguchi et 
al., 2004; Sengottaiyan et al., 2012). However, it was discovered that only Gtr1 deletion led to a 
reduction in RNA pol I and III activity, further proving its role in interacting with nuclear proteins 
(Todaka et al., 2005; Wang et al., 2009). These are possible mechanisms by which the overexpression 
of GTR1 may lead to an increase in GLuc expression due to roles outside of amino acid signalling that 
might be expected to influence rP production. 
Interestingly, only Gtr1 and not Gtr2, can form a homodimer (Nakashima et al., 1999; Valbuena et al., 
2012), which may explain why overexpressing GTR1 in the wild type led to a bigger increase in GLuc 
produced compared to the overexpression of GTR2 (Figure 5.5). In Drosophila, where the TOR pathway 
is very similar to mammals, overexpression of activated variants of the Rag proteins increases cell size, 
even when there is a lack of amino acids (Kim et al., 2008; Avruch and Long, 2009). This may be due 
to an increase in general protein synthesis increasing GLuc production, as TORC1 stimulation increases 
S6K phosphorylation needed for protein synthesis. In addition, it was observed that rapamycin 
treatment to Δgtr1 had an additive effect compared to the wild type, suggesting that TORC1 is still 
functional without Gtr1. This implies that rP production lost in the Δgtr1 mutant was through a loss of 
processes independent of TORC1 signalling (Figure 5.7).  
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As a crucial signalling pathway, TOR is highly conserved in all eukaryotes with both TORC1 and TORC2 
in CHO cells(although TORC1 only has one TOR gene (mTOR) compared to yeast, which contains two 
redundant genes (TOR1 and TOR2)) (Dann and Thomas, 2006). In CHO cells, amino acid sensing 
upstream of mTORC1 is different to yeast where there are two orthologues for each Gtr protein, 
RagA/B for Gtr1, and RagC/D for Gtr2. These proteins still function by activating mTOR signalling with 
the correct guanine nucleotide binding, activating mTORC1 (Bar-Peled et al., 2012). RagA/B (GTP 
bound) and RagC/D (GDP bound) heterodimers recruit mTORC1 (at raptor) to Rheb, another GTPase 
at the lysosome when amino acids are available (Long et al., 2005; Sancak et al., 2008; Avruch and 
Long, 2009). mTORC1 also receives growth factor and energy signals from the TSC1/ TSC2 complex 
which negatively regulate mTORC1 by acting as a GTPase-activating protein (GAP) for Rheb. Rheb only 
activates TORC1 when GTP bound, although the mechanisms behind this interaction are unknown 
(Laplante and Sabatini, 2009; Bar-Peled et al., 2012).  
By utilising a CHOK1 cell line stably expressing GLuc, we examined the effects of altered mTOR 
signalling by transient knockdown using shRNA to measure the effects on rP production. As the yeast 
screen of TOR deletion strains identified that loss of amino acid sensing caused a reduction in rP 
production (Figure 5.5), the knockdowns of RagC and RagD (Gtr2 in yeast) were explored in CHO cells, 
where similar effects were observed. Although these genes were knocked down and not deleted as in 
yeast, any reduction in expression of the gene that was achieved led to a significant loss in GLuc 
expression in both RagC and RagD knockdowns (Figure 6.5). Although the qRT-PCR data did not 
conclusively show knockdown of these genes (Figure 6.4), repetition of RagC and RagD knockdown 
confirmed the loss of GLuc production in CHO cells (Figure 6.3 and 6.5), suggesting perturbation of 
these genes in CHO cells impacts upon recombinant protein production. 
When comparing the yeast and CHO result (Figure 5.5 for yeast and figure 6.3/6.5 in CHO), there was 
a loss of secretion in yeast yet a loss of GLuc detected in both the supernatant and pellet in CHO cells. 
This suggests a difference in the effects of interfering with amino acid sensing between the single cell 
yeast organism and the CHO cell system. This likely reflects the differences between the regulation of 
amino acid sensing between yeast and mammalian cells. In mammalian cells, stimulation of TORC1 
signalling requires Rheb-GTP unlike yeast cells, and even with depleted Rag protein amounts, 
overexpressed Rheb is able to activate mTORC1 and downstream signalling which is largely unaffected 
under these conditions (Long et al., 2005). The regulation of the Rag proteins vary in CHO, as the Vam6 
homologue Vps39 has been shown not to act as a GEF. However, it has been suggested that the protein 
complex Ragulator is responsible for activating the Rag proteins while functioning as an anchor to the 
lysosome, sharing a role with EGO proteins in yeast (Dubouloz et al., 2005; Sekiguchi et al., 2014).  
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Despite differences in their regulation, deletion of RagC/D (Gtr2) still produced the same outcome 
with hindered rP production in both yeast and CHO cells, confirming the importance of amino acid 
signalling to TORC1 and its influence on rP production. 
7.4.2 Autophagy in rP production  
 
Autophagy is negatively regulated by TOR, but is also controlled by RAS/cAMP/PKA signalling which 
sense nutrients in the environment (Wei et al., 2008; Stephan et al., 2014). The RAS/cAMP/PKA 
pathways influence many TOR kinases involved in glucose sensing, controlling ribosome biogenesis 
(via IFH1) and stress responses (via RIM15). For example, both pathways control RIM15 through its 
binding to 14-3-3, which controls MSN2/4 and GIS1 in stress responses to glucose starvation, causing 
reprogramming of the transcription machinery to change/modify cell growth and proliferation 
(Claudio De Virgilio and Loewith, 2006; Wei et al., 2008; Galdieri et al., 2010).  In Drosophila, under 
nutrient starvation TOR is inhibited, as ATG1 negatively regulates S6K by blocking its phosphorylation, 
demonstrating cross talk between Atg1 and S6K signalling (Lee et al., 2007). This strict control between 
autophagy and cell growth is essential, as uncontrolled autophagy is detrimental to the cell.  
Autophagy is necessary for degrading organelles and protein complexes, recycling biological material 
needed for protein production (Levine and Klionsky, 2004). This process is also protective for the cell 
as it clears protein aggregates formed during ER stress, which are elevated during recombinant protein 
production. Yet, this process is important during normal cell growth when TOR is active as there is 
basal level autophagy occurring (Mizushima et al., 2008). Autophagy also has a link to apoptosis 
through its interaction with Beclin1, with a role to prevent apoptosis by replenishing the cell with 
nutrients and eliminating proapoptotic stimuli (Kroemer et al., 2010). Furthermore, autophagy 
increases lifespan as it removes damaged cellular structures such as the mitochondria. As the 
mitochondria plays a key role in apoptosis by the release of apoptotic factors, selective elimination of 
mitochondria is a cell defence mechanism (Codogno and Meijer, 2005). Autophagy therefore, is crucial 
to cell survival and efficient protein production by supplying the cell with recycled nutrients.    
From the yeast screen undertaken in this work (Figure 5.5), we found that deleting ATG1 hindered rP 
production as expected due to its fundamental role in autophagy. This data demonstrated that losing 
this function impairs protein synthesis, as cells lose their ability to survive during starvation when 
nutrients become limited. Additionally, there may have been a build-up of toxic protein aggregates 
from ER stress causing mitochondrial collapse leading to cell death (Yorimitsu and Klionsky, 
2007)(Bravo et al., 2012). As autophagy is essential for an efficient secretory pathway, energy 
bioenergetics and cell survival, it is well conserved across CHO cells and other mammals (Figure 6.3). 
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Unfortunately we did not observe a positive effect on GLuc expression in yeast when overexpressing 
Atg1 in the wild type. This may be because Atg13 is also needed in the formation of the complex to 
initiate autophagy when it is no longer phosphorylated by TORC1 (Kamada et al., 2010; Chen and 
Klionsky, 2011). If both Atg1 and Atg13 were overexpressed, this could be beneficial to the cell by 
improving the cells nutritional balance such as amino acids and energy via microautophagy. In 
addition, the energy status is also vital for cell’s growth (Singh and Cuervo, 2011).  
In summary, the screen performed with various TOR deletion strains in the yeast model system 
identified Gtr1 and Gtr2 from the Ego complex as involved in amino acid signalling. Additionally Atg1 
is needed for autophagy induction, as a target for altering rP production (see Figure 7.2). Both the Ego 
complex and Atg1 are involved in TORC1 signalling but with opposing effects, yet both processes 
ensure the cell has sufficient nutrients for protein synthesis and cell growth.  There are new roles 
emerging from the GTPases Gtr1 and Gtr2 in parallel to TOR signalling, which may account for the 
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Figure 7.2 Targets identified from a screen of TOR related genes which reduce rP production when 
removed.  Amino acids are sensed by the EGO complex (containing Gtr1 and Gtr2), activating TORC1 
which induces protein synthesis downstream. Gtr1 also associates with various proteins involved in 
RNA processing and nuclear function, independent of amino acid signalling which may  influence 
protein synthesis (Todaka et al., 2005; Wang et al., 2009). Autophagy is inhibited by TORC1 when 
nutrients are available by inhibiting the complex formation of Atg1 and Atg13 needed for the induction 
of autophagy (Kroemer et al., 2010). During starvation, autophagy can also inhibit TORC1 and recycle 
nutrients such as amino acids in order to improve protein synthesis, or induce cell death when 
autophagy levels are high. Yet, there is still a basal level of autophagy needed when cells are nutrient 
enriched (Mizushima et al., 2008).      
 
 
7.5 Conclusion and future work 
 
This research has demonstrated how both model systems investigated here, yeast and CHO cells, can 
be exploited for investigating stress signalling, nutrition and energy regulation as well as how this 
alters rP production using the model rP GLuc and killer toxin proteins. From previous work in the lab 
and further investigation here, we have identified that the actin binding protein cofilin plays a role in 
stress signalling which influences rP production, outside of its actin binding region. It was also shown 
that the loss of mitochondrial function effected rP production significantly. However, this loss was not 
as significant in cofilin mutants with mtDNA removed, confirming the signalling between cofilin and 
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mitochondria.  The link between cofilin and MAPK signalling was confirmed by unpublished work in 
the Gourlay lab where cofilin mutation alleles caused high Ste12 activity with rapamycin resistance 
due to high mitochondrial function and upregulated drug transporters PRD10, PDR18 and TF PDR8. 
However, there were no changes to TOR signalling in these cofilin mutant strains as previously 
hypothesised (unpublished work). A new role for STE12 was identified in protein processing, where its 
deletion led to an increase in incorrectly processed forms of GLuc product. This suggests that the cells 
have an inability to cope with the workload through the secretory pathway.  
In this work, how the control of amino acid sensing through TORC1 is important through the EGO 
complex and basal level autophagy in dealing with the demands of rP production has been 
investigated.  The Gtr proteins have emerging roles in the control of gene transcription and association 
with nuclear proteins, impacting protein synthesis parallel to their role in TOR signalling.  
Below are some of the questions still to be addressed in further understanding the changes observed 
to rP production upon manipulation of the pathways and genes described in this thesis: 
 Does increasing mitochondrial function in CHO cells enhance GLuc production? PGC1α, which 
is under the transcriptional control of TORC1, controls mitochondrial oxidative function which 
may benefit rP production. It is known that ER-mitochondrial coupling is important during ER 
stress as it triggers mitochondrial damage. Therefore by increasing mitochondrial function, 
the cell may be buffered against this stress while promoting energy supply to protein synthesis 
when exploiting the cell to produce heterologous protein. It is predicted that we would see 
enhanced expression of GLuc with PGC1α overexpression.  
 
 Are the ERMES junctions interrupted in rho0 cells of cofilin mutants, causing loss of cross talk 
between the ER and mitochondria? And how does this compare between the wild type and 
cofilin mutants? As these junctions are important for cross talk between the mitochondria and 
ER, alterations may cause retardation to protein synthesis. Any alterations to the ERMES 
junction between the wild type and cofilin mutants perhaps seen with loss of mtDNA, may 
explain the significant loss off GLuc to the wild type. Perhaps cofilin co-localises to 
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 What is causing differences in GLuc production between cofilin mutant alleles and the wild 
type? To develop a further understanding as to how these mutations may be affecting changes 
to stress signalling and rP production, the phosphorylation of cofilin can be investigated using 
2D gel western blotting. As cofilin is believed to be inactivated by phosphorylation at serine 4 
in yeast, alterations to this region (mutant expressing allele cof1-4) may alter its activity.  By 
examining the differences in phosphorylation states, further evidence on how changes to its 
activity may cause alterations to rP production may be revealed.  
 
 Is STE12 deletion affecting the cell’s capability to cope with the load imposed on the cell as a 
result of rP production through the secretory pathway?  When deleting Ste12 there was an 
increase in incorrectly processed forms of GLuc in all cofilin mutant strains and the wild type. 
Perhaps the overexpression of a chaperone in the ER would assist the cell, for example PDI 
which has a role in disulphide formation would enhance the capacity of the secretory pathway 
in Δste12 strains. Overexpression of PDI has been shown to be beneficial in rP production 
(Wittrup, 1995). An increase in rP production from PDI or other enhancing chaperones, may 
explain the effects of removing STE12 in the secretory pathway.   
 
 Does the deletion of PDR10 cause rapamycin sensitivity in strains without STE12? We have 
found that rapamycin is a substrate for the multi-drug transporter PDR10, which was 
upregulated in the microarray analysis performed on mutant allele cof1-6. Therefore, it would 
be interesting to determine if Δste12 strains lose their resistance to rapamycin when this drug 
pump is removed. This information would provide further evidence towards understanding 
the connection between MAPK signalling and mitochondrial function. 
 
 
 How would a polysome profile compare between Gtr1 and Gtr2 strains? As Gtr1 plays a bigger 
role in RNA processing, Δgtr1 compared to Δgtr2 may show reduced 80S monosome levels, 
with an increase in monosome levels with GTR1 overexpression. An increase in monosome 
levels in wild type with GTR1 overexpression may increase the rate of protein synthesis, 
explaining why only overexpression of GTR1 enhances GLuc production. Alternatively, this 
overexpression may be due to increased amino acid sensing in the TOR pathway as only GTR1 
can form homodimers. 
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The research discussed above has proven how our ability to alter cell signalling through genetic 
engineering in both mammalian and yeast model systems, due to their conservation between 
organisms, can be exploited in finding alternative ways to alter rP production. This research is also 
important in furthering our knowledge of the mechanisms in these complex signalling pathways, and 
how changes can lead to a number of diseases. For example, TOR is being investigated in cancer due 
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